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General introduction
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ANATOMY OF THE MENISCUS
The knee menisci fill the gap which is the result of a mismatch in form between 
the femoral condyles and the tibial plateau. The main function of the meniscus 
is to distribute stresses in a homogeneous way over the articular cartilage of the 
joint surfaces of tibia and femur, and in a lesser degree it has also a function in the 
stabilization of the knee joint. To enable these functions, the meniscus is a highly 
specialized fibrous structure which is optimized to resist compressive, tensile shear 
and is able to transfer axial loading into circumferentially directed forces1,2. 
The meniscus is composed of fibrocartilaginous tissue. The prominent fibrous 
nature is reflected by the high type I collagen content. The cartilage nature is reflected 
by the presence of lower levels of type II collagen and glycosaminoglycans (GAGs). 
Besides these major matrix constituents a number of minor collagens (types IV, V, 
VI, IX and XI) and some elastin are present in meniscus tissue3. 
The numerous type I collagen bundles, which are strong in tensile stress, but 
week in compression, are mainly oriented in a 
circumferential direction and are considered to 
be very important in preventing radial extrusion 
of the meniscus and maintaining the structural 
integrity during load bearing (Figure 1)4,5. The 
GAGs play an important role in the maintenance 
of optimal visco-elastic behavior, compressive 
stiffness and tissue hydration. Furthermore, 
GAGs and surface zones proteins are facilitating a 
smooth frictionless movement of the menisci over 
the articular surfaces of the tibia and femur5-7.
DAMAGE TO THE MENISCUS
 
Injuries to a healthy meniscus are often induced by a compressive force in 
combination with tibio-femoral rotation in the transverse plane during a movement 
from flexion to extension or during rapid cutting or pivoting8. A number of clearly 
different types of lesions have been described. Besides the flap tear, one of the most 
prominent and frequently occurring types is the bucket-handle lesion, which is a 
tear in the avascular white inner zone of the meniscus in a circular direction9. The 
circumferential arrangement of collagen bundles in the central portion of the meniscus 
provides a functional explanation for the same orientation of the bucket-handle tears 
10. However, more complex degenerative tears also occur in lower frequencies11. 
The etiology of these degenerative tears is still unknown. It has been suggested that 
the disease process associated with the development of osteoarthritis (OA) of the 
joint cartilage, may also be active in the meniscus and that a degenerative tear in a 
meniscus might be regarded as one of the first signs of OA12.
Figure 1. Safranin O stained cross-section 
of native meniscus tissue showing the 
collagen bundles. The red stained areas are 
GAGs (x100).
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CONSEQUENCES OF MENISCUS RESECTION
A tear in the meniscus will classically result in locking phenomena, abnormal 
(tibio-femoral) stresses and pain. These complaints will immediately disappear after 
resection of the tear. In the 60’s and 70’s a total meniscectomy was a very common 
surgical intervention. It was quick and easy to perform. However, in time it became 
clear that the removal of the meniscus generates mechanical overloading of articular 
cartilage which leads to the development of osteoarthritic changes in tibia and femur 
13-15. Therefore, only partial resection of the meniscus was recommended and together 
with introduction of arthroscopic surgery, partial meniscectomy became the state of 
the art. However, it also appeared that even a partial meniscectomy still induces 
osteoarthritic changes, whereby the damage to the articular cartilage appeared to 
be directly related to the amount of tissue removed12,13. When more than 30% of the 
meniscus is removed during partial meniscectomy, preservation of the peripheral 
rim of the meniscus is essential16,17. The importance of the peripheral rim for the load 
transmission trough the joint was first emphasized by Ahmed et al.18. The remaining 
rim will prevent peripheral extrusion of the meniscus by which transfer of the axial 
joint load into hoop stresses is still possible and the remaining part of the meniscus 
will also protect the uncovered articular cartilage from peak stresses. The presence 
or absence of an intact peripheral rim has also consequences for the type of repair 
technique that can be used after meniscus trauma19,20. 
REPAIR
In view of the progressive osteoarthritic changes, a great deal of effort has been 
put into devices to fix meniscus tears to preserve the meniscus, especially in younger 
patients. Suturing is a safe traditional procedure but can be time-consuming. Also the 
rehabilitation after meniscectomy is usually quicker than after suturing, making the 
choice for a particular treatment often an ethical one, especially in the competitive 
athlete, who wants to be back in training as soon as possible. However, when a meniscal 
tear occurs in combination with a rupture of the anterior cruciate ligament (ACL), the 
results of meniscal suturing are relatively good, also because the long rehabilitation 
period after ACL reconstruction offers an optimal time frame for an optimal healing 
period of the meniscus in the athlete19. Biomechanical tests under cyclic loading 
have shown that vertical sutures are superior to both horizontal sutures and knot-end 
techniques21. The last decade anchors, screws, staples and a variety of other devices 
have been advocated for the rapid fixation of loose segments21,22. However, some of 
them might damage the articular cartilage when not completely sunk beneath the 
surface of the meniscus23. If tears do not heal, the mechanical forces might in time 
lead to failure of the fixation. Failure rates of up to 28%-30% of meniscus repair 
have been reported in literature24,25. However, in a review from Boyd and Myers on 
surgical intervention techniques of the meniscus only a preliminary failure rate of 
5.9% was reported19. Apparently the results of repair of tears may be compromised 
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by the lack of vascularity in the white zone of the meniscus. Vessel ingrowth is 
commonly associated with the ingrowth of non-differentiated progenitor cells, which 
might be needed in the repair process. A key growth factor in revascularization is 
vascular endothelial growth factor (VEGF). VEGF is down-regulated in the adult 
meniscus 26. The idea rose that coating sutures with VEGF could possibly stimulate 
vessel ingrowth and subsequent healing of tears. Although more endothelial cells 
were found in the VEGF/PDLLA sutured intervention group, the tears did not heal. 
In addition, immunohisto-chemistry showed a strong immunostaining against matrix 
metalloproteinase 13 (MMP-13). MMPs are involved in the degradation of collagens 
in the articular cartilage27-29. Their effect on meniscus tissue is not known, however 
the up-regulation of MMPs by VEGF may have unwanted weakening effects on the 
still healthy matrix of the meniscus and articular cartilage. Devices that stimulate 
vessel ingrowth by growth factors should therefore be used with great care.
SCAFFOLD MATERIALS FOR MENISCUS REPAIR
The ideal scaffold material should be biocompatible and biodegradable in the 
long term. Moreover, it should permit unrestricted cellular ingrowth, allow free 
diffusion of nutrients, may be used as a carrier for stimulatory and inhibitory growth 
factors, and it should be strong enough to withstand the load in the joint and maintain 
its structural integrity under these loaded conditions. Furthermore, it should have 
a degradation profile that allows ingrowth of new tissue and thereafter allows 
remodeling of these tissues under the influence of load30. 
STIMULATION OF REPAIR BY ACCESS CHANNELS
In the light of the lacking vascularization in the inner white zone, the concept of 
creating access channels to allow vessel ingrowth was developed. In this approach 
an extra, preferable small, defect is created in the peripheral rim of the meniscus. The 
created defect connects the vascularized synovial area and red peripheral zone of the 
meniscus with the white zone. Various materials can be used to fill the channels and 
by that stimulate ingrowth of vessels and new tissue. If the channel is left empty, 
repair is not stimulated 31. Besides biological tissues31, also porous polymers, with 
or without reinforcement with carbon fibers32-34, were extensively investigated for 
channel filling. Polymers appeared to be more reliable compared to biological 
materials 35. In the polymer implant that is inserted in the access channel, generally, a 
fibrous tissue is formed that remodels into fibrocartilage-like tissue in time (between 
3-6 months)32,33,36-38. The tissue that is formed in the tear itself is mainly fibrous32,33. 
The mechanical properties of the newly formed tissues in the inserted scaffold and 
in the tear are unknown. However, the most important goal of meniscus repair is 
protection of the articular cartilage. In only a few studies, the effect of polymer filled 
access channel on the prevention of osteoarthritic degradation was investigated. Van 
Tienen et al. investigated the effect of lesion healing with an access channel filled 
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with L-lactide/ε-caprolactone in Beagle dogs39. Although a positive effect was found 
on the number of lesions which did heal, the procedure and/or polymer initiated 
articular cartilage damage39.
PARTIAL REPLACEMENT AFTER PARTIAL MENISCECTOMY
 
When a partial meniscectomy is performed and the peripheral meniscal rim is 
still intact, replacement of the resected tissue only by an implant might be the option 
of choice. So far, mainly two types of scaffold were advocated for this application 
in patients. At this moment collagen based scaffolds and synthetic scaffolds based 
on polymers are being used in clinical trials. The MenaflexTM collagen meniscus 
implant (CMI) was developed in the 90’s. The CMI acts as a temporary template 
for tissue infiltration, and seems to have the ability to fill the defect with functional 
repair tissue in time40-44. Based on these reports it can be stated that the CMI is 
biocompatible, resorbable, and may be easily remodeled by new infiltrating tissue. 
Tissue ingrowth into the CMI may be stimulated by punching the rim with an awl 
to allow blood infiltration but other mechanisms may also be involved35. The main 
function of the CMI is to conduct tissue to differentiate into neo-meniscal tissue 
and by that to protect the articular cartilage. Indeed, tissue infiltration occurs in 
the CMI implant and preclinical and clinical biopsies showed a differentiation into 
fibrocartilage-like tissue44. After 5 years follow-up, partial meniscus replacement with 
MenaflexTM improved clinical scores in patients and articular cartilage degradation 
did not progress45. However, due to a lack in controls, improvements compared to 
meniscectomy  alone cannot be made.
The second type of scaffold, still in the first clinical test phase (Actifit®, Orteq 
BV), is based on polycaprolacton-polyurethane (PCLPU), and has been developed 
and tested for total meniscal replacement in animals (see below in this chapter)37-39. 
This implant is now assessed as a scaffold for partial meniscal replacement as an 
alternative for the CMI. Based on the preclinical tests, the PCLPU is supposed to be 
a stiffer material and more resistant to tear which makes this material easier to handle 
and to suture to the peripheral rim. In addition, mechanical data of contact stresses in 
sheep cadavers after partial meniscus replacement showed lower contact pressures 
compared partial meniscectomy only46. Recently, results of a case series showed that 
patients with partial meniscus replacement had an improved clinical outcome and 
stabilization of improved cartilage condition  after 2 years follow-up47.
COMPLETE REPLACEMENT OF A MENISCUS
 
If the peripheral rim of the meniscus is damaged, partial replacement is no 
option and the entire meniscus should be replaced. Several techniques have been 
evaluated in mainly experimental animal studies, i.e. autologous tissues, like tendon 
or synovial tissue48-50, allograft menisci 51-59, various synthetic polymer materials60-63, 
and a combination of synthetic materials with autologous tissues44,51,64. 
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Allograft meniscus transplantation is the only clinically available technique for 
total meniscus transplantation. From a biomechanical perspective an allograft may 
contribute to the restoration of the normal biomechanics of the knee joint65. The role 
in the protection of the articular cartilage remains a point of discussion. Some studies 
mention the prevention of further osteoarthritic changes66, however, some animal 
studies prove the opposite67. In rabbits, the observation that a delayed meniscal 
transplantation induced even more osteoarthritic changes than a meniscectomy 
without transplantation is worrying68. Clinically, disappointing results are often 
associated with too severe osteoarthritis69, improper leg alignment58,70,71, and irradiated 
donor menisci72. By avoiding all these negative determinants, success rates were 
reported to be in between 60% and 94%58,69-71,73-75. Also a study by Wills and Laprade 
showed excellent results two years after allograft transplantation76. However, mainly 
the poor availability, the sizing of the implant, logistics and costs of the transplant 
are responsible for the small amount of procedures performed worldwide. An 
alternative might be a decellularized porcine meniscus77. This scaffold was used as 
xenograft for tissue regeneration after implantation in human. The remaining tissue 
after processing seemed to be of good biomechanical quality and not cytotoxic in 
cell culture experiments. This may be an alternative for the allografts in the future. 
Nevertheless, the search for an artificial replacement material is still ongoing. 
The first animal studies on artificial meniscus replacement go back to the 
early 80’s. Already in 1983, the use of a histocompatible Teflon net for ingrowth 
of regenerating meniscal tissue was described78. Although the authors commented 
on the regenerative effect of the material and the function of the knee joint as 
being hopeful, later studies on this material were never reported. Messner et al. 
started to use polyurethane coated Teflon or Dacron for meniscus replacement in 
rabbits79-81. The coating seemed favorable for infiltration of tissue, however, all the 
joints showed signs of degeneration and osteoarthritis. Also coverage of the implant 
with periosteal tissue did not lead to favorable results62. Others studied polyvinyl-
alcohol hydrogel scaffold in rabbits. This material seemed to be promising in terms 
of chondroprotection82. However, the material properties needed to be improved to 
provide higher tear strength for suturing it to the synovium. Other material features 
like stiffness, and wear- or degradation characteristics were not provided. 
In the 80’s, our group started a collaboration with the department of polymer 
chemistry of the State University of Groningen for the development of a biodegradable 
porous polymer as a scaffold for meniscal tissue regeneration. Already in 1944, 
Smillie reported some meniscus regenerative capacity in humans83. Experimental 
studies from Moon et al. showed also a regenerative capacity in rabbits84. Based on 
this regenerative capacity, we hypothesized that a biodegradable porous polymer 
implant might be promising. Such an implant would enable the regeneration of a 
new meniscus in time by tissue ingrowth, and differentiation of the ingrown fibro-
vascular tissue simultaneously with a slow degradation of the polymer into non-
toxic products. A great advantage of polymers is that the porosity, the degradation 
rate and the mechanical properties can be adapted to the desired specifications. 
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The first scaffolds used in this approach consisted of polyurethanes reinforced with 
carbon fibers and were used for partial replacement of the meniscus34. However, the 
carbon particles induced a synovial inflammation causing extra damage to the joint. 
Nevertheless, tissue infiltration proved to be possible with porous materials. Newer 
materials based on polyurethanes have been proven to be superior. These materials 
were used for meniscus replacement in dogs, and after 6 to 12 weeks the scaffolds 
were filled with tissue and even had some cartilage protective effect on macroscopic 
evaluation85. In this study, the porous PCLPU polymer, which consists of well-defined 
hard segments in combination with slowly degrading polyester soft segments, was 
used85,86. The hard segments in combination with the length of the soft segment 
determine the stiffness of the polymer. Both the initial mechanical properties and the 
pore size and geometry are important parameters for the final result. Klompmaker 
et al. investigated the ingrowth of new tissue into four polyurethanes with different 
pore sizes (50-90, 90-150, 150-250 and 250-500 µm) in wedge-shaped defects in the 
meniscus of rabbits87. The macroporosity was 48% to 55%, and total pore volume 
was between 84% and 86%. In the scaffolds with the large pores, ingrowth into all 
pores was found. It was concluded that for complete ingrowth and incorporation of 
partial or total meniscus prostheses, macro-pore sizes must be in the range of 150-
500 µm. By varying the initial compressive modulus, the rate of ingrowth and nature 
of ingrown tissue could be modified. Alternatively the mechanical properties can be 
controlled by the degree of porosity86,88. Even though polymers with a compression 
modulus of 40 kPa showed fast fibrous tissue ingrowth, no differentiation into 
fibrocartilage occurred in these scaffolds. The polymers with a compression modulus 
of 100 kPa however did show abundant fibrocartilage formation87. Others found that 
the scaffolds should have an initial compression modulus of at least 150 kPa to 
stimulate fibrocartilage formation5. 
A couple of years ago, the results of two short-term studies (3 and 6 months 
follow-up periods) were published, which used a dog model in which tissue ingrowth, 
remodeling in the scaffold and changes in mechanical properties were analyzed37,38. 
These data were compared with results of total meniscectomy. After 6 months, the 
ingrown tissue was fibrous-like in the peripheral zones of the meniscus prosthesis, 
but in the central areas cartilage-like tissue had developed (Figure 2). The collagen 
bundles in the pores of the scaffold were mainly directed toward the interconnections 
between pores, and thus the organization of the matrix was clearly different from 
the highly organized extracellular matrix of the native meniscus (Figure 3). The 
stiffness of the implant (compression modulus) after 6 months was intermediate 
between the compression modulus of the native meniscus and the porous polymer 
foam. Both the implant and the meniscectomy group showed a similar pattern of 
cartilage degeneration37,39. The results of a two-year study with the same polymer, 
using an implant with a smoother surface in the same model, did not show additional 
chondroprotection46. This study also showed that the scaffold was initially filled with 
vital fibrocartilage-like tissue but later on the core of the scaffolds became acellular 
with the extra-cellular matrix still in place (Figure 4). An explanation for this necrosis 
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might be the decrease in vascularity that was already observed in the 6 months follow 
up experiments. Together with the non-resorbed foam and suboptimal loading in the 
joint, this might have led to an insufficient oxygen supply. The implants did not cause 
any severe synovitis and microscopically there were no distinct signs of foreign 
body reaction on the degradation products. Considering the results at this stage, 
replacement of the whole meniscus with this polymer in a clinical setting seems 
not justifiable. As we have addressed earlier in this chapter, partial replacement of 
resected meniscus with this new material might be a valuable alternative at this stage 
(see paragraph “Partial replacement after partial meniscectomy”). 
From these experiments it is clear that the developed scaffolds did not have the 
properties needed for optimal chondroprotection. In fact, the scaffolds induced more 
cartilage abrasion then a meniscectomy at two years follow up. A number of factors 
may have been contributed to this negative result.
- The initial mechanical tensile strength was too low. However, after tissue 
ingrowth and differentiation the mechanical properties improved 38,89. 
- The tear strength was too low. Although the initial tear strength might have 
been sufficient, after the follow up periods of 6 and 24 months most implants were 
severely damaged by the popliteus tendon. By this the implants might have been 
pushed peripherally by which they might have lost their chondroprotective properties.
Figure 4. Area in the central region of the anterior 
part of the PCLPU implant at 24 months after 
implantation. Notice the absence of living cells (x200).
Figure 5. Sudan black stained section of implant at 24 
months follow up. Notice the exposure of the PCLPU 
to the joint cavity (x200).
Figure 3. Picro Sirius red stained section showing the 
direction of the collagen fibers at 6 months follow-up 
(x200).
Figure 2. Safranin O stained section of cartilage-like 
tissue in the highly loaded inner part of the PCLPU 
implant at 6 months follow up (x200).
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 - The degradation of the scaffold was not complete. Even after 24 months, 
polymer was exposed to the articular surfaces of tibia and femur (Figure 5). The 
exact effect of this polymer exposure is not known but the more severe degradation 
of cartilage present in the 24 months implant group indicated that exposure of the 
implant to the cartilage surface is a negative factor.
- The animal model might have been suboptimal. The beagle dog is a relatively 
small animal for open meniscus surgery. 
NEW APPROACHES
An important property of implants is their initial mechanical properties. When 
mechanical properties of the scaffolds are insufficient, osteoarthritic changes can 
occur before the infiltrated tissue has differentiated into the typical fibrocartilage 
that increases the mechanical properties of the implanted scaffold. Because of the 
relatively poor initial mechanical properties of many scaffolds (e.g. PGA and PGLA 
scaffolds), pre-seeding the scaffold and subsequently implanting it subcutaneously 
for a few days in the animal that has to be treated for a period of time (depending on 
the animal model) to allow tissue ingrowth, may be an option. Then the construct 
could have improved its mechanical properties, where after it can be used to replace 
the meniscus90. The alternative is to make implants that perfectly match both the 
geometry of the implant site and have the same initial mechanical properties as the 
native meniscus.
Furthermore, seeded cells might enhance meniscus regeneration in polymers after 
transplantation. A promising approach to decrease the initial friction is to pre-seed 
the scaffolds with cells that can produce matrix before they are implanted90. Poly-
glycolic acid (PGA) fiber meshes which were mechanically reinforced by bonding 
PGA fibers at cross points with 75:25 poly(lactic-co-glycolic) acid, were seeded 
with allogenic meniscal cells. After one week of culture they were implanted into 
rabbits knees and a regenerated meniscus was formed. Although the authors state 
that the effect on osteoarthritic changes was improved by the cell-seeding technique, 
no quantitative data were added to substantiate this statement91. More recently, a 
research group from Bologna, Italy, investigated the use of a novel hyaluronic acid/
polycaprolactone material for meniscal tissue engineering92. This novel material was 
implanted in sheep with and without augmentation with chondrocytes. In addition, 
two different surgical procedures were tested. Adding chondrocytes did not have 
any macroscopically detectable effect. A transosseous horn fixation performed 
better compared to a fixation of the implant to the meniscal ligament. In cell seeded 
implants more cartilage tissue was found and this implant seemed to reduce cartilage 
degradation if compared to cell free implants.
Using a self-assembly (SA), scaffoldless method, Aufderheide and Athanasiou 
showed that a co-culture of meniscal fibrochondrocytes (MFCs) with chondrocytes 
in an agarose mould resulted in the generation of anisotropic collagen fibrils after 
8 weeks93. The mechanical properties were even better compared to cells cultured 
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in PGA scaffolds93. It was suggested that the geometric constraint imposed by the 
ring-shaped, nonadhesive mold guides collagen fibril directionality and, thus, alters 
mechanical properties. Co-culturing articular chondrocytes (ACs) and MFCs in 
this manner appears to be a promising new method for tissue engineering fibro-
cartilaginous tissues exhibiting a spectrum of mechanical and biomechanical 
properties. A Japanese study showed an increased regenerative and reparative effect 
on meniscal cells when these cells were added to a platelet rich plasma gel94. 
Murphy and Barry showed that stem cell therapy could be promising for cartilage 
and meniscus regeneration95. They injected mesenchymal stem cells in osteoarthritic 
knees as a result of earlier ACL transsection and lateral meniscectomy. They showed 
that this treatment induces a meniscus-like regenerative tissue containing collagen 
type II and signs of hyaline matrix formation95.
With the currently available salt leaching techniques our and other groups 
were able to create open structures in polymers with acceptable biomechanical 
properties96,97. Recently, techniques are developed as Rapid Prototyping to fabricate 
3-dimensional scaffolds for tissue-engineering purposes. The mechanical properties 
of many different soft and hard tissues, including bovine cartilage, could be mimicked 
by copolymers by using a 3-dimensional fiber deposition technique, simply by 
varying the scaffold porosity, the scaffold architecture, and/or the copolymer 
composition88. It may be possible to make scaffolds with an optimized pore structure 
for meniscus regeneration. Ideally, such scaffolds could guide the infiltrating tissue 
into the preferable direction, for example peripheral collagen fibers into peripheral 
circumferential tunnels to better withstand hoop stresses during loading of the joint 
(Figure 6). Furthermore, these techniques may improve the biomechanical properties 
of the scaffolds and as such their initial performance in the knee joint before the 
actual tissue infiltration has completed. 
An approach to avoid initial damage by high friction of the implant could be 
to coat the implant materials with substances to promote a smooth frictionless 
movement in the joint. Particularly hyaluronic acid (HA) and the other constituents 
Figure 6. Schematic representation of scaffold design to enable the differentiation of tissue into the desired 
configuration.
-17-
1
of GAGs, such as the highly hydrated chondroitin sulphate, keratan-sulphate and/
or dermatan-sulphate could be used for this purpose. Particularly hyaluronic acid, a 
non-sulphated glycosaminoglycan, is present in high quantities in the synovial fluid 
and has a function in the lubrication of the joint. Currently, this substance is used as 
an injectable material to relieve complaints associated with severe osteoarthritis in 
patients. It also seems to have a protective effect on cartilage degeneration when used 
in animal models to prevent damage to the cartilage by surgical interventions98,99. HA 
can also be used as a building block for drug delivery, tissue engineering, wound 
repair and visco-supplementation100. 
OUTLINE OF THIS THESIS
This thesis shows the results of new potentials for meniscus tissue engineering. 
The first chapters are mainly focused on engineering a cell based meniscus 
construct. As stated in the paragraph “Scaffold materials for meniscus repair” the 
ideal scaffold material for meniscus tissue engineering should be biocompatible 
and biodegradable. The aim for CHAPTER 2 was to study a new scaffold material 
for meniscus tissue engineering. Besides biocompatibility and biodegradability, the 
scaffold should permit cell ingrowth, allow free diffusion of nutrients and should 
be strong enough to withstand the load in the knee-joint. The scaffold studied is a 
polyurethane (PU) based on poly D/L lactic acid and polycaprolactone with urethane 
linkers. Via solvent leaching a porous scaffold was obtained and subsequently tested 
for above mentioned properties for in vitro meniscus tissue engineering.
To increase the potential of the PU scaffold further, incorporation of bioactive 
macromolecules or growth factors are wanted (paragraph “Scaffold materials for 
meniscus repair”). These macromolecules should increase regeneration speed and 
quality of repair tissue. The macromolecule of interest is heparin, known for its 
growth factor adhering capacity and ability to re-differentiate meniscus cells. In 
CHAPTER 3 a new surface treatment to coat this PU scaffold was studied.
In paragraph “New approaches”, current studies of meniscus tissue engineering 
have been discussed. An interesting option would be pre-culturing cells inside the 
scaffold. These cells would synthesize matrix and thereby increase mechanical 
stiffness and reduce incorporation time of the tissue engineered constructs. However, 
a big limitation of cell cultured constructs lies in the supplements added to the 
culture medium. Fetal bovine serum is a widely used and potent supplement of 
culture medium. It is known to induce proliferation and matrix synthesis of a wide 
variety of cells, including meniscus cells. But due to its bovine origin, application 
of cell cultured constructs with fetal bovine serum supplemented to the medium is 
limited due to potential bovine pathogens. Replacement for this fetal bovine serum 
is highly wanted for safety reasons and could facilitate future clinical applications of 
cell cultured tissue engineered constructs. In CHAPTER 4 we analyzed if platelet 
rich plasma could replace bovine serum in meniscus tissue engineering.
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Scaffolds for musculoskeletal tissue engineering, e.g. meniscus and articular 
cartilage, should follow a number of requirements. A number of these requirements 
have been tested in chapter 2 and chapter 3. One property of scaffolds not mentioned 
before is the effect of scaffold architecture in tissue engineering. As proposed in 
paragraph “New approaches”, anisotropic scaffolds with a high porosity and 
aligned channels can guide extracellular matrix into similar organization as the 
native meniscus. In CHAPTER 5 we provided an overview of all current methods 
to produce different types of anisotropic scaffolds used for musculoskeletal tissue 
engineering. Subsequently, in CHAPTER 6 one of the described methods, modified 
Thermal Induced Phase Separation, was used to obtain anisotropic scaffolds from the 
studied PU scaffold material (chapter 2). Subsequently, these anisotropic scaffolds 
are tested for the ability to guide extra cellular matrix into similar organization as the 
native meniscus in a subcutaneous rat pocket model.
 
In addition to guidance for extracellular matrix, anisotropic scaffolds can also 
be used to guide cell migration. In articular cartilage repair, micro-fracturing/Pridy-
drilling is used to create a channel between the cartilage and the subchondral bone. 
This enables mesenchymal stem cells from the underlying bone marrow to migrate 
into defect and regenerate the articular cartilage surface. However, in large defects 
regeneration is of an inferior fibrous cartilage type. In these large defects, scaffolds 
can be inserted into the defect to guide and stimulate cell migration, thereby 
increasing regeneration speed and quality. In CHAPTER 7 isotropic and anisotropic 
collagen scaffolds were inserted into articular cartilage defects of a rabbit model, 
and the effects of scaffold architecture on stem cell migration and articular cartilage 
regeneration were tested.
 
In CHAPTER 8 the results of the studies performed in this thesis were summarized 
and the implementation of this research into future perspectives of meniscus tissue 
engineering are discussed in CHAPTER 9.
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ABSTRACT 
The aim of this study was to investigate if newly developed polyurethane 
(PU) scaffolds are suitable as scaffold for cell seeded meniscus tissue engineered 
constructs. Scaffolds were seeded with goat meniscal fibrochondrocytes and cultured 
to assess changes in biological and mechanical properties. Furthermore, the effect 
of TGF-β on these properties were investigated. For this PU scaffolds were made 
from poly D/L lactide and caprolactone as soft segments and 1,4-butanediisocyanate 
for the urethane hard segments. The porosity of the scaffolds was 95%. Isolated 
goat meniscal fibrochondrocytes were seeded on the scaffolds and cultured with or 
without the addition of 10 ng/ml TGF-β in standard culture medium. After 2, 4 and 
6 weeks of culture, scaffolds were analyzed for cell proliferation, matrix synthesis 
and mechanical properties. 
Results of scanning electron microscopy and histology showed that the scaffolds 
had an interconnected isotropic pore structure. Without addition of TGF-β cells did 
not proliferate during the culture period and isolated meniscus fibrochondrocytes were 
more frequently located in the peripheral parts of the scaffold. Fibrochondrocytes 
supplemented with TGF-β were distributed throughout the construct. Clustered cells 
were surrounded by matrix which stained slightly positive for GAGs. Also collagen 
production was increased significantly after 4 and 6 weeks of culture compared to 
cultures without TGF-β and also more GAG staining was found after 4 and 6 weeks 
in the sections of the TGF-β stimulated cultures. Despite the increase in matrix 
production, the compressive stiffness of the constructs was not increased during the 
culture period. 
In conclusion, meniscal fibrochondrocytes were able to adhere to the polyurethane 
scaffold. However, the scaffold itself does not stimulate proliferation and matrix 
production. The addition of TGF-β resulted in a strong induction of both proliferation 
and extracellular matrix production.
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INTRODUCTION 
Menisci are semilunar shaped structures located in pairs in each knee joint. 
They fill the gap between the round femoral condyle and the rather flat (medial) 
or even concave (lateral) tibia plateau. Although the meniscus has quite a number 
of functions in the knee joint, the main function of the meniscus is to distribute 
stresses in a homogenous way over the articular surfaces of the tibia and femur. To 
withstand the high forces in the knee, the fibro-cartilage of the meniscus has a highly 
circumferentially oriented type I collagen fiber organization. Moreover, it contains 
also type II collagen and some glycosaminoglycans (GAG’s), particularly in the 
inner highly loaded part of the meniscus1. The composition of the tissue enables 
the meniscus  to withstand compressive and tensile shear forces and to maintain its 
position under load. Thereby it transfers axial loads into circumferential directed 
forces2,3.
Meniscus injury will generate pain and cause mechanical locking of the knee 
joint. The most frequent occurring meniscus trauma’s are tears. The peripheral part 
of the meniscus is the so-called red zone which is vascularized. Since vascularization 
is a key player in regeneration after trauma4,5, tears in this location normally can 
heal4-6. When tears occur in the inner 2/3 of the meniscus, also called the white 
zone of the meniscus, no or very limited regeneration is possible due to a lack of 
vascularization. 
The flap tear and bucket handle tear are the most common meniscus injuries. 
In the past, the resulting loose fragments were arthroscopically removed. Although 
this treatment is an enormous improvement compared to a total meniscectomy, 
even a partial meniscectomy will result in osteoarthritic changes in the articular 
cartilage7. Also the amount of meniscal tissue removed has a direct relationship with 
the induction of late osteoarthritis8,9. Upon removal of meniscal tissue more load is 
directly transferred from the condyles to the tibial plateau resulting in large peak 
stresses which causes an early onset of osteoarthritis3,7. Therefore, in order to preserve 
the contact area of the meniscus, the general practice these days is fixation of the 
loose fragment to the main body of the meniscus by suturing, anchors or screws10. 
Unfortunately the used fixation devices are still inferior to cope with the forces 
applied on the meniscus, resulting in high rates of ruptures or even osteochondral 
defects11. When fixation is not possible or insufficient, a partial meniscectomy is 
inevitable. 
Regeneration of the lost part of the meniscus would be the most optimal treatment. 
A scaffold that replaces the meniscus tissue could guide new tissue ingrowth into 
the lost meniscus and by that meniscus regeneration could be established. Two 
implants based on scaffolds are already in clinical use, namely a scaffold based 
on collagen (Menaflex™) and one based on a synthetic polymer(Actifit®)12,13. The 
Menaflex™ implant has already been implanted for a number of years and supports 
ingrowth of new meniscus like tissue. However, the scaffold shrinks in size after 5 
years13-15. The Actifit® implant, based on a synthetic caprolactone-urethane polymer, 
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is only recently available in Europe. Preclinical animal experiments showed that 
implantation of this scaffold in a partial defect will enable equal contact pressures 
as a normal meniscus, whereas without implantation contact pressures increase16. 
After implantation the scaffold had rapid ingrowth of tissue and no cartilage defects 
were present after one year17. These experiments were conducted in partial meniscus 
defects, but when implanted as a total meniscus replacement, the scaffold was not 
strong enough and failed to protect the cartilage from damage18,19. Recently, the first 
patient study with Actifit® as a partial replacement has been published. After one 
year follow up, implant was integrated with native meniscus tissue, and biopsies 
showed fully vital tissue20. 
In contrast to partial meniscal replacement, the only clinical used treatment for 
total meniscus replacement is allograft transplantation21. Even though clinical results 
are satisfactory, there exists a minor risk of disease transfer, the availability is limited 
due size matching and the allograft meniscus can re-tear, shrink and dislocate22.
Tissue engineering could be a promising alternative approach to replace the lost 
tissue after (partial) menisectomy. Pre-cultured cell seeded scaffolds showed better 
integration with the surrounding meniscus tissue in an ex vivo setup23. Also in in 
vivo  experiments cell seeded constructs showed better integration with adjacent 
tissue after implantation in defects24,25. Pre-seeding cells on a scaffold also strongly 
improved the mechanical properties compared to the initial scaffold26. Three 
cell types are most often used so far, namely mesenchymal stem cells (MSC)23, 
chondrocytes27, meniscal fibrochondrocytes (MFCs)28, or a combination of these 
cell types27. Which cell type is best suited for these cell seeded constructs remains 
unknown. To stimulate these cell based meniscal constructs, a number of growth 
factors (GF) have been tested. Most commonly used are TGF-β, IGF, bFGF and 
PDGF28-32. These GFs stimulate cell proliferation, matrix production and migration, 
thereby reducing the time needed to engineer new meniscus tissue.
Which type of scaffold is best suited for meniscus TE is still pending. Scaffolds 
of many different composites, e.g., based on hydrogels, biologic polymer (collagen / 
silk) or synthetic polymer (PLA / PGA / PCL), have been described in literature18,33,34. 
A synthetic polymer scaffold with very promising characteristics has already been 
described in detail by Spaans et al. and van Minnen et al.35,36. They synthesized a 
polyurethane (PU) co-polymer porous scaffold with poly D/L lactic acid and poly-
ε-caprolactone as soft block segments and 1,4-butanediisocyanate as hard block 
urethane segments36. These highly porous scaffolds were tested both in vitro and 
in vivo for cytotoxicity and degradation. The in vitro experiments showed that after 
12 weeks only 3.4% mass was degraded, thereby categorized as a slow degrading 
scaffold. Cytotoxicity tests showed that scaffolds did not change the proliferation 
speed and metabolic activity of fibroblast after direct contact37. The long term 
test showed some cytotoxicity, however, this was ascribed to the accumulation of 
degradation products in their in vitro test system37. The in vivo experiments of short 
till long term subcutaneous implantation showed no toxicity. The scaffolds followed 
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a gradual resorption pattern over 3 years. First encapsulation and infiltration with 
connective tissue was observed. Subsequently, degradation and resorption by 
macrophages and giant cells was found. Scaffolds were not completely resorbed 
after 3 years but they expected it to be totally resorbed after 3.5 – 4 years38. 
The PU described above has a number of novel aspects compared to other synthetic 
polymer scaffolds previously used for meniscus tissue engineering purposes or in 
clinical practice. The scaffold described in this study has a 95% porosity compared 
to approximately 80% porosity of most other scaffolds19,39. This high porosity is 
required to increase surface area for cell attachment, tissue ingrowth and moreover, 
facilitating adequate transport of nutrients and cellular waste products40. With 
decreasing porosity, nutrient and waste exchange of cells in the deeper regions is 
limited, leading to necrotic sites in the center of the scaffold19. Another advantage of 
a high porosity is that it, in general, will lead to a faster speed of resorption as less 
polymer material has to be degraded. Reducing the time foreign materials remain 
present in the body has been shown to lower the risk on immunological responses. 
In addition, with smaller amounts of polymer material to be degraded, lower acidic 
levels will be reached. Higher acidity levels are known to reduce tissue regeneration 
speed37. The high porosity of the material used in our study also aims to ensure a 
faster resorption rate, low immunological risk, and high tissue regeneration speed. 
Furthermore, the use of a co-polymer from caprolactone and both isomers of lactic 
acid exclude crystalline regions in this material. It has been described that increasing 
crystallinity results in highly stable remnants and increase inflammatory risk in a late 
degradation stage41.
The aim of this study was to improve the properties of the PU scaffolds 
as described by van Minnen et al.36 by a tissue engineering approach for total 
meniscus replacement. Pre-seeding cells on scaffolds could have beneficial effects 
on biological and mechanical properties. In this study biological properties (i.e. 
proliferation, distribution and matrix production)  were tested after culture MFCs 
on this PU scaffold. Furthermore, we tested the effect of TGF-β on these biological 
properties. Finally the mechanical properties of this tissue engineered construct was 
determined to assess whether it is comparable to native meniscus.
MATERIAL AND METHODS
Scaffold preparation.
Scaffolds were composed of 50% DL(50/50)-lactide (PDLLA, Purac) and 
50% ε-caprolactone (PCL, Acros Organics) by ring opening polymerization 
with 1,4-butanediol (BDO) as initiator. The final macrodiol prepolymer had a 
molecular weight (MN) of 2000 g/mole. Subsequently this was end-capped with 
1,4-butanediisocyanate (BDI). Chain extension was performed with a BDO-BDI-
BDO urethane block which resulted in a hard block urethane segment with a uniform 
length of five urethane moieties. Final PU consisted of 22.5 w/w % hard urethane 
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segments and 77.5 w/w % amorphous polyester soft segments. Polymers were 
solvent casted, frozen and lyophilized. The obtained scaffolds had a 95% porosity36. 
Finally, scaffolds were frozen in liquid N2, punched with a 6 mm internal diameter 
dermal punch and cut into 3 mm high cylinders. After cutting the scaffolds, SEM 
images were made to evaluate the internal pore structure of the scaffolds (JEOL JSM 
6310, JEOL Ltd, Herts, UK).
Cell isolation
Both lateral and medial menisci from four skeletal mature female Dutch milk 
goats (Capra Hircus Sana) were isolated immediately after sacrifice under aseptic 
conditions. Tissue collection was approved by the Animal Ethics Committee of 
the Radboud University, Nijmegen. Isolation of meniscal fibrochondrocytes was 
performed according to earlier reported protocols28. In short, menisci were washed 
3 times with PBS/1x PSF (Penicillin/streptomycin/fungizone, Gibco, Carlsbad, 
CA USA). Subsequently, the outer rim was removed and inner part was cut into 
small pieces. These pieces were digested in DMEM/F12 + 1x PSF with 3 mg/ml 
collagenase II (Worthington, Lakewood, NJ USA) for 48 hour in a 5% CO2, 37
OC 
controlled culture incubator. Digest was filtered over 70 µm tissue filter bags and 
filtrate was centrifuged for 10 min at 1100 rpm to pellet the cells. Cells were washed 
2 times with PBS and plated in culture flasks. Cells were cultured in standard medium 
(DMEM/F12 + 10% FBS + 1x PSF) in a culture incubator. At 70% confluence cells 
were passed once by trypsinization using standard procedures. Passage 1 cells were 
harvested, frozen in cryo-vials and preserved in liquid nitrogen until use. 
Cell culture
Before start of the experiment cells were defrosted and expanded twice. Finally, 
cells were isolated, counted and used for cell culture experiments. MFCs isolated 
had a >95% cell viability determined by trypaan blue exclusion. Scaffolds were 
ethanol desinfected in series till 96% EtOH, washed three times with sterile PBS 
and incubated o/n in standard culture medium. Scaffolds were squeezed to remove 
excess medium and passage 4 MFCs, a total of 5x105 in 50 µl, were placed on top of 
each scaffold and incubated for 60 minutes in an incubator. After incubation standard 
medium was added with or without 10 ng/ml TGF-β (R&D Systems, Minneapolis, 
MN USA). Total medium was refreshed three times a week.
Pilot tests were performed with different concentrations of TGF-β (1 ng, 10 
ng and 100 ng/ml). If 10 ng/ml or 100 ng/ml was added, proliferation was shown 
to increase. However, no differences were observed between 10 ng and 100 ng. 
Therefore 10 ng/ml was used in the current experiments. Scaffolds were cultured for 
2, 4 and 6 weeks without or with the addition of 10 ng/ml TGF-β in standard medium 
and performed in triplo.
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Picogreen analyses
After 2, 4 and 6 weeks of culture samples were washed with PBS and frozen in 
Milli Q. After repeated freeze/thaw cycles samples were measured using PicoGreen 
dsDNA assay kit as per manufacturer’s protocol (Invitrogen, Carlsbad, CA USA).
Collagen analyses 
After 2, 4 and 6 weeks of culture samples were washed and frozen in PBS. Samples 
were analyzed to quantify the amount of collagen using a colorimetric hydroxyproline 
assay42. In short, samples were hydrolyzed in 6N HCl by autoclaving for 20 hours 
at 110OC. The hydrolyzate was washed twice with Milli Q. Chloramin-T was added 
and incubated for 20 minutes at room temperature. Subsequently, Ehrlich’s reagent 
was added and chromophore was developed during 20 minutes at 60OC. Finally, 
absorbance was read at 570 nm using a spectrophotometer.
Routine histology
Scaffolds were paraffin embedded and sections of 7 µm in thickness were cut. 
Sections were deparaffinized, and rehydrated. Oil Red O with hematoxylin (ORO/H) 
for cell staining, and alcian blue for GAG staining, were used for routine histology. 
For ORO/H staining, sections were shortly incubated in oil red O. Hereafter cell 
nuclei were counterstained with hematoxylin and mounted with aquamount. For 
alcian blue, sections were washed in 3% acetic acid, incubated for 45 min in alcian 
blue. After washing cell nuclei were counterstained with nucleus red and mounted 
with DPX. All samples were analyzed under light microscopy and pictures were 
recorded with an Olympus digital camera and a photo program software (analySIS 
Soft Imaging System, GmbH, Münster, Germany).
Mechanical analyses
At day 0 and after 2, 4, and 6 weeks of culture samples were tested for mechanical 
stiffness. Samples were placed in a Bose ElectroForce BioDynamic bioreactor 
mounted with a 22N load cell housed in a 37OC incubator (BOSE, MN USA). The 
specimen chamber was filled with PBS and scaffolds were compressed at 1 mm/min 
till 20% compression. With the obtained stress/strain curve the Young’s Modulus 
was calculated as the steepness of this curve.
Statistics
A two way ANOVA was used on all datasets with treatment (TGF yes/no) and 
time (0, 2, 4 and 6 weeks) as factors. All data were expressed as mean ± SEM. For all 
experiments, differences were considered statistically significant for P values <0.05. 
Statistical analysis was performed using SPSS 16.0 software (SPSS Inc., Chicago, 
IL USA).
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RESULTS 
SEM analyses
SEM images showed that the scaffolds had macro-pores in the range from 100-
300 µm in diameter. All macro-pores were interconnected by micro-pores ranging 
from 10-30 µm. Furthermore, an overall isotropic pore architecture was observed 
(Figure 1). Histology of scaffolds not used for culture experiments confirmed the 
isotropy of the scaffolds.
Cell quantification
The picogreen analyses showed a significant increase in the amount of DNA 
of TGF-β stimulated cultures at each time point compared to the non-stimulated 
cultures (p<0.001, Figure 2). The effect of treatment was also shown over time. 
Untreated samples did not differ over time, in contrast to DNA content of TGF-β 
treated samples, that did increase over time (p<0.001). The difference  in cell quantity 
was highest after 6 weeks of culture. DNA content was 3.75x higher in the TGF-β 
stimulated group compared to the non-stimulated group (Figure 2).
Collagen quantification
Non-stimulated cell cultures did not 
show any increase in collagen production 
per scaffold over time (p>0.99). TGF-β 
stimulated cell cultures expressed a 
higher amount of collagen content. After 
6 weeks of culture the TGF-β stimulated 
group synthesized 15.6 times more 
collagen compared to standard culture 
medium group, 15.6 µg/scaffold and 1.0 
µg/scaffold, respectively (p<0.001). This 
increase was also time dependant since 
Figure 1: SEM image of the PU scaffold used for cell 
culture. Diameters range from 100 – 300 µm for the 
macro pores and 10 - 30 µm for the interconnected 
pores. Pores were isotropically distributed throughout 
the scaffold.
Figure 2: Picogreen assay of cell cultures on scaffolds 
treated with of without TGF-ß. Untreated samples did 
not increased significant in time. Treated samples did 
significantly increase over time. Treated samples are 
also significant higher in DNA content compared to 
untreated samples (n=3).
Figure 3: Collagen synthesis of constructs after 2, 4 
and 6 weeks of culture determined by a colorimetric 
hydroxyproline assay. The 6 week TGF-ß treated 
group is significantly higher compered to the 
untreated group (n=3).
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this was significantly higher compared to the 2 and 4 week cultured scaffolds with 
TGF-β (p<0.001, Figure 3). 
Histological analyses
Irrespective to the culture period, isolated MFCs were homogeneously distributed 
throughout the scaffolds which were not stimulated by TGF-β, however, in the 
periphery slightly more cells were present. After 6 weeks of culture more cells were 
present at the outer surface but they did not formed a continuous layer. No matrix was 
seen around the cells with alcian blue staining indicating that cells did not produce 
matrix (Figure 4).  
In the cultures stimulated with TGF-β, more cells were present. Already after a 
culture period of two weeks more cell clusters were found than isolated cells, not 
only on the surface of the scaffolds but also in the deeper regions. After 4 and 6 
weeks the difference with the non-stimulated scaffolds was even more pronounced. 
On the surface of the scaffold a continuous layer of MFCs surrounding the scaffold 
was present. Clusters of cells were found up to the centre of the scaffolds. With the 
alcian blue staining the difference between non stimulated and stimulated cultures 
was further illustrated. After 4 and 6 weeks GAG positive matrix was observed 
around cells in the TGF-β treated groups (Figure 4). 
Figure 4: Oil red O / Hematoxylin (A, B) and aclian blue stainings (C,D) of the scaffolds cultered with MFCs 
after 6 weeks. Panel A and C are non-stimulated cultures. Panels B and D with TGF-ß. Proliferation and higher 
numbers of MFCs in the center are clearly visible in the TGF-ß treated group. Lower panel showes alcian blue 
staining to visualize GAG’s. Only in the TGF-ß treated groups GAG formation is seen around cell clusters.
-34-
2
Mechanical analysis
No signifi cant differences were found in Youngs moduli between scaffolds 
cultured with or without TGF-β. In time the control scaffolds without cells did not 
change in mechanical stiffness. For the cell cultured constructs no change in Young’s 
modulus in time was measured as well (Figure 5).
DISCUSSION 
Until this date, scaffolds based on collagen or caprolactone urethane (PU) have 
been developed to regenerate partial defects in human menisci13,20. These scaffolds 
are implanted without cells. Results are promising for partial defect repair, but not 
applicable for all patients. Furthermore, it is not possible to treat defects involving 
the rim of the meniscus with these scaffolds. To repair such a defect with a scaffold, 
it is worthwhile to invest the possibility to enhance the biological and mechanical 
properties by seeding cells prior implantation. These pre-cultured scaffolds are able 
to integrate with the host tissue stronger and faster23. To supply suffi cient volume for 
cells to grow and synthesize matrix a 95%, highly interconnective porous scaffold 
was used.
The fi rst aim of this study was to investigate the biological properties of cell 
seeded scaffolds. Scaffolds made from 50/50 P(D/L)LA / PCL with BDI were seeded 
with MFCs and cultured up to 6 weeks. This study shows that MFCs can be cultured 
on this scaffold. However, they did not proliferate and ECM synthesis did not 
increase in time. Also the number of cells in the center of the scaffold was limited. 
This could be due to the hydrophobic nature of the scaffold, or by a lack of nutrition 
in the center43. Another explanation could be that passage 4 MFCs lose the ability to 
proliferate or synthesize matrix. 
To enhance biological response, 10 ng/ml TGF-β was added to standard medium. 
TGF-β is known to induce proliferation and matrix syntheses. Addition of TGF-β 
increased proliferation of MFCs cultured in these scaffolds. This effect of TGF-β is 
in line with results described by others30,44,45. Moreover, collagen and GAG, which are 
two main components of the meniscus ECM, also increased after TGF-β stimulation. 
Increase in matrix was not only due to an increase in cell numbers. As indicated 
with the picogreen assay total cell number was 3.75 times higher compared to non-
stimulated cultures. Collagen synthesis was increased more than 15 times compared 
Figure 5: The compressive Young’s modulus was 
determined by compressing the scaffolds till 20% at 
1 mm/min in PBS at 37OC. No signifi cant decrease or 
increase of mechanical stiffness was observed (n=3).
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to non-stimulated cultures. This means that collagen production per cell was also 
strongly increased by TGF-β. In addition, this proves that passage 4 MFCs are still 
able to proliferate, if correct stimuli are presented to the cells. Which indicates that 
the aforementioned loss of proliferation is not the case. The result that MFCs will 
not proliferate in the scaffold, under normal culture conditions, points out that the 
surface characteristics of this scaffold is not bio-inductive for these cells. A study 
from  Gunja et al. reported that environmental characteristic have a great effect on 
MFCs. They showed that with increasing passage number, up to passage 4, MFCs 
alter gene expressions for collagen and GAG’s. Reversal effects could be initiated 
if re-cultured on a collagen or GAG coated surface46. For future applications of this 
scaffold it could be advantageous to coat the scaffolds surface with bioactive markers 
such as collagen or GAG. This would improve correct gene expression, and in the 
end, lead to native like meniscal tissue.
The second aim of this study was not realized. The initial Young’s Modulus of 
the scaffold was 26 kPa and did not reduce significantly after 6 weeks of culture due 
to degradation. This short term degradation stability is in line with previous studies. 
In here it was shown that scaffolds remained physically intact up till 20 weeks47. 
The initial compressive stiffness measured is below that of human meniscal tissue. 
Others showed that native menisci vary in mechanical stiffness between 30 – 100 
kPa depending on sample site48,49. Since cell proliferation and matrix deposition can 
increase stiffness, the cell seeded scaffolds were expected to have a higher stiffness50. 
The TGF-β stimulated group, which synthesized the most ECM, did not increase 
significantly in mechanical stiffness. However, the mean Youngs modulus of these 
cultures after 6 weeks was 43 kPa. Possibly, if culture times prolonges matrix synthesis 
will increase, thereby the Youngs modulus will increase further and could become 
similar as native meniscus tissue. On the other hand, perhaps initial cell density was 
too low. Many methods have been described to increase cell density. The most obvious 
would be to increase total number of seeding cells. Alternatively, optimizing seeding 
efficiency can increase initial cell density and distribution. Cell seeding techniques 
can be divided into static or dynamic systems. Examples of static systems are droplet 
and cell suspension51. Recently more dynamic seeding systems have been described 
which uses specially developed devices such as perfusion systems, spinner flasks of 
bioreactors51. These dynamic seeding techniques yield higher densities and better 
homogeneous cell distribution51. Also bioreactors can be promising to increase the 
biological properties. When dynamic mechanical loading is applied on cell seeded 
scaffolds, proliferation and matrix synthesize increase compared to static cultures52. 
Furthermore the produced matrix was unorganized while in the meniscus collagen 
fibers are highly oriented. Methods to increase biological properties further, could 
lead to more in vivo like mechanical properties. New methods to increase mechanical 
properties are in vivo cultures of cell seeded constructs. If pre-seeded scaffolds are 
cultured subcutaneously, the mechanical modulus becomes higher when compared 
to in vitro pre-seeded constructs53. On the other hand, scaffolds could be adapted to 
create initially stiffer scaffolds resembling native meniscus more closely.
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In summary, meniscal fibrochondrocytes can be cultured in PU scaffolds made 
from poly D/L lactide and caprolactone and 1,4-butanediisocyanate. However, the 
scaffold did not permit proliferation of these cells. Addition of TGF-β will increase 
the biological properties significantly. The mechanical properties, however, remained 
similar. Further research needs to focus on changing the scaffolds properties to 
increase biological and mechanical behavior during culture. Methods to change 
these properties could be coating the scaffolds surface with biologic cues such as 
proteins. This can increase the cellular response during cell cultures.
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ABSTRACT 
Polyurethane scaffolds (PU’s) have a good biocompatibility, but lack cell 
recognition sites. In this study we functionalized the surface of a PU, P(D/L)LA 
and PCL (50:50) containing urethane segments, with heparin. The first step in this 
functionalization, aminolysis, lead to free amine groups on the surface of the PU. 
Free amine content was determined to be 6.4 nmol/ml/mg scaffold, a significant 
increase of 230%. Subsequently, heparin was cross-linked. Immunohistochemistry 
demonstrated the presence of heparin homogeneous throughout the 3D porous 
scaffold. Young’s modulus decreased significantly till 50% of the native stiffness 
after aminolysis and did not change after heparin cross-linking. Contact angle on PU 
films significantly decreased from 82.7 to 64.3 degrees after heparin cross-linking, 
indicating a more hydrophilic surface. 
This functionalization beholds great potential for tissue engineering purposes. 
When used in a load bearing environment, caution is necessary due to reduction in 
mechanical stiffness. 
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INTRODUCTION 
Recent advances in polymer chemistry have significantly improved biomaterial 
scaffolds for use in Tissue Engineering (TE), but a need for optimalization of the 
currently available scaffolds remains. A synthetic scaffold material widely used for 
TE purposes is polyurethane (PU). Although many PU’s are biocompatible1, their 
hydrophobic nature limits cell adhesion. Cell adhesion is one of the key factors 
affecting the eventual results of tissue engineering constructs. It is known that cells 
have a higher affinity for hydrophilic surfaces2. Several techniques to increase the 
hydrophilicity of polymer surfaces have been published. Recently, a surface activation 
technique using diamines has been described3,4. Highly reactive diamines are able to 
break ester groups of the polymer open, and subsequently covalently bind with one 
amine group to the scaffold leaving the second amine group unreacted. This free 
amine group can be used for the covalent coupling of a variety of macromolecules, 
such as collagen and chondroitin sulphate. Subsequently, these macromolecules 
might influence cell proliferation, differentiation and matrix synthesis4-6. 
A group of macromolecules of major interest are glycosaminoglycans (GAGs), 
and in particular heparin. GAGs can create an appropriate environment for cellular 
signaling, and are common constituents of cell surfaces and extracellular matrices. 
In addition, heparin is able to bind and modulate various proteins including growth 
factors, cytokines, and extracellular matrix proteins7. Attachment of GAGs may 
therefore offer the opportunity to exploit their bio-characteristics and valorize the 
biomaterials they are attached to. It has been shown that gene expression alters with 
increasing passage number of isolated meniscal fibrochondrocytes. However, re-
culturing of these cells on collagen or GAG coated surfaces has been shown to partly 
restore gene expression8. 
 The purpose of this study was to functionalize PU scaffolds with diamines 
and subsequently bind heparin as a carrier for future applications in tissue 
engineering. Functionalized scaffolds were evaluated mechanically, biochemically 
and histologically. 
MATERIAL AND METHODS
Scaffold preparation
Scaffolds were composed of 50% DL(50/50)-lactide (PDLLA, Purac) and 
50% ε-caprolactone (PCL, Acros Organics) by ring opening polymerization 
with 1,4-butanediol (BDO) as initiator. The final macrodiol prepolymer had a 
molecular weight (MN) of 2000 g/mole. Subsequently this was end-capped with 
1,4-butanediisocyanate (BDI). Chain extension was performed with a BDO-BDI-
BDO urethane block which resulted in a hard block urethane segment with a 
uniform length of five urethane moieties. Final PU consisted of 22.5 w/w % hard 
urethane segments and 77.5 w/w % amorphous polyester soft segments. Polymers 
were solvent casted, frozen and lyophilized. The obtained 3D porous scaffolds had a 
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95% porosity (kindly provided by Polyganics BV, the Netherlands) 9. Scaffolds were 
frozen in liquid nitrogen, and cylinders of 8.0mm in diameter and 5.0mm in height 
were cut using a dermal punch. In addition, polymer films were made of the same 
polymer solution. The solution was poured into glass petridishes and dried by air, 
resulting in polymer films with a thickness of 0.2mm. From these films, 16.0 mm 
diameter samples were punched.
Surface coating with heparin
Aminolysis of the scaffolds was performed by immersing the samples in 5% 
1,6-hexanedamine (Merck, NJ, USA) in isopropanol. Different incubations times 
were tested. However, when scaffolds were incubated over 120 minutes, samples 
started to fall apart (results not shown). Therefore an incubation time of 60 
minutes at room temperature was chosen for all future experiments. After stringent 
washing with demineralized water samples were freeze dried over night. From the 
3D porous scaffolds the amount of free amines was quantified via 1M ninhydrin 
staining and absorbance spectroscopy at 535 nm  (n=5) 10. Subsequently, scaffolds 
were prepared for cross-linking with heparin. Scaffolds were saturated with 50mM 
2-morpholinoethane sulphonic acid buffer (MES, pH 5.0). The reaction was 
performed via standard carbodiimide cross-linking 11,12. A total of 0.25% heparin 
sulphate (w/v) (Organon, Oss, the Netherlands) was added to 33mM 1-ethyl-3-
dimethyl aminopropyl carbodiimide (EDC) and 6mm N-hydroxysuccinimide (NHS) 
in MES buffer. After 4h of incubation at room temperature, the scaffolds were 
washed in 0.1M Na2HPO4, 1M NaCl, 2M NaCl and demineralized water.
Immunofluorescence staining
Surface coated 3D porous scaffolds were analyzed with heparin specific 
immunofluorescence staining (n=5) 13. Cryosections of 4µm were prepared and 
blocked for one hour with 1% BSA/PBS. Subsequently, sections were incubated 
with the following antibodies in 1% BSA/PBS for one hour: HS4C3 1:10 , P5D4 
1:10 and finally ALEXA 488 labeled goat anti mouse IgG 1:200 (HS4C3 and P5D4 
were kindly provided by Dr. T.H. van Kuppevelt, Radboud University Nijmegen, 
NCMLS, the Netherlands). Sections were mounted with Mowiol and analyzed with 
fluorescence microscopy.
Hydrophilicity test
The sessile droplet method was used to calculate the surface hydrophilicity of 
each of the surface treated polymer films produced 14. A water droplet was placed on 
top of the film and photographed. The contact angle was determined by measuring 
the angle between polymer film and droplet (n=5).
Mechanical analyses
Porous 3D scaffolds with and without diamine activation and subsequent heparin 
cross-linking were subjected to mechanical compression (n=6) under physiological 
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conditions (PBS, 37OC). Mechanical tests were performed with a BOSE® 
ElectroForce® BioDynamic™ bioreactor with an orthopaedic chamber, equipped 
with a 22N load-cell (BOSE, MN, USA). Scaffolds were compressed at a speed of 
1mm/min and forces were recorded till 50% compression using WinTest® software 
(BOSE, MN, USA). The Young’s modulus (YM) was calculated as the slope of the 
straight line portion of the stress-strain curve.
Statistical analyses
Statistical analyses were performed by one-way ANOVA with a Tukey HSD post-
hoc test (SPSS v18, Chicago, IL, USA). P-values < 0.05 were considered significant. 
All quantitative data were expressed as mean ± SEM.
RESULTS 
Aminolysis
After aminolysis for 60 min, the amount of free amines significantly increased 
from 2.8 ± 0.71 nmol/ml/mg scaffold to 6.4 ± 0.66 nmol/ml/mg scaffold for native 
and aminolyzed 3D porous scaffolds respectively as measured by ninhydrin 
quantification (p = 0.006) (Figure 1). 
Immunofluorescence staining
Immunofluorescence analysis showed positive heparin staining after completing 
the two step reaction (see + + group in Figure 2). Omitting aminolysis, no heparin was 
detected on the scaffolds (- + Figure 2). Heparin staining was visible homogenously 
throughout the entire porous scaffold and over the entire film.
Figure 1: Ninhydrin assay. Aminolyzed scaffolds 
contained significant more free amines after diamin 
treatment (p=0.006, n=5).
Figure 2: Heparin specific immuno-fluorescence 
staining on 3d porous PU scaffolds. First mark -/+ 
aminolysis, second mark -/+ heparin cross-linking. 
Notice that only activated and heparin cross-linked 
scaffolds (++) show positive heparin staining (n=5).
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Hydrophilicity test
Droplets on native films had a contact angle of 82.7O ± 0.71. After aminolysis, the 
contact angle significantly decreased till 65.4O ± 0.98 (p = 0.006) indicating a more 
hydrophilic surface compared to the native scaffold. Heparin cross-linking caused no 
further change in contact angle  64.3O ± 1.03 compared to aminolyzed scaffolds, but 
was significantly lower compared to the native films (p = 0.006) (Figure 3).
Mechanical stiffness
The Young’s modulus of the native scaffold was 23.3 ± 2.0 kPa. The aminolyzed 
scaffolds had a significant lower modulus of 12.2 ± 0.9 kPa (p = 0.003). Heparin 
cross-linking had no further influence on the scaffolds’ stiffness (13.2 ± 0.4 kPa) 
(Figure 4).
DISCUSSION 
The aim of this study was to test the possibility to coat a PU scaffold with heparin. 
The PU of interest was a co-polymer of P(d/l)LA and PCL further reacted with 
butanediisocyanate to introduce urethane bonds. The method for surface coating this 
PU scaffold with heparin showed to be effective. A two step reaction was necessary 
to cross-link heparin. The first reaction, aminolysis, resulted in free amines that could 
be employed to immobilize heparin. The amines measured in untreated scaffolds 
were due to the reaction of isocyanate endgroups with water. During this reaction 
amine groups can be formed. This reaction happens most likely during the stringent 
washing after the aminolyse step. However, these “background” amines are not able 
to result in successful cross-linking of heparin as shown with the immunofluorescence 
analysis since without this first step no heparin could be detected. 
For successful tissue engineering of in vitro seeded constructs it is important that 
cells will adhere, proliferate and synthesize extracellular matrix. With respect to the 
biological effects of the heparin coating, we showed that the surface hydrophilicity 
Figure 3: Aminolyzed and heparin cross-linked PU 
films show significant lower contact angle, meaning 
an increased hydrophilicity (p=0.006, n=5).
Figure 4: Young’s Modulus after 50% compression. 
Aminolyzed and heparin cross-linked scaffolds have 
lower Young’s moduli compared to native scaffold 
(p=0.003, n=6).
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increased, indicated by the lower contact angle. This increase in hydrophilicity 
potentially result in a faster ingrowth of cells and tissue when cultured or implanted. 
Furthermore, other studies showed that heparin coated on polymer scaffolds 
increased neo-vascularization when implanted subcutaneously15. This increase in 
neo-vascularization can boost tissue regeneration even further. 
In this study aminolysis caused a reduction in mechanical stiffness of nearly 
50%. Cross-linking of heparin to the free amine had no further effect on mechanical 
stiffness. If this coating technique would be used for a cell based tissue engineered 
construct, this effect on mechanical properties seems to be less important since it 
has been shown that cell based constructs will increase in modulus over time due to 
matrix production by the seeded cells16. To increase matrix synthesis by cells, future 
research should focus on growth factor binding to heparin. An interesting growth 
factor for cell based tissue engineered constructs is TGF-β. It is known that TGF-β 
has heparin binding sites and, in addition, can induce proliferation of a wide range 
of cell types17,18. Other growth factors with heparin binding sites are amongst others: 
VEGF, EGF, BMP and FGF15,19.  In contrast, if this construct would be used for a 
cell-less application, mechanical stiffness could be increased by reducing overall 
porosity of the scaffold. However, decreasing porosity of the scaffold is known to 
compromise cell migration and tissue regeneration20.
In conclusion, this two step reaction results in a surface coating of heparine on a PU 
scaffold. Special care has to be taken to find a balance between mechanical properties 
and surface adaptation. For each specific application in which these functionalized 
scaffolds will be used, the porosity of the scaffold should be considered.
 
-48-
3
REFERENCE LIST 
1. Marois Y, Guidoin R. Biocompatibility of Polyurethanes. In: Vermette P, Griesser HJ, Laroche G, Guidoin R, 
editors. Biomedical Applications of Polyurethanes. Georgetown: Landes Bioscience; 2001. p 77-96.
2. Hsieh CH, Kuo WT, Huang YC, Huang YY. High-efficiency cell seeding method by relatively hydrophobic 
culture strategy. J Biomed Mater Res B Appl Biomater 2011;98(1):38-46.
3. Zhu Y, Gao C, Liu X, Shen J. Surface modification of polycaprolactone membrane via aminolysis 
and biomacromolecule immobilization for promoting cytocompatibility of human endothelial cells. 
Biomacromolecules. 2002;3(6):1312-1319.
4. Chang KY, Cheng LW, Ho GH, Huang YP, Lee YD. Fabrication and characterization of poly(gamma-glutamic 
acid)-graft-chondroitin sulfate/polycaprolactone porous scaffolds for cartilage tissue engineering. Acta 
Biomater. 2009;5(6):1937-1947.
5. Zhu Y, Chian KS, Chan-Park MB, Mhaisalkar PS, Ratner BD. Protein bonding on biodegradable poly(L-
lactide-co-caprolactone) membrane for esophageal tissue engineering. Biomaterials 2006;27(1):68-78.
6. Zhu Y, Gao C, Liu X, He T, Shen J. Immobilization of biomacromolecules onto aminolyzed poly(L-lactic acid) 
toward acceleration of endothelium regeneration. Tissue Eng 2004;10(1-2):53-61.
7. Stringer SE, Gallagher JT. Heparan sulphate. Int J Biochem Cell Biol 1997;29(5):709-14.
8. Gunja NJ, Athanasiou KA. Passage and reversal effects on gene expression of bovine meniscal 
fibrochondrocytes. Arthritis Res.Ther. 2007;9(5):R93.
9. van Minnen B, van Leeuwen MB, Stegenga B, Zuidema J, Hissink CE, van Kooten TG, Bos RR. Short-term 
in vitro and in vivo biocompatibility of a biodegradable polyurethane foam based on 1,4-butanediisocyanate. 
J Mater Sci Mater Med 2005;16(3):221-7.
10. Chang KY, Hung LH, Chu IM, Ko CS, Lee YD. The application of type II collagen and chondroitin sulfate 
grafted PCL porous scaffold in cartilage tissue engineering. J.Biomed.Mater.Res.A 2009.
11. Pieper JS, Hafmans T, Veerkamp JH, van Kuppevelt TH. Development of tailor-made collagen-
glycosaminoglycan matrices: EDC/NHS crosslinking, and ultrastructural aspects. Biomaterials 2000;21(6):581-
93.
12. Nuininga JE, Koens MJ, Tiemessen DM, Oosterwijk E, Daamen WF, Geutjes PJ, van Kuppevelt TH, Feitz 
WF. Urethral reconstruction of critical defects in rabbits using molecularly defined tubular type I collagen 
biomatrices: key issues in growth factor addition. Tissue Eng Part A 2010;16(11):3319-28.
13. van Kuppevelt TH, Dennissen MA, van Venrooij WJ, Hoet RM, Veerkamp JH. Generation and application 
of type-specific anti-heparan sulfate antibodies using phage display technology. Further evidence for heparan 
sulfate heterogeneity in the kidney. J.Biol.Chem. 1998;273(21):12960-12966.
14. Das T, Sharma PK, Krom BP, van der Mei HC, Busscher HJ. Role of eDNA on the adhesion forces between 
Streptococcus mutans and substratum surfaces: influence of ionic strength and substratum hydrophobicity. 
Langmuir 2011;27(16):10113-8.
15. Singh S, Wu BM, Dunn JC. The enhancement of VEGF-mediated angiogenesis by polycaprolactone scaffolds 
with surface cross-linked heparin. Biomaterials 2011;32(8):2059-69.
16. Talukdar S, Nguyen QT, Chen AC, Sah RL, Kundu SC. Effect of initial cell seeding density on 3D-engineered 
silk fibroin scaffolds for articular cartilage tissue engineering. Biomaterials 2011;32(34):8927-37.
17. de Mulder EL, Hannink G, Giele M, Verdonschot N, Buma P. Proliferation of meniscal fibrochondrocytes 
cultured on a new polyurethane scaffold is stimulated by TGF-ss. J Biomater Appl 2011.
18. McCaffrey TA, Falcone DJ, Du B. Transforming growth factor-beta 1 is a heparin-binding protein: identification 
of putative heparin-binding regions and isolation of heparins with varying affinity for TGF-beta 1. J Cell 
Physiol 1992;152(2):430-40.
19. Ashikari-Hada S, Habuchi H, Kariya Y, Itoh N, Reddi AH, Kimata K. Characterization of growth factor-binding 
structures in heparin/heparan sulfate using an octasaccharide library. J Biol Chem 2004;279(13):12346-54.
20. van Tienen TG, Heijkants RG, Buma P, de Groot JH, Pennings AJ, Veth RP. Tissue ingrowth and degradation 
of two biodegradable porous polymers with different porosities and pore sizes. Biomaterials 2002;23(8):1731-
8.
-49-
3
-50-
-51-
Chapter 4
 
Platelet rich plasma can replace 
foetal bovine serum in human 
meniscus cell cultures 
Tissue Engineering, Part C, in press
Eric de Mulder #
Veronica Gonzales #
Trix de Boer
Gerjon Hannink
Tony van Tienen
Waander van Heerde
Pieter Buma
# both authors contributed equally
-52-
4
 ABSTRACT  
Concerns over foetal bovine serum (FBS) limit the clinical application of cultured 
tissue engineered constructs. Therefore we investigated if platelet rich plasma (PRP) 
can fully replace FBS for meniscus tissue engineering purposes. 
Human PRP and platelet poor plasma (PPP) were isolated from three healthy 
adult donors. Human meniscal fibrochondrocytes (MFCs) were isolated from 
resected tissue after a partial meniscectomy on a young patient. Passage 4 MFC’s 
were cultured in monolayer for 24 hours, 3 and 7 days. Six different culture media 
were used containing different amounts of either PRP and PPP and compared to a 
medium containing 10% FBS. dsDNA was quantified and gene expression levels 
of collagen types I and II and aggrecan were measured at different time points with 
qPCR in the cultured MFCs. 
After 7 days the dsDNA quantity was significantly higher in MFCs cultured in 10% 
and 20% PRP compared to the other PRP and PPP conditions, but equal to 10% FBS. 
Collagen type I expression was lower in MFCs cultured with medium containing 5% 
PRP, 10% and 20% PPP compared to FBS. When medium with 10% PRP or 20% PRP 
was used, expressions were not significantly different from medium containing 10% 
FBS. Collagen type II expression was absent in all medium conditions. Aggrecan 
expression did not show differences between the different media used. However, 
after 7 days a higher aggrecan expression was measured in most culture conditions, 
except for 5% PRP, which was similar compared to FBS. Statistical significance 
was found between donors at various time points in DNA quantification and gene 
expression, but the same donors were not statistically different in all conditions. At 7 
days cell cultured with 10% PRP and 20% PRP showed a higher density, with large 
areas of clusters, compared to other conditions. 
In MFC culture medium FBS can be replaced by 10% PRP or 20% PRP without 
altering proliferation and gene expression of human meniscal fibrochondrocytes. 
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INTRODUCTION  
Meniscal tears are one of the most common injuries of the knee joint. Only tears 
in the red vascularized outer 1/3 zone can repair spontaneously. Spontaneous repair 
of tears in the white avascular inner 2/3 zone, however, is limited due to lack of 
vascularization1,2. Treatment for meniscal tears depends on type, size and location 
of the tear. Preferably tears will be sutured to the main body of the meniscus to 
maintain the integrity of the meniscus. If fixation is impossible or fails, a (partial) 
meniscectomy can be considered to relieve pain and improve function of the knee 
joint. However, with increasing portion of meniscus tissue removed, the risk of early 
osteoarthritis increases due to overloading of the articular cartilage3,4. For partial 
meniscectomized knees two clinical available scaffolds, Menaflex™ and Actifit®, 
are used to replace the lost part of the meniscus. They have been shown to improve 
the clinical performance to some extent5-7. A biomechanical analysis showed that 
the Actifit implant restores contact mechanics8. For total meniscus replacements a 
caprolactone-urethane based scaffold appeared mechanically too weak to cope with 
the high forces in the joint and cartilage degradation was not prevented9,10. Tissue 
engineering would potentially resolve the problem of scaffolds that are initially too 
weak to be implanted. 
Meniscus tissue engineering will lead to improved biological and functional 
mechanical properties of the pre-seeded scaffold11. Meniscal fibrochondrocytes 
(MFCs) have shown to be suitable cells for meniscus tissue engineering12. MFCs can 
be easily isolated from resected meniscus tissue of the patient itself thereby avoiding 
immunological responses and providing the proper phenotype4. Furthermore, MFCs 
have been shown to enable in vitro meniscus tissue engineering12,13. 
In research for tissue engineering applications foetal bovine serum (FBS) is 
widely used as a supplement to standard cell culture media to induce proliferation 
and matrix synthesis of a variety of cells. However, the potential risk of bovine 
pathogens in FBS serum limits its use in clinical applications14,15. An alternative for 
FBS is therefore urgently needed. Platelet rich plasma (PRP) could potentially be 
a good alternative for FBS. Platelets contain a variety of growth factors, of which 
TGF-beta, IGF, VEGF and PDGF are the most abundant16-20. PRP has been shown to 
stimulate the repair of a wide variety of soft and hard musculo-skeletal tissues such as 
bone, muscle, skin, tendon and cartilage21,22. In a number of tissue engineering studies 
the effect of various PRP volume percentages supplemented to medium on MFCs, 
chondrocytes and subchondral mesenchymal progenitor cells was investigated23-26. 
Ishida et al studied the effect of PRP (3%, 10% and 30%) on rabbit MFCs in culture 
and showed increased proliferation and matrix synthesis compared to their FBS 
control23. Currently there are three concentrations of FBS used for meniscus cell 
cultures: 1%, 10% and 20%19. However 10% FBS has been most widely used in 
meniscus fibrochondrocyte cultures19,20,24,27-29.
The objective of this study was to determine if and which volume concentrations 
(5%, 10%, 20%) of PRP can be used as a functional substitute for the standard 10% 
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FBS in meniscus fibrochondrocyte cell culture medium.  
MATERIALS AND METHODS  
Cell Isolation 
Meniscal tissue was obtained during a partial meniscectomy on a young physically 
very active male donor (age 18). MFCs where isolated from the meniscus tissue 
according to previously described protocols13. Isolated MFCs were washed twice 
with PBS and expanded in monolayer culture. Once cells reached 70% confluence 
the cells were passed once and subsequent confluent cell cultures were trypsinized 
and cryopreserved until use. All cell cultures were performed in a 5% CO2, 37OC 
controlled incubator with standard culture medium. Standard culture medium was 
defined as DMEM/F12 + 10% FBS + 1% PSF (penicillin/streptomycin/fungizone, 
Gibco, Carlsbad, CA, USA). 
Platelet Rich Plasma and Platelet Poor Plasma 
Blood samples were collected from healthy human donors (n=3) after informed 
consent was obtained. Peripheral venous blood was collected in 4.5ml hirudin 
containing blood collection vials (S-Monovette, Sarstedt AG & Co. Numbrecht, 
Germany) to avoid any influence of platelet-dependent Protease Activating Receptor 
(PAR) signalling by thrombin30,31. One half of whole blood was centrifuged at 200g 
for 15 min to obtain PRP, the other half at 2750g for 15 minutes to obtain PPP. 
After centrifugation, the upper phase containing PRP and PPP respectively, were 
transferred and pooled for each donor. Whole blood, PRP and PPP were measured 
with fluorescent flow cytometry to quantify platelet concentration (Sysmex XE-
5000; Hamburg-Norderstedt, Germany). PRP and PPP were stored at -20 °C until 
use. PRP samples were not normalized for platelet count. 
Cell culture experiment 
MFCs were defrosted and expanded in monolayer till passage 3 in standard culture 
medium. Afterwards, cells were trypsinized medium was added to neutralize trypsin, 
counted (with trypan blue exclusion and DMEM/F12), seeded (50,000 MFCs per 
well) in 24-well plates and cultured overnight in standard culture medium containing 
FBS. Following overnight culture, cells were washed twice with DMEM/F12 and 
subsequently experimental culture medium was added to each well. Seven different 
experimental culture media were tested. Base medium was DMEM/F12 + 1% PSF 
with one of the following conditions: 10% FBS, 5%, 10%, or 20% PRP or 5%, 10% 
or 20% PPP (v/v). PRP and PPP vials of each donor were defrosted only once before 
use. MFCs were cultured for 24 hours, 3 and 7 days in triplicate for each donor. 
On day 3 and day 6 the experimental medium was refreshed with corresponding 
experimental culture medium. 
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 Picogreen analysis 
After 24 hours, 3 and 7 days of culture, cells from each experimental culture 
medium (n=3) were frozen in MilliQ (-20°C). After repeated freeze/thaw cycles, 
PicoGreen dsDNA assay kit was used according to manufacturer’s protocol to 
quantify the amount of dsDNA (Invitrogen, Carlsbad, CA, USA). 
RNA isolation and gene expression 
After 24 hours, 3 and 7 days, trizol (Sigma-Aldrich, MO, USA) was added 
to the cells of each condition (n=3) and stored at -80°C. RNA was isolated via 
standard chloroform phase separation32. The supernatant was isolated and RNA was 
precipitated with isopropanol, washed twice with 75% ETOH, air dried, solubilised 
in RNAse free water and subjected to reverse transcriptase polymerase chain reaction 
(RT-PCR) to obtain cDNA. Finally, a quantitative PCR (qPCR) was performed on 
individual samples by an “ABI/PRISM 7000 sequence detection system” (Aplied 
Biosystems, Foster City, USA). qPCR was prepared as follows: 1µl forward primer 
(5µM), 1 µl reverse primer (5µM) and 5 µl of Sybr Green PCR Master mix (Applied 
Biosystems, Foster City, USA) were added to 3µl cDNA. qPCR was performed for 
40 cycles. Three specific gene expression markers for meniscus tissue engineering, 
i.e. collagen type I and II, and aggrecan, were measured with GAPDH as household 
gene (see table 1 for primer sequences). The Ct value shows the point in which the 
amplification plot passes the threshold, due to the release of the fluorescence from 
mRNA transcription. GAPDH was the internal control for all genes and used to 
normalize delta Ct levels for any variability in cell numbers. Delta delta Ct levels 
were calculated by subtracting the delta Ct level of the gene of interest from the delta 
Ct level of the control (FBS). The fold change in the gene expression relative to the 
control was calculated using the equation 2-ΔΔCt. FBS is designated with a dashed 
line at 1 on the y-axis, as seen in Figure 2 and 3. All primers were validated in the 
Rheumatology department at Nijmegen Centre for Molecular Life Sciences33.
 
Gene forward primer (5’ → 3’) reverse primer (5’ → 3’)
Collagen type I CAAGGAGTCTGCATGTCTAAGTGCTA ACTCTTGTAAAGAAATTGGCATGTTG
Collagen type II CACGTACACTGCCCTGAAGGA CGATAACAGTCTTGCCCCACTT
Aggrecan GCCTGCGCTCCAATGACT ATGGAACACGATGCCTTTCAC
GAPDH ATCTTCTTTTGCGTCGCCAG TTCCCCATGGTGTCTGAGC
Table 1: primer sequences used for real-time PCR. Primers were obtained from Biolegio bv, Nijmegen, 
Netherlands. 
 
Histology 
Monolayer cell cultures were fixated after 24 hours, 3 and 7 days in their wells, 
stained with haematoxylin and eosin and mounted using Permacol UV (Permacol, 
the Netherlands) (n=3). All samples were analyzed with light microscopy and 
photographed with an Olympus digital camera at the same magnification. 
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Statistics 
All data were expressed as mean ± SEM. Picogreen data were log transformed 
and subjected to a Two-Way ANOVA with a post-hoc Fisher-LSD test. For qPCR, 
delta Ct levels were subjected to Two-Way ANOVA with a post-hoc Fisher-LSD 
test. P-values < 0.05 were considered significant. Statistical analysis was performed 
using SPSS v16.0 software (SPSS Inc., Chicago, IL, USA). Statistical analysis of 
the Picogreen and qPCR data was completed in two steps. In the first Two-Way 
ANOVA the effect of condition and the time points on dsDNA or gene expression 
was analysed with the donors pooled. The second Two-Way ANOVA analysed the 
effect of donor and condition on time points. 
RESULTS  
Platelet count 
 Platelet concentrations were measured in whole blood, PRP and PPP from each 
donor. The platelet concentration in whole blood was on average 131±26 x109/L 
(donor 1: 148 x109/L, donor 2: 105 x109/L, donor 3: 141 x109/L). For PRP average 
platelet count was 140±20 x109/L (donor 1: 165 x109/L, donor 2: 98 x109/L, donor 3: 
162 x109/L). In PPP platelet concentrations were not detectable in all three donors.  
DNA quantification 
The average amount of dsDNA in cells cultured for 24 hours and 3 days in 
standard medium containing 10% FBS was 51.5 ± 1.7 ng/ml and 90.1 ± 7.9 ng/
ml, respectively. During these time points no differences were measured between 
conditions or in time as a condition (p>0.050, data not shown). However, at 7 days 
of culture a significant increase of dsDNA was measured compared to 24 hours 
and 3 days cultures. In addition, significant differences between culture conditions 
were measured. Cells grown in medium containing FBS, 10% and 20% PRP had 
a significant higher amount of dsDNA compared to all other conditions at 7 days 
(Figure 1). Statistical significance between donors was found only at 7 days; dsDNA 
in cells cultured with plasma of D2<D3=D1 (respectively, 55.2, 76,4, 64,9 ng/ml). 
The average minimum and maximum values of donors pooled dsDNA are presented 
in table 2. 
Figure 1: Average dsDNA of all donors after 7 days of 
monolayer cell culture (n=3). A significant increase 
of 10% and 20% platelet rich plasma was measured 
compared to all platelet poor plasma concentrations 
(p<0.05). When 5% of platelet rich plasma was used, 
dsDNA was significantly lower compared to the 
control (FBS).
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Time point Condition Min value dsDNA (ng/ml) Max value dsDNA (ng/ml)
24hour PRP 5% 14.2 93.1
10% 25.0 105.5
20% 50.7 103.7
PPP 5% 17.6 118.7
10% 21.3 123.8
20% 38.1 88.2
3 days PRP 5% 29.9 75.4
10% 46.0 83.1
20% 42.8 88.0
PPP 5% 40.9 100.7
10% 35.3 88.7
20% 36.7 77.1
7 days PRP 5% 23.0 99.5
10% 64.2 354.1
20% 77.0 376.0
PRP 5% 19.0 48.3
10% 30.0 92.0
20% 38.0 90.8
Gene expression 
mRNA of Collagen type I in cells cultured for 24 hours was up-regulated 
compared to 3 and 7 days (time: p < 0.050, Figure 2). Furthermore, there was a 
significant difference between the different media and control medium containing 
10% FBS at 3 and 7 days (Fig. 2B and 2C). At 3 days Collagen type I mRNA in 
cells cultured with medium containing 5% PRP was significantly up-regulated if 
compared to media containing 10% and 20% PRP (Figure 2B). At 7 days of culture 
no differences in collagen type I expression were found between the different culture 
conditions. All PRP and PPP conditions were down-regulated at 7 days in collagen 
type I expression (Figure 2C). No donor-specific differences were measured at 24 
hours and 7 days in collagen type I expression. However, at 3 days D2<D3 (p<0.050) 
and D1=D2 and D3 (p=0.062 and 0.097, respectively).
Expression of collagen type II mRNA was late or not detected at all time points 
for all treatments (Ct>40, data not shown). 
Aggrecan showed to have stable expression for all cells independent of plasma 
supplement and culture time (Figure 3). Although at 7 days all treatments, except 
5% PRP, were up-regulated by a minimum of 6-fold increase (Figure 3C, p=0.096). 
Donor variability for Aggrecan expression was significantly different after 24h (D1 
< D2 = D3, p<0.050) and 3 days (D3 > D1 = D2, p<0.050) but absent at 7 days of 
culture (p=0.166).
Table 2: The minimum and maximum values of dsDNA (ng/ml) in DNA quantification in all PRP and PPP 
conditions of pooled donors.
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Histological analysis 
At 24 hrs MFCs were distributed homogeneously throughout the well plate 
(Figure 4). Locally small clusters of cells were present in each condition. At 24 hours 
of culture cells reached an approximate 20% confluence and their phenotype was 
mainly fibroblast like or spindle shaped if located individually and more rounded 
Figure 2: MFC related gene expression of collagen 
type I at 24 hours, 3 and 7 days expressed in fold 
change (A, B and C respectively, n=9). At 3 days 
medium containing 10% PRP and 20% PRP showed a 
statistical significance compared  to FBS, designated 
with an *. The A represents  statistical significance 
between 5% PRP and a specific condition. At 7 days 
of culturing in medium containing 5% PRP, 10% PPP 
and 20% PPP collagen type I was  significantly later 
expressed compared to FBS. FBS is designated with a 
dashed line at 1 on the y-axis, all the conditions were 
adjusted to FBS.
Figure 3: MCF-related gene expression of aggrecan 
at 24 hours, 3 and 7 days expressed in fold change 
(A, B and C respectively, n=9). No significant 
differences between treatments were measured. FBS 
is designated with a dashed line at 1 on the y-axis, all 
the conditions were adjusted to FBS.
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/ chondrocyte-like if cells were clustered. The phenotype changed at 3 days of 
culture. More cells were clustered. Cells in the centre of the clusters were rounded, 
towards the edges of the clusters and isolated cells showed to be mainly spindle 
shaped / fibroblast like. Cells reached an approximate confluence of 40%. At 7 days 
the phenotype remained spindle shaped / fibroblast-like, however, differences in 
confluence were observed. Cells cultured with 10% PRP and 20% PRP showed a 
higher density (approximately 70% confluence) with large areas of clusters that were 
fused together, compared to other conditions (40%-50% confluence). No differences 
between donors were observed (results not shown). 
Figure 4: Haematoxylin & Eosin histological analysis of MFCs in 24 hours, 3 days and 7 days in all conditions. 
-60-
4
DISCUSSION  
Tissue engineering appears to be a promising treatment option for (partial) 
meniscus replacement34. In most meniscal tissue engineering studies FBS is used 
as a potent supplement in the culture medium23,34. However, clinical application of 
FBS in a cultured construct is not allowed because of the risk of disease transfer 
or xeno-immunization14,15. In the present study, we showed that concentrations of 
10% and 20% of PRP as an alternative for FBS supplementation, induce similar 
effects for proliferation and gene expression on cultured meniscal fibrochondrocytes 
as compared to the standard medium containing 10% FBS. 
PRP can easily be isolated from patients’ own blood or donors. Surprisingly in 
this study, the platelet concentrations did not increase from whole blood to PRP. This 
could be related to the method used for PRP isolation. Differences in centrifugation 
speed, the vials used and centrifugation time have shown to influence final platelet 
concentrations in PRP22,35-38. Further, during centrifugation platelets might be trapped 
in the buffy coat located between the RBCs and plasma. Since we observed that in 
hirudin blood vials, as were used in this study, the buffy coat was thinner compared 
with citrate blood vials, we speculate that this might be one of the reasons for the 
relative low platelet counts. Hirudin also inhibits PAR signalling by thrombin which 
also might be a factor to cause a thinner buffy coat30,31.
We showed that proliferation of MFCs remained similar until 3 days, but at 7 days 
differences in cell numbers were found between conditions. Supplements of 10% 
and 20% PRP strongly showed an increase in the number of cells compared to PPP 
samples. Therefore the effects can be related to the platelet content and not solely 
to the plasma. Furthermore this effect seems platelet concentration dependent since 
the effect was not observed at 5% PRP. Ishida et al. studied also PRP concentration 
dependent effects on meniscus fibroblasts. They investigated short-term effects (48 
hrs) of PRP and PPP on the vitality of cultured meniscus cells23. After a pre-culture 
of 24 hrs in 10% FBS, cultures were continued for 24 hrs in 1% FBS supplemented 
with 3, 10, 30% PRP or similar concentrations of PPP23. PRP concentrations up-
regulated the viability of meniscus cells in a dose dependent manner after 48 hrs. 
A clear comparison with our data is difficult since the study of Ishida et al. was 
shorter (48 hrs), the control was 1% FBS and the PRP sand PPP was added to this 
1% FBS23. In our study we compared the effect of PRP and PPP to 10% FBS and 
studied increase in cell numbers based on DNA and not vitality of the cells. In an in 
vivo model they described a positive effect of PRP on defect healing in the meniscus 
compared or PPP, but no details were included about the concentration of PRP or 
platelets that accounted for this positive effect23. 
Collagen type I was initially up-regulated in 5% PRP as well as 5% and 10% PPP 
at 24 hours. However, in time collagen type I was down-regulated in both PRP and 
PPP compared to FBS at 3 and 7 days. Collagen type II was not expressed in our 
experiment, which might be due to MFCs were used at passage 4 according to Gunja 
et al.39. Collagen type II expression decreases as the passage number increases39. 
-61-
4
Aggrecan at 24 hours and 2 days had similar or lower expression than that of FBS 
in all conditions of PRP and PPP. However, at 7 days aggrecan was up-regulated 
in 10% & 20% PRP and all PPP concentrations compared with FBS. The 5% PRP 
concentration was comparable to the 10% FBS control. This shows that potentially 
in the PPP and RRP serum interesting factors are present that can influence the 
expression of fibrochondrocyte specific genes independent from the effect of the 
platelets. Since it is well known that meniscus fibroblast change their phenotype in 
cultures at increasing passages28,39, further research in specific factors in PPP and 
PRP might be beneficial for future meniscus tissue engineering. Our result also 
differs from the reported decreased aggrecan expression in PRP conditions reported 
by Ishida et al.23. A possible explanation for this discrepancy in the amount of 
aggrecan expression might be that the metabolic half-life of aggrecan is much shorter 
compared to collagen40. We speculate that the age of the MFCs might play a crucial 
role, since aggrecan expression increases after puberty41. McAlinden et al. stated 
that aggrecan in the meniscus is important to withstand compressive forces41. The 
increased amount of aggrecan expression in our results maybe a combined effect of 
the age of the subject and the fact that the donor was physically very active. Karube 
and Shoji already showed that GAG content of menisci decreases with aging42. The 
age of the rabbits of the study of Ishida was not mentioned in their paper and further 
detailed studies are needed to clarify this. 
There are not many studies which describe a clear effect of PRP and PPP on 
cell proliferation. Mazzocca et al. studied the effect of PRPs obtained by different 
separation methods on osteoblasts, monocytes and on tenocytes22. They compared 
the effects of three different PRP isolation procedures on proliferation (assessed by 
thimidine incorporation). They found a similar positive effect of all PRPs compared 
to 2, 5, 10 or 15% BSA which was used as a control (dependent on the cell type). 
The different PRP had all a stimulatory effect on the proliferation of the investigated 
cell types compare to the FBS controls, but since they mixed PRPs with 2% FBS in 
the final test their results did not allow the conclusion that PRPs can replace FBS 
completely. 
Besides an effect on proliferation PRP might stimulate the migration and 
differentiation of cells. Kruger et al. showed that PRP can stimulate the migration 
of subchondral progenitor cells and stimulate a chondrogenic differentiation of the 
stem cells26. This might also explain the positive effect on gap healing as described 
by Ishida et al. by PRP added to an a-cellular gelatine hydrogel23. 
Collagen type II expression remained undetermined at all times points. This lack 
of expression can be due to improper mRNA isolation. However, based on published 
results in which collagen type II expression was clearly detectable in chondrocytes 
cells with the same set of primers, it is more likely due to a low or a lack of 
expression of collagen type II in these cells33. It has been reported that differences in 
stimulation or culture conditions can influence the expression of collagen type matrix 
proteins28. In an engineered meniscus construct, the final extracellular matrix should 
predominantly consist of collagen type I similar to that of the native meniscus tissue. 
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Although, other collagens such as collagen type II, III and VI have been shown to be 
present in the meniscus as well43. 
Some differences in responsiveness between donors were measured at the earlier 
time points for collagen type I and aggrecan expressions, while results between 
donors levelled out at 7 days of culture. Despite the fact that platelet number may be 
responsible for these observed variations, a large study reported a poor correlation 
between platelet counts and specific growth factor concentrations18,44. However other 
studies demonstrated a clear effect between the growth factor content of platelets and 
the biological activity which was induced45. Further, it is well known that besides the 
growth factors platelets contain a variety of other proteins or chemokines which also 
might influence the reaction of cells or tissues46. 
In conclusion, medium supplemented with 10% and 20% PRP can replace standard 
medium supplemented with 10% foetal bovine serum in meniscal fibrochondrocytes 
culture while maintaining proliferation and gene expression levels. This opens new 
perspectives with respect to the clinical utility of MFC in tissue engineering and the 
use of PRP as autologous supplement. 
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ABSTRACT 
It has been generally accepted that tissue engineered constructs should closely 
resemble the in-vivo mechanical and structural properties of the tissues they are 
intended to replace. However, most scaffolds produced so far were isotropic porous 
scaffolds with non-characterized mechanical properties, different from those of the 
native healthy tissue. Tissues that are formed into these scaffolds are initially formed 
in the isotropic porous structure and since most tissues have significant anisotropic 
extracellular matrix components and concomitant mechanical properties, the formed 
tissues have no structural and functional relationships with the native tissues. The 
complete regeneration of tissues requires a second differentiation step after resorption 
of the isotropic scaffold. It is doubtful if the required plasticity for this remains 
present in already final differentiated tissue. It would be much more efficacious if the 
newly formed tissues in the scaffold could differentiate directly into the anisotropic 
organization of the native tissues. Therefore, anisotropic scaffolds that enable such 
a direct differentiation might be extremely helpful to realize this goal. Up to now, 
anisotropic scaffolds have been fabricated using modified conventional techniques, 
solid free-form fabrication techniques, and a few alternative methods. In this review 
we present the current status and discuss the procedures that are currently being used 
for anisotropic scaffold fabrication.
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INTRODUCTION 
Damage to the tissues of the musculoskeletal system often result in failure to 
repair or the formation of regenerated tissue of inferior mechanical quality. Tissue 
engineering (TE) and regenerative medicine (RM) apply the principles of biology, 
embryology and engineering to develop functional substitutes for these damaged 
tissues. TE and RM typically involve implanting cells, with or without stimulating 
growth factors, into some form of supporting structural device, the so-called scaffold. 
The cells are allowed to grow, differentiate, and produce new tissue with their own 
specific extracellular matrix (ECM). In time, the formed tissue should also replace 
the space occupied by the scaffold. After resorption of the scaffold, the tissue formed 
should remodel into tissue with a large resemblance to the native tissue. This can be 
before or after implantation into the patient. In some cases the in-vitro culture period 
can be omitted and the scaffold can replace the deceased tissue directly, utilizing the 
host’s own body as a ‘bioreactor’. Cell harvest, scaffold seeding and implantation can 
then be performed in a single surgical event1. Taking this approach one step further, 
the scaffolding material can be inserted without cells. In this case, regeneration 
relies totally on the recruitment of native cells into the implanted scaffold and the 
subsequent deposition of an ECM2. Another option is the incorporation of cells 
directly into the scaffold during the scaffold fabrication process3. No matter which 
strategy is used, the scaffold itself is critical to the success of the construct, and in 
most cases actively directs the behavior of the cells within the scaffold. 
Factors governing scaffold design are complex and include considerations of 
scaffold architecture, pore size and pore morphology, mechanical properties, surface 
properties, degradation speed, and degradation products. The scaffold architecture 
and surface properties should enhance initial cell attachment and allow efficacious 
seeding into the entire scaffold, or if this is difficult, migration into the scaffold. The 
scaffold should enhance the mass transfer of metabolites, provide sufficient space for 
remodeling of the newly formed tissue matrix and the development of vascularization. 
Furthermore, it must provide sufficient mechanical strength, particularly initially 
before the new tissue has matured into functional tissue. In other words, the scaffold 
degradation profile should be designed in a way it supports the construct during the 
remodeling process. Factors affecting the rate of remodeling include the type of 
tissue, and the anatomy and physiology of the host tissue. 
A variety of materials have been used to produce scaffolds for the replacement and 
repair of damaged or traumatized musculoskeletal tissues. These materials include 
metals, ceramics, natural and synthetic polymers, and their combinations. In this 
review we will focus only on polymers. Both natural and synthetic polymers have 
been studied for use as scaffold materials in both TE and RM. Natural polymeric 
scaffolds have been produced from processed ECM constituents, such as collagen, 
elastin or hyaluronic acid. Natural polymeric scaffolds may also be produced from 
polymers derived from plants (alginate) or insects (chitosan). The most frequently 
used synthetic polymers are poly(lactic acid) (PLA), poly(glycolic acid) (PGA), 
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poly(lactic-co-glycolic acid) (PLGA), poly(caprolactone) (PCL) and copolymers 
of these materials4-7. Generally, these materials have been approved for human use 
by the Food and Drug Administration. In addition, their degradation rates can be 
tailored to match that of new tissue formation. PLA is more hydrophobic and less 
crystalline than PGA and degrades at a slower rate, while PCL degrades even slower. 
The degradation rate of the polymers can be easily controlled by altering the ratio 
of the different copolymers in the  formulation, by changing the chain-length of the 
monomers or by changing the cross-linking density4,8. In addition to degradation rate, 
certain physical characteristics of the scaffold must be considered when designing a 
substrate to be used in TE. In order to promote tissue growth, the scaffold must have 
a large surface area to allow cell attachment. This is usually done by creating highly 
porous scaffolds. In these foam-like scaffolds, the pores should be large enough and 
interconnected with each other to allow cells to penetrate deeply into the scaffold and 
to facilitate nutrient and waste exchange by cells deep inside the scaffold. Moreover, 
the scaffolds should have appropriate mechanical properties to provide temporary 
support within a specific application. These characteristics are often dependent on 
both polymer and method of scaffold fabrication. 
Several methods have been developed to create highly porous scaffolds, including 
particle leaching9,10, gas (CO2) foaming11, freeze-drying12, thermal induced phase 
separation (TIPS)13,14, liquid/liquid phase separation in combination with freeze 
extraction15, electrospinning16, and particle sintering17,18. Also combinations of these 
techniques have been described19. More sophisticated tissue engineered constructs 
may utilize polymer scaffolds as a delivery vehicle for cells or bioactive proteins. 
Recently, a new class of scaffolds has been described in which synthetic polymers 
have been coated or blended with natural polymers20,21.
Although these conventionally produced scaffolds hold great promise and have 
been applied to engineer a variety of tissues with varying success, most are limited 
by some flaws, which restrict their scope of applications22. In addition, the processing 
methods offer little capability to precisely control pore size, pore geometry, pore 
interconnectivity, spatial distribution of pores, and construction of internal channels 
within the scaffold. The major limitation of the conventionally fabricated scaffolds is 
their isotropic nature. The tissue that is formed into the pores of an isotropic scaffold is 
a negative or mirror image of the scaffold itself, and since most tissue has significant 
anisotropic arranged extracellular matrix components and concomitant mechanical 
properties, the tissue formed has no structural and mechanical relationship with 
the native tissue23. For complete regeneration of the tissue a second differentiation 
step is needed during and after resorption of the isotropic scaffold. It is doubtful if 
such a plasticity can be expected from already final differentiated tissue. It would be 
much more efficacious if the newly formed tissues in the scaffold could differentiate 
directly into the anisotropic organization of native tissues. Anisotropic scaffolds with 
a porous, tubular or other structure, that enable direct differentiation into the native 
tissue configuration might be extremely helpful to realize this goal.
The introduction of solid free-form (SFF) technologies have initiated the start 
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of a new exiting and revolutionary era for scaffold design and production22. SFF 
techniques are computerized fabrication techniques that can produce highly 
complex, layer-by-layer build, three-dimensional physical objects, using data 
generated by computer aided design (CAD) systems or computer-based medical 
imaging modalities. The most promising techniques to generate scaffolds with a 
highly anisotropic pore structure are SFF technologies, such as 3D fiber deposition 
(3DF), fused deposition modeling (FDM), bioplotting, stereolithography (STL), and 
selective laser sintering (SLS), but also modified “conventional” techniques, such as 
modified thermal induced phase separation (modified TIPS) and electrospinning. In 
this review we will present the current status and discuss the procedures which are 
currently in use for anisotropic scaffold production.
SOLID FREE-FORM FABRICATION 
Solid free-form technologies, also commonly known as rapid prototyping (RP), 
are computer aided manufacturing (CAM) techniques that can rapidly produce 
highly complex three dimensional physical objects using data generated by computer 
aided design (CAD) programs, or converted from computerbased medical imaging 
modalities, such as MRI and CT24,25. Unlike conventional computerized machining 
processes, which involve the removal of materials from a stock, SFF techniques use 
the underlying concept of layered manufacturing whereby three-dimensional objects 
are fabricated with layer-by-layer building via the processing of solid sheet, liquid or 
powder material stocks22. The flexibility and outstanding manufacturing capabilities 
of SFF have been employed for biomedical applications, such as production of scale 
replicas of human bones26, body organs27, and advanced customized drug delivery 
devices28. The direct utilization of CAD models as inputs for scaffold fabrication 
allows complex scaffold designs to be realized. Patient specific data and scaffold 
structural properties required for regenerating specific tissues can be incorporated 
into scaffold design via CAD. The application of CAD strategies in conjunction 
with SFF fabrication will allow scaffolds with highly uniform pore morphologies, 
unlimited range of pore sizes, porosities and complete pore interconnectivity 
to be realized with unprecedented accuracy and consistency for patient specific 
application22. In addition, SFF techniques employ a diverse range of processing 
conditions which include solvent and/or porogen free processes and processing at 
room temperature. Some SFF techniques allow pharmaceutical and biological agents 
to be incorporated into the scaffold during fabrication28-30. The utilization of CAD 
will also allow scaffolds with optimized mechanical and structural properties to be 
fabricated. The following sections will focus on SFF techniques that have been used 
for fabricating anisotropic scaffolds.
3D fiber deposition / fused deposition modeling
3D fiber deposition and FDM are similar techniques. The majority of 3DF/FDM 
techniques are nozzle-based systems. Polymers are thermally processed when they 
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pass a nozzle and are deposited as a relatively thick fiber on a collector plate. After 
deposition on the collector plate, the fibers cool down, solidify and the scaffold 
is ready for use (Figures 1A, 1B). Fiber diameter can be controlled by changing 
parameters, such as nozzle diameter, deposition speed, extrusion speed and viscosity 
of the polymer, and can range between 170-750 μm31-33. A wide range of polymers, 
including hydrogels, have been used in 3DF/FDM34-37. However, most of the 
produced scaffolds have an internal isotropic organization. Each successive layer is 
deposited under a different angle, creating a specific lay-down pattern38,39. Most used 
lay-down patterns are 0/90º, 0/45/90/135º and 0/60/120º. The compressive stiffness 
of the scaffold can range from 4 - 80 MPa, depending on the lay-down pattern, fiber 
thickness, and the polymers used for fabrication38. Using a 0/45º lay-down pattern, 
the compressive stiffness in the z plane is different compared to the compressive 
stiffness in the x/y plane, thereby resulting in mechanical anisotropy. Anatomically 
3D fiber deposited trachea, menisci and vertebra have recently been fabricated from 
patient-derived computer-based medical imaging modalities25,35,40. In addition, shell/
core fibers have been produced by exploiting viscous encapsulation, a rheological 
phenomenon in polymeric blends flowing through narrow ducts41. Furthermore, by 
printing fibers directly aligned in one layer followed by a semi-open layer, anisotropic 
scaffolds with aligned channels can be created (unpublished data). In this way, also 
nutrient supply in the deeper zones of the scaffolds could be facilitated42.
Bioplotter
Bioplotting was first described by Wilson and Boland43. They modified a 
commercial inkjet printer into a custom-made bioplotter. After cleaning the ink 
cartridges, the containers were refilled with solutions containing marker proteins 
(y-biotine, steptavidine, streptavidine-BSA and BSA) or with endothelial or smooth 
muscle cells. The resolution of this technique has been shown to be approximately 
25-50 μm in both the x and y directions43,44. Using this technique, complex structures 
containing viable cells after printing have been produced45. However, after printing 
a 25% cell death was observed43. It has been shown that cell death could be strongly 
reduced by avoiding dehydration of the cells after printing by increasing the water 
content of the gels in which the cells are encapsulated43,46,47. Incorporation of growth 
factors or other biological cues, such as calcium phosphates, specific adhesive 
peptides, and collagen can modulate cell function and degradation of the scaffold34. 
In this way, an instructive microenvironment for embedded or seeded cells can be 
created48. Cohen et al. were able to fabricate a geometrically complex structure 
in the shape of a meniscus using alginate as scaffold material44. However, so far, 
no anisotropic scaffolds have been fabricated using bioplotting. Using multiple 
cartridges, zonal distribution of multiple cell types and biological cues anisotropic 
scaffolds should be relatively easily achieved34.
Stereolithography
Stereolithography is the oldest RP technique49. It is based on spatially controlled 
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photopolymerization of a liquid resin by a laser. As the resin only solidifies where 
illuminated, a specific pattern can be created in one single layer. By repeating 
this process, three-dimensional structures can be built in a layer-by-layer manner 
(Figures 1C, 1D)50,51. In conventional STL machines one laser beam is used for 
photopolymerization. However, recently new systems have been developed which 
use two lasers in the near infrared spectrum, the so-called two photon polymerization 
technique (2PP)52-55.
A prerequisite for polymers to be used in STL are end-groups that can be 
polymerized by light3,50,54-60. Epoxy resins are very popular for the generation of non-
resorbable STL molds. These molds are used to shape polymers into conventional 
made scaffolds for various tissue engineering or regenerative medicine purposes61-63. 
Two resorbable materials are particularly interesting for STL scaffold production. 
First, scaffolds based on poly-DL-lactic acid (PDLLA) are very popular for bone 
tissue engineering. A second very promising material that has been recently 
introduced is poly(propylene fumarate) (PPF)64,65. Hydrolysis of the ester bonds 
allows PPF to degrade into fumaric acid and propylene glycol, both of which are 
non-toxic products55. Scaffolds made from PFF have mechanical properties in the 
MPa range (15-40 MPa) and are also suitable for bone tissue engineering.
The accuracy of STL is dependent on a number of parameters. The most important 
ones are the machine, the method (one photon versus two photon polymerization)49,53,54, 
the laser power53,65, the scan speed65, and the length of the laser beam path into the 
polymer66. In general, commercial STL machines have a resolution in the order of 
200–250 μm. Some claim a resolution of 75 μm or even lower but then they might 
fail to create open pores59. Others claim even accuracies of 10–100 μm, however this 
has been shown to be the ultimate limit of accuracy with conventional machines54. 
The penetration depth, and by that the accuracy in the z-direction, may be increased 
by adding specific dyes to the polymer which reduce the penetration depth of the UV 
beam. With conventional STL the layer thickness can then be reduced from 29 to 7 
μm66. The structural resolution of 2PP polymerization is in general much higher and 
can be even lower than 100 nm53,54.
A matter of attention is the matching between CAD files and the produced scaffold 
structures. Shrinkage of resins used for STL is a general phenomenon and might be 
up to 25%64,65. However, if the shrinkage is isotropic, which is generally the case, 
the CAD files might be adapted to the expected percentage of shrinkage of a specific 
polymer with a good matching as a result3,65. Generally, the difference between the 
CAD file and the produced structure will not exceed 0.5%. For porous scaffolds the 
differences between CAD files and the produced pores have been described to be 
larger, ranging from 0.2% for the large pores to 8.3% for the very small pores65.
Amongst the pitfalls in STL are diluting the polymers before the polymerization 
process and the use of non-reacted chemicals after polymerization66. Diluting the 
polymers negatively influences the mechanical properties of the produced structures67. 
Non-reacted chemicals inside the scaffold can potentially cause problems if they 
are not adequately removed from the fabricated structures. Particularly non-reacted 
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photo-initiator might be cytotoxic68. The use of biocompatible non-reacted polymers 
and non-reactive diluents would be a solution66.
Functional studies on STL scaffolds are scarce. Engelmayer et al. have shown 
that pore dimensions influence collagen orientation and deposition by rat skin 
fibroblasts69. Using 2PP STL, sub-micron needle like structures have been produced 
on which the reaction of fibroblast cells (NIH-3T3) and epithelial cells (MDCK) 
has been shown to be dependent on the pattern of actin microfilament bundles in 
the cells. For bone TE scaffolds with channels were produced to study the optimal 
channel diameter to facilitate cell ingrowth70. Functional animal studies related to 
the in-vivo tissue reactions are very scarce. The group of Jansen studied the soft and 
hard tissue response to photo-crosslinked PPF scaffolds in a rabbit model58. These 
scaffolds appeared to induce a mild inflammatory reaction in both tissue types. A 
powerful future application might be the blending of cells into SLT scaffolds during 
photopolymerization56.
MODIFIED CONVENTIONAL TECHNIQUES 
Conventional methods for manufacturing scaffolds include particle leaching9,10, 
gas (CO2) foaming11, freeze-drying12, thermal induced phase separation 
(TIPS)13,14, liquid/liquid phase separation in combination with freeze extraction15, 
electrospinning16, and particle sintering17,18. However, there are inherent limitations 
in these processing methods. These methods offer little capability to control pore size, 
pore geometry, pore interconnectivity, spatial distribution of pores and construction 
of internal channels within the scaffold71. Consequently, it has been tried to modify 
the conventional techniques to overcome these inherent process limitations17,72-75. 
The following sections will focus on modified conventional techniques that have 
been used to fabricate anisotropic scaffolds.
Modified thermal induced phase separation (TIPS)
A commonly used procedure to create porous polymer scaffolds is TIPS. This 
technique is based on the principle that a homogeneous polymer solution made at 
elevated temperature is converted via the removal of thermal energy (cooling) into 
two-phase separated domains. Through extraction, evaporation or sublimation the 
solvent containing phase will be removed and give rise to the pores of the scaffold. 
Two different phase separations have been described, namely solid-liquid and 
liquidliquid phase separation. In solid-liquid phase separation the temperature is 
lowered to solidify the polymer solution. The solvent will form crystals and thereby 
separate the polymer from the solvent. Finally, the crystals are removed which exposes 
the pores. In the second method, liquid-liquid phase separation, phase separation is 
based on a polymer-rich and a polymer-lean phase. The solvent part will be present 
in the polymer lean phase which will be processed further to create the pores in the 
scaffold14,76. For example, polymers such as PLA and PLGA are diluted in dioxane/
water in the desired polymer concentration and subsequently cooling down of the 
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polymer induces the phase separation. A porous foam-like scaffold is available after 
removal of the solvent in a freeze-dryer. The formed scaffolds have a randomly 
distributed isotropic pore structure77-79.
In the modified TIPS a uni-axial thermal gradient is applied between top and 
bottom instead of uniformly cooling during the phase separation step (Figures 1E, 
1F)80. Via insulation of the walls of the polymer/solvent container a longitudinal 
temperature gradient is created resulting in longitudinal crystal formation. The result 
is a scaffold containing micro-channels instead of pores, which are orientated in a 
top to bottom direction. The diameter of these micro-channels can range between 
15–240 μm72,81,82. The diameter can be controlled by changing the thermal gradient 
and/or the proportion polymer/solvent. Using a higher thermal gradient and higher 
polymer concentration the diameter of the channels has been shown to decrease. 
The micro-architecture of the channels can be influenced by the type of solvent 
used. Using benzene as a solvent, microtubules will be open, while with dioxane 
the channels have ladder-like structures72,80. The anisotropic structural properties of 
the scaffold is reflected in higher compressive modulus and yield strength in the 
longitudinal direction compared to the transverse direction72,80. Culture studies show 
that cells grow along the direction of the microtubules and synthesize oriented neo-
tissue83. Modified TIPS has also been applied to natural polymers such as collagen. 
A temperature gradient between bottom and top of the container, according to 
the Bridgman technique84, resulted in an ice front growth in an opposite direction 
than the temperature gradient85. Applying this temperature gradient to collagen 
suspensions resulted in unidirectional collagen scaffolds, also with some ladder-like 
characteristics86-88. The channels were in the range 20-40 μm and were predominantly 
controlled by the temperature gradient and solvent type (either ethanol or acetic 
acid). The scaffolds can be molded in discs or tube like shapes. It should be noticed 
that after polymerization skin formation can occur on the edge, thereby limiting cell 
penetration into the scaffold.
Electrospinning
A conventional method for fiber deposition is electrospinning. Using a high 
voltage/low current a very thin fiber (tenths of nanometers) can be produced from 
a polymer droplet, which is directed toward a grounded counter plate electrode, 
the so-called collector plate. On a static collector plate the fibers will be displayed 
in a random orientation. Scaffolds can be fabricated in various different tubular 
configurations with different surface patterning using different shaped, static 3D, 
columnar patterned collectors89. With help of a rotating cylinder or rotating disc type 
collector it is possible to produce orientated/aligned fibers (Figures 1G, 1H)90,91. It 
has been shown that fiber diameter and degree of fiber alignment can determine the 
behavior of cells16. Cells orientate themselves and migrate into the direction of the 
fiber orientation with higher proliferation and synthetic rates92,93. Aligned nanofibers 
seeded with ligament fibroblasts induced more elongated fibroblasts compared to 
randomly orientated fibers, and these cells also produced more collagen compared to 
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cells on non-aligned scaffolds94. Multiple spinneret tips with different polymers can 
create multilayer scaffolds95. These layers can also be separated by seeded cells. Using 
different cell types in between layers, complex 3D structures with living cells have 
been produced96. With a set-up using a syringe-inside-a-syringe core/shell nanofibers 
Figure 1. (A) Schematic representation of 3D fiber deposition (3DF)/Fused deposition modeling (FDM). (B) 
SEM micrographs of a PCL scaffold with varying multiple-layer design prepared using 3DF/FDM, showing 
a scaffold architecture with (i) a 0/60/120° laydown pattern for the top part, (ii) a nonporous structure for the 
middle part, and (iii) a 0/90° lay-down pattern of the bottom part of the scaffold. Reproduced and modified 
with permission from Hutmacher et al. 99. Copyright John Wiley & Sons, Inc. (C) Schematic representation of 
stereolithography (STL). (D) SEM micrographs of a STL prepared scaffold, showing (i) a single-layer scaffold, 
and (ii) a multilayered scaffold. Reproduced and modified with permission from Mapili et al. 59. Copyright John 
Wiley & Sons, Inc. (E) Schematic representation of modified thermal induced phased separation (TIPS). (F) SEM 
micrographs of the uniaxial microtubular scaffolds prepared using modified TIPS, showing (i) a cross-section 
of a scaffold prepared from 2.5% (w/v) polymer/benzene under liquid nitrogen, (ii) a longitudinal section of this 
scaffold, (iii) a cross-section of a scaffold prepared from 3.0% (w/v) polymer/benzene under liquid nitrogen, 
and (iv) a longitudinal section of this scaffold. Reproduced and modified with permission from Chen et al. 
72. Copyright John Wiley & Sons, Inc. (G) Schematic representation of modified electrospinning. (H) SEM 
micrographs of scaffolds prepared with electrospinning, showing (i-iii) aligned nanofibers, and (iv) uniaxially 
aligned nanotubes. Reproduced and modified with permission from Li et al. 100. Copyright Wiley-VCH Verlag 
GmbH & Co. KGaA.
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have been created97. This technique is has also been used to produce aligned collagen 
nanofiber scaffolds with a similar cellular response to fiber orientation as described 
above98. 
ALTERNATIVE METHODS TO CREATE ANISOTROPIC SCAFFOLDS 
Using the techniques outlined above, the production of aligned channels in a 
scaffold has been realized. However, most of the above mentioned techniques are 
technically demanding. Alternative methods might be cheaper, more easy to use, 
or useful if the size of features in the scaffolds is limited by the resolution of the 
technique. Therefore, a number of alternative methods have been proposed to 
incorporate aligned channels into the general structure of the scaffold. Some of these 
alternative methods can be applied directly during scaffold polymerization, while 
others are applied after polymerization as a post-processing step.
Direct methods
Most polymers are in the liquid phase before molding. Using arrays of needles 
and/or wires placed in the mold, porous scaffolds with aligned channels can easily 
be fabricated. The diameter of these channels depends on the thickness of the 
needles and/or wires used. The architecture can vary on the needle array applied99,100. 
Unfortunately, removal of the needles and/or wires after polymerization has been 
shown to damage these scaffolds. To prevent damage, coated wires and/or needles 
have been used101. After polymerization of the scaffold, the coating on the wires 
or needles can be dissolved, facilitating the removal of the wires and/or needles. 
An alternative approach is to use wires that can dissolve completely18,101. Nazhat 
et al. incorporated unidirectional aligned soluble 30–40 μm diameter phosphate 
glass fibers (PGFs) into dense compacted collagen scaffolds102. The degradation 
time of PGFs can range from minutes to years depending on their chemistry. Their 
biocompatibility has been demonstrated with a number of cell types103,104. In addition, 
the use of phosphate glass particles as reinforcing agents, and eventually as porogens 
through their degradation in synthetic biodegradable composites, has been carried 
out in PCL105,106 and lactide107,108 matrices developed for drug delivery and tissue 
engineering. Therefore, PGFs might also be used as channel-creating devices in 
synthetic biodegradable composites. Besides solvable wires or retracting wires, it 
is also possible to leave the wires inside the scaffold but then the effect of creating 
access for mass transport is lost109.
Another direct method to create anisotropic scaffolds is the use of conventional 
porogens, such as sugar, salt, alginate, or bovine serum albumin micro-bubbles110-113. 
Capes et al. have managed to arrange sugar strands in a mold114. Subsequently, the 
polymer solution was casted over the sugar strands, and after polymerization the 
strands were washed out. Similar methods can be applied using other porogens like 
paraffin, sodium alginate and/or gelatine115.
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Post-processing methods
Various methods have been described to create channels in scaffolds after 
polymerization. Silva et al. produced an array of aligned 400 μm thick channels 
into a random, porous PDLLA scaffold structures using a computer controlled drill 
system100. Using relatively thin polymer sheet, excimer laser ablation has been used 
to create specifically sized channels in polymer scaffolds116-119. For musculoskeletal 
tissue engineering purposes stacking these single-layer sheets might be an option. 
Recently, Vishnubhatla et al. have fabricated micro-channels in fused silica by 
femto-second laser irradiation120. They have created cylindrical micro-channels with 
uniform cross-sections and a length of 4 mm. As mentioned above, Capes et al. used a 
traditional solid porogen technique for the fabrication of PGLA scaffolds114. Besides 
the use of close-packed sugar strands to create a 3D polymer scaffold with multiple 
aligned channels, they also created single-layer scaffolds using sugar spheres. Multi-
layer scaffolds were created by stacking the single-layer to form a 3D structure. 
Also known porogens such as, paraffin, sodium alginate, and gelatine might be used 
to create anisotropic scaffolds using single-layer stacking. Using phase separation 
micromolding, Papenburg et al. reported a one-step method to fabricate highly 
porous micro-patterned polymer 2D scaffold sheets121. These 2-D micropatterned 
sheets can be built into a 3-D scaffold by multi-layer stacking immediately after 
casting. Residues of the solvent still present in the sheets enabling the layers to bond. 
Stacking was achieved through two different methods: by either clamping several 
films between glass-plates or rolling up one or more sheets around a tube. By tuning 
size of the channels and the sheet thickness, the scaffold architecture can be designed.
DISCUSSION 
Tissue engineered biomaterials should ideally bear close resemblance to the in 
vivo mechanical and structural properties of the tissues that they are intended to 
replace. Since mechanical loads can vary spatially and temporally within the tissues 
of an organ, they exhibit complex, mechanically anisotropic behaviors optimized for 
their respective physiological functions122.
Many tissues in the musculoskeletal system, particularly those that bear 
mechanical loads in a defined direction, exhibit preferential fiber alignment123. 
This alignment endows such tissues to functional properties that vary depending 
on the testing direction. For example, in tendons and ligaments, tensile properties 
are 200-500 times higher along, compared to perpendicular to, the fiber direction124. 
In articular cartilage, tensile properties are greatest in the superficial zone along the 
split line direction125,126. In the meniscus, circumferentially oriented collagen fibers 
predominate127, resulting in higher tensile properties in the circumferential compared 
to the radial direction128-130. When damage occurs, the architecture is interrupted and 
the ability of the tissue to withstand load is compromised. As such, the architecture 
must be one of the first considerations when engineering replacement constructs131.
Using conventional scaffolds, it has been shown that the tissues formed had 
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no relationship with the native tissue but were oriented into the direction of the 
isotropic distributed pores23. Differentiation of the newly formed tissue directly into 
the anisotropic organization of the native tissue would be much more efficacious. 
Therefore, one of the considerable challenges remaining in the field of tissue 
engineering is to produce a construct with an anatomically correct architectural 
framework, both in terms of cell morphology and matrix deposition123.
The use of SFF techniques will allow control over localized pore morphologies 
and porosities to suit the requirements of different cell types within the same scaffold 
volume. This is achieved by incorporating different controllable macroscopic and 
microscopic design features on different regions of the same scaffold. Depending on 
the TE strategy used, this can be realized either using negative anisotropic scaffolds, 
positive anisotropic scaffolds, or a combination of both. Negative anisotropic 
scaffolds, often referred to as “mirror imaged” scaffolds, are fabricated based on 
guidance or entubulization TE strategies. Newly formed tissues growing into the 
scaffold will be guided and subsequentially differentiate directly into the anisotropic 
organization of the native tissues (indirect) 72,80,82,83,88,101. On the other hand, positive 
anisotropic constructs are fabricated directly into the anisotropic organization of 
the native tissue, resembling the hierarchical structure of multiple cell types, and/
or ECM compounds, such as collagen and elastin34,45,96,132. Scaffolds consisting of 
aligned fibers were found to possess controllable anisotropic mechanical properties 
and to dictate cellular morphology, with cell polarity following the prevailing fiber 
direction123. Under conditions of maximal fiber alignment, meniscal chondrocytes 
attached to these scaffolds and their directionality was prescribed in both the short 
and long term culture. It has previously been shown in organized monolayer cultures 
that fibroblasts deposit an organized ECM according to cell orientation133, and that 
ligament fibroblasts on an aligned fiber meshes produce more collagen than on 
random meshes94.
A common problem encountered when using conventional scaffolds for tissue 
engineering is the rapid formation of tissue on the outer edge, leading to the 
development of a necrotic core due to limitations of cell penetration and nutrient 
exchange100,134,135. Most tissues possess a network of blood and capillary vessels that 
perform this function in vivo, but engineering such a complex construct in vitro has 
been shown to be quite challenging136,137. Even avascular tissue, such as cartilage, has 
been shown challenging to engineer since the in vivo nutrient supply still cannot be 
adequately simulated in vitro134. A common approach used to overcome this issue is 
to utilize sophisticated culture systems or bioreactors to perfuse culture media around 
and/or through the scaffold138-140. Although these bioreactors have been successful, 
even in an optimized in vitro culture system, there is still a need to ensure tissue 
growth occurs evenly throughout the construct. Furthermore, for strategies where the 
scaffold alone will be implanted and the body is used as bioreactor, it is important 
to ensure that native tissue can infiltrate the whole scaffold to ensure adequate 
integration of the construct141. Another strategy to encourage tissue formation and 
cell differentiation within scaffolds, in vitro or in vivo, is to incorporate biological 
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factors, such as growth factors, ECM compounds, or pharmaceutical agents which 
can also act as chemotactic factors to encourage cell migration and differentiation142.
Patient specific data and scaffold structural properties required for regenerating 
specific tissues can be incorporated into scaffold design via CAD, often referred to 
as ‘reverse engineering’22. SFF techniques can be easily automated and integrated 
with these imaging techniques to produce scaffolds that are customized in size and 
shape allowing tissue engineered grafts to be tailored for specific applications or 
even for individual patients143. In musculoskeletal applications, so far, these patient 
specific scaffolds have been used for the reconstruction of cranial144,145, calvarial146, 
and maxillofacial defects147.
A key factor used to enhance the versatility of scaffold fabrication by SFF is 
construction of a scaffold matrix using a wide variety of biomaterials143. One 
emerging method is to fabricate a negative mold based on the scaffold design and cast 
the scaffold using desired polymeric and/or ceramic biomaterials. This alternative 
technique is known as ‘indirect’ SFF. Based on a lost mold technique by combining 
epoxy resin molds made by stereolithography and CAD data HA scaffolds with 
interconnecting pores have been created148. Despite a few fabrication inaccuracies, 
in-vivo experiments demonstrated osteoconductivity and biocompatibility in a 
minipig model. In addition, a series of biomimetic scaffolds have been fabricated 
by mold removal in combination with conventional sponge fabrication149. The 
fabricated scaffolds had interconnected pores ranging from 500–800 μm as specified 
by the prefabricated mold, and when local pores were formed they ranged from 
10–300 μm depending on the local pore creating method. Similarly, an indirect SFF 
method for ceramic scaffolds with a defined and reproducible 3D porous architecture 
has been developed150. They reported ectopic bone formation for all scaffold and cell 
constructs. Manufacturing of collagen based scaffolds by using the SFF technique to 
fabricate a mold has also been reported151.
The main restriction on casting with the conventional techniques was the inability 
to create molds to produce complex geometries and internal architecture but with 
indirect SFF conventional casting processes with these molds can meet specific tissue 
engineering requirements143. Indirect SFF allows use of a wider range of biomaterials 
or combinations of materials, such as composites and/or copolymers. However, 
some drawbacks still exist with this technology, including the use of organic solvents 
and the resolution of the SFF method. For example, the cast model copies errors 
and defects from the mold, such as cracks and dimensional changes. In addition, a 
method has to be developed to remove the mold precisely while preserving the cast 
scaffold intact without compromising its properties143.
 
CONCLUSIONS 
Although many options are available to fabricate anisotropic scaffolds for 
musculoskeletal tissue engineering, each method has its own set of strengths and 
weaknesses. For all techniques described, the choice of scaffold material seems to be 
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endless since almost every polymer, natural or synthetic, can be used in combination 
with the desired technique. However, it has to be ensured that choice of materials 
for the scaffold is compatible with the selected method. Important considerations 
that should be made during the selection of materials used for musculoskeletal 
tissue engineering include mechanical properties of the material, scaffold design, 
degradation profile, bioactivity and biodegradability, as well as issues of cell seeding 
and vascularization
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ABSTRACT 
Clinically used scaffolds are suboptimal in regenerating the highly oriented 
meniscus fiber structure in full meniscal defects. The objective of this study was to 
test whether anisotropic porous scaffolds with channels resulted in a more meniscus 
like matrix organization compared to isotropic porous scaffolds.
Isotropic polyurethane scaffolds were made via standard solvent leaching 
techniques. Anisotropic porous scaffolds with channels were made via modified 
thermal induced phase separation. Both scaffold types were analyzed with light 
microscopy, scanning electron microscopy and computed nano-tomography. Finally, 
isotropic and anisotropic scaffolds were bilateral subcutaneous implanted on the 
back of 32 Wistar rats for 1, 4, 8 and 24 weeks to assess tissue ingrowth and matrix 
organization.
Isotropic scaffolds had a pore diameter of 35±14.7µm  and a degree of anisotropy 
of 0.18, while anisotropic scaffolds had a channel diameter of 20±6.0µm and a degree 
of anisotropy of 0.39. After implantation full tissue ingrowth was achieved after 8 
and 24 weeks for isotropic and anisotropic, respectively. Isotropic scaffolds had a 
random tissue infiltration with unorganized collagen deposition, whereas anisotropic 
scaffolds showed tissue infiltration and collagen alignment in the direction of the 
channels. 
Anisotropic scaffolds resulted in a matrix organization that resembled the tissue 
in the vascularized zone of the meniscus, while isotropic scaffolds resembled the 
tissue in the avascular zone of the meniscus.
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INTRODUCTION 
Most tissues in the human body have anisotropic characteristics. Mainly 
musculoskeletal tissues, such as articular cartilage and the fibro-cartilage of the 
meniscus, show well-defined anisotropic properties. Generally, the anisotropy is 
presented in the organization of the extracellular matrix. With respect to the meniscus, 
large collagen type I fibers, which make up to 75% of the total protein content of 
the extracellular matrix, are oriented circumferentially1. Due to the anisotropic fiber 
arrangement, the meniscus is able to withstand high compressive forces and redirect 
them into tensile stresses with limited strains in circumferential direction2,3. This 
makes the meniscus efficient shock absorbers in the knee joint.
The meniscus has a poor vascularization, thereby its healing capacity is impaired 
depending on the location and the type of tear4. Therefore, surgeons will often 
proceed to (partial) removal of the injured meniscus if repair is unlikely. It is well 
understood that with an increasing amount of tissue being removed, peak forces 
on the articular cartilage increase, and thereby the risk of cartilage damage5-7. To 
prevent cartilage damage the resected part of the meniscus can be replaced with a 
scaffold. This meniscus scaffold will allow new tissue ingrowth into the resected part 
of the meniscus8,9. The ultimate aim of these scaffolds is that, after resorption of the 
scaffold, the newly formed tissue can restore the original functional behavior of the 
meniscus tissue. Two types of scaffolds for partial meniscus replacement/repair are 
now available for treatment of patients8,10. In case of a total meniscus replacement, 
the only available treatment option would be a transplantation of a donor meniscus. 
However, due to size matching issues these donor menisci have a limited availability. 
In a previous study, a polymer scaffold was tested as a material for total meniscus 
replacement11. The organization of the neo-tissue in this polymer scaffold was not 
similar to that in the native meniscus. The collagen bundles formed were orientated 
in a random way guided by the isotropic pore architecture of the scaffold11. The 
morphology was far different from the highly organized and anisotropic morphology, 
mainly present in the vascularized zone of the native meniscus. It is not known if the 
unorganized neo-tissue can re-differentiate into the anisotropic organized tissue of 
the native meniscus and how long this process would take12. To optimally replace a 
total meniscus a scaffold should promote anisotropic tissue formation similar to the 
tissue organization in the vascularized zone of the native meniscus. 
It has been shown that scaffolds with an anisotropic microgrooves promote cell 
alignment in culture13,14. Furthermore, these aligned cells are able to synthesize 
aligned extracellular matrix15. To enable the formation of aligned collagen bundles in 
vivo, as in the vascularized zone of the native meniscus, the first requisite is a scaffold 
with an anisotropic orientated pore structure. Preferentially the anisotropic channels 
inside the porous scaffolds should have diameters similar to that of the collagen fiber 
bundles in the meniscus. Numerous techniques are available to obtain anisotropic 
scaffolds depending on the material properties of the scaffold16. A scaffold material 
with promising characteristics for meniscus tissue engineering is polyurethane (PU) 
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made from P(D/L)LA and PCL7.
In this study we tested whether in vivo extracellular matrix orientation could be 
guided by scaffold pore architecture. We hypothesized that neo-tissue produced in 
channel-like porous anisotropic scaffolds would resemble meniscus tissue present in 
the vascularized zone. 
 
MATERIAL AND METHODS 
Scaffold preparation
Scaffolds were composed of 50% DL(50/50)-lactide (PDLLA, Purac) and 
50% ε-caprolactone (PCL, Acros Organics) by ring opening polymerization 
with 1,4-butanediol (BDO) as initiator. The final macrodiol prepolymer had a 
molecular weight (MN) of 2000 g/mole. Subsequently, this was end-capped with 
1,4-butanediisocyanate (BDI). Chain extension was performed with a BDO-BDI-
BDO urethane block which resulted in a hard block urethane segment with a uniform 
length of five urethane moieties. The final PU consisted of 22.5 w/w % hard urethane 
segments and 77.5 w/w % amorphous polyester soft segments. Polymer solutions 
were made of 5% polymer and 95% solvent to obtain 95% porous scaffold at the final 
stage. Isotropic scaffolds were prepared via solvent leaching as previously reported 
18. In short, polymer solution was casted in malls and subsequently frozen at -18OC. 
The frozen polymers were lyophilized at -18OC, 1 mbar, overnight to remove water 
and dioxane crystals. Anisotropic scaffolds were produced using thermal induced 
phase separation (TIPS)19-22. Polymers were solvent casted in a glass container with 
an isolating wall (Chapter 5, Figure 1E). This setup was placed on an alumina disc 
which was pre-cooled with liquid N2 and kept cooled with N 2 during polymerization 
to create a temperature gradient. After the polymer was frozen, samples were 
lyophilized similar to the isotropic scaffolds. 
Both porous materials were frozen in liquid nitrogen and cut with a surgical blade 
into rectangular blocks of 5x5x10mm. The anisotropic scaffolds had the channel 
orientation parallel to the longest axis of the rectangular blocks.
To evaluate the internal pore structure of the scaffold, scaffolds were inspected 
macroscopically with light microscopy. In addition, isotropic and anisotropic 
scaffolds were further analyzed with scanning electron microscopy (n=2) (JEOL 
JSM 6310, JEOL Ltd, Herts, UK) and computed nano-tomography (n=1) (nano-CT; 
SkyScan 2011, SkyScan, Kontich, Belgium). High-resolution (0.85 µm) scanning 
was performed at an energy of 40 kV and intensity of 180 µA. Specimens were 
attached to a stage that rotated 180° with images acquired every 0.3°. After scanning, 
cross-sectional slices were reconstructed (NRecon 1.6.3.2, SkyScan, Kontich, 
Belgium) and the degree of anisotropy (DA) and pore diameters were calculated 
from 250x250x250µm VOIs from the center of each specimen using BoneJ v1.3.5 
software23. 
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Collagen fiber measurement
 Menisci were isolated from 3 skeletal mature male New Zeeland White 
rabbits, 3 skeletal mature female Dutch milk goats (Capra Hircus Sana), and 1 
human male and 2 female knees (mean age 75yr). From each knee the lateral and 
medial menisci were isolated and fixated in 4% buffered formaldehyde. Animals 
were available from non-related research projects. Human knees were obtained from 
the Department of Anatomy of the Radboud University Nijmegen Medical Centre 
(Nijmegen, The Netherlands). All menisci used were from healthy knees without 
macroscopical signs of osteoarthritis. Subsequently, tissues were embedded in 
PMMA plastic for sectioning in the transversal plane. Sections were stained with 
picrosirius red staining and analyzed with polarized light microscopy. Of each 
meniscus three transversal sections were photographed and the diameters of ten 
circumferential collagen fiber bundles per section were measured using computer 
aided image analysis software (analySIS Soft Imaging System, GmbH, Münster, 
Germany).
Analysis of tissue ingrowth and polymer behavior
Isotropic and anisotropic scaffolds were inspected with light microscopy to verify 
the isotropic/anisotropic architecture. These scaffolds were disinfected three times 
with 70% ethanol and subsequently rinsed with sterile PBS. To rule out the influence 
of load on tissue orientation, the scaffolds were implanted subcutaneously. One 
isotropic and one anisotropic scaffold (with alternating location) were implanted 
bilaterally on the back of 32 male Wistar rats (weight range: 200-220gr). Rats were 
anesthetized with isoflurane and individual subcutaneous pockets were made with 
blunt scissors. Scaffolds were inserted and pockets were closed with surgical staples. 
Rats were housed under standard conditions with ad libitum food and water. After 1, 
4, 8 and 24 weeks follow-up, the rats were killed by CO2, the samples were retrieved 
and fixated in 4% buffered formaldehyde (n=8 per time point for both scaffold types). 
The animal experiment was approved by the institutional Animal Ethics Committee 
of the Radboud University. 
Ex vivo histology
Fixated samples were embedded in PMMA and cut in half. One half was sectioned 
(7µm thickness) in the coronal plane, the other half in the sagittal plane. Sections 
were stained with heamatoxilin/eosin (HE), Masson’s trichrome and picrosirius red. 
Sections were analyzed with normal and polarized light microscopy, respectively. To 
calculate the percentage of tissue ingrowth, photographs of one HE stained sagittal 
mid section per sample were recorded with an Olympus digital camera and analyzed 
using computer aided image analysis software. Tissue ingrowth was measured using 
a method previously described by Ramrattan et al.24.  In short, the total scaffold 
surface area and tissue ingrowth surface area were measured to calculate the 
percentage of tissue ingrowth.
-94-
6
Statistics
A two way ANOVA was used on all datasets with factors time (1, 4, 8, 24 weeks) 
and scaffold (isotropic, anisotropic). All data were expressed as mean ± SEM unless 
stated otherwise. For all experiments, differences were considered statistically 
significant for P values <0.05. Statistical analysis was performed using SPSS v18.0 
software (SPSS Inc., Chicago, IL, USA).
RESULTS 
SEM and nano-CT
SEM imaging showed a difference in pore structure between isotropic and 
anisotropic scaffolds (Figures 1A, 1C). The isotropic scaffold had random pores 
with small interconnective pores, whereas the anisotropic scaffolds showed a more 
channel-like pore structure with ladder like appearance. Nano-CT images confirmed 
these observations (Figures 1B, 1D). The DA was calculated to be 0.18 and 0.39 
for isotropic and anisotropic scaffolds, respectively. A lower value indicating a 
more isotropic structure while a higher value indicates a more anisotropic structure. 
Isotropic scaffolds had a mean pore diameter of 35.4 ± 14.7 (SD) µm with a maximum 
diameter of 68.9 µm, while anisotropic scaffolds had a mean pore diameter of 20.0 
± 6.0 (SD) µm with a maximum diameter of 39.7 µm.
Collagen fiber bundles
Diameter of collagen fiber bundles varied between species. Rabbit meniscus 
collagen fibers had a diameter of 25 ± 1.3 µm. For goat and human, collagen fiber 
bundle diameter was 65 ± 1.5 µm and 88 ± 4.0 µm respectively (Figure 2).
Histology
After one week a thin capsule had already been formed around the scaffolds. 
The first signs of tissue ingrowth into the scaffolds were seen. In isotropic scaffolds 
ingrowth was circumferentially present in larger pores which showed in many cases 
direct access to the capsule (Figure 3A). In the anisotropic scaffolds ingrowth was 
mainly seen in longer channels that were in direct contact with the capsule interface 
which was perpendicular to the long axis of the channel structure (Figure 3B). In the 
surface perpendicular to the channel structure no or very little ingrowth of tissue was 
found. Ingrown tissue consisted of fibroblasts that surrounded small capillary blood 
vessels (Figure 3B, 3C). In the channels in the anisotropic scaffolds fibroblast, and 
the synthesized matrix,  were already aligned in the direction of the channel. (Figure 
3C). In the isotropic scaffolds a more randomly organized tissue was found.  
After four and eight weeks more tissue was found inside the scaffolds. In the 
isotropic scaffold tissue penetrated the scaffold in a rather random way. In the 
anisotropic scaffolds tissue penetrated along the long channels and then filled small 
pores adjacent to each main channel (Figures 3D, 3E). A similar pattern of main 
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Figure 1: Scanning electron microscopy and nano-
CT images of isotropic and anisotropic scaffold in 
sagittal plane. Isotropic scaffold show a more random 
distribution of pores in both SEM (A) and nano-CT 
(B) images. Anisotropic scaffolds have a channel-like 
pore distribution. The walls of the channels have a 
ladder-like appearance visible in both SEM (C) and 
nano-CT (D) images. Scale bars represent 250µm.
Figure 2: Diameter of circumferential meniscal 
collagen fiber bundles from rabbits, goats and 
humans.
Figure 3: Histological HE sections of scaffolds after subcutaneous implantation. A: isotropic scaffold after 1wk 
implantation. B, C: anisotropic scaffolds after 1wk implantation with tissue infiltration via channels (*). D: 
anisotropic scaffold after 8wk of implantation showing tissue infiltration of the channels. E: anisotropic scaffold 
after 8wk implantation with collagen alignment. F: isotropic scaffold after 8wk of implantation with infiltration 
of pores with side-pockets. G: anisotropic scaffold after 24wk implantation with scaffold degradation(#). Scale 
bars represent 250µm.
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channels that branched in a regular way was found in the isotropic channels but here 
the main channels were not aligned as in the anisotropic scaffolds (Figure 3F). After 8 
weeks of implantation macrophages and giant cells were visible on the surface of the 
scaffold. Macrophage and giant cells were present in both isotropic and anisotropic 
scaffolds in same intensity but scaffold material was not located inside the giant 
cells. The capsule consisted of a thin layer of fibroblasts surrounded by fat tissue. 
After 24 weeks of implantation the 
scaffold shape integrity at a macroscopic 
scale was lost for both isotropic and 
anisotropic scaffolds as shown by a 
more flattened scaffold shape in sagittal 
sections. Both scaffold types were 
completely filled with tissue. The collagen 
structure was still present in both types of 
scaffolds and seemed not to be degraded 
by the macrophages (Figure 3G). More 
macrophages and giant cells were present 
in the tissue that had engulfed the degraded 
scaffold which was seen as foamy material 
in their cytoplasm. 
Figure 5. Picrosirius red stained (A, B, D, E, H), HE stained (G) and Masson trichrome stained (C, F, I) sections 
of scaffolds (A)–(F), follow-up period 24 weeks and of human meniscus (G)–(I). (A–C) Unorganized collagen 
formation in isotropic scaffolds. (D) Collagen alignment in anisotropic scaffold. (E) Collagen alignment in 
channels of anisotropic scaffolds with side-pockets. (F) Section of similar group but Masson trichrome stained. 
(G–I) Sections of the inner avascular part of a human meniscus. Notice the poor cellularity compared to the 24-
week scaffold (compare I with C and F). Scale bars represent 250 µm.
Figure 4: Tissue ingrowth in isotropic and 
anisotropic scaffolds after 1, 4, 8 and 24 week of 
subcutaneous implantation in rats. Sagittal sections 
were used to measure the tissue ingrowth area and 
the total scaffold area to calculate percentage of 
tissue ingrowth. After 4 and 8 wks of implantation 
percentage of tissue ingrowth was bigger in isotropic 
scaffolds compared to anisotropic scaffolds (* = 
p<0.005).
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After 1 week of implantation no difference in tissue ingrowth surface area 
was measured between the isotropic and anisotropic scaffold. After 4 weeks of 
implantation, tissue ingrowth surface area was 80% ± 3.6 versus 65% ± 5.2 for 
isotropic and anisotropic respectively (Figure 4). After 8 weeks all samples of the 
isotropic type have full tissue ingrowth while in the anisotropic scaffolds tissue 
ingrowth surface area was 83% ± 10.6. At 24 weeks of follow up both scaffold types 
showed complete tissue ingrowth. 
Collagen fiber formation was visualized by polarized light microscopy of the 
picrosirius red staining and compared with the Masson trichrome staining of scaffold 
and human native meniscus tissue (Figure 5). No clear birifringent matrix was seen 
in the tissue that was formed after 1 week. The isotropic scaffolds contained collagen 
fibers from 4 weeks onward and appeared in random orientation following the 
random pore structure (Figures 5A–5C). The anisotropic scaffolds showed collagen 
fiber content from 8 weeks onward and the  collagen fibers followed the typical 
pattern of the channels. In the main branches, the collagen orientation was aligned 
along the channels, whereas in the adjacent pores, the collagen was more randomly 
aligned in the pore structures (Figures 5D–5F). The collagen in the scaffolds was 
less organized and dense compared to the collagen in the inner avascular part of the 
human meniscus (Figures 5G–5I).
DISCUSSION 
The goal of this study was to produce and test anisotropic scaffolds for future 
total meniscus tissue engineering purposes. The PU composition of the scaffold used 
in this study has a number of novel aspects compared to other polymer scaffolds 
previously used for meniscus tissue engineering purposes or in clinical practice. The 
advantage of synthetic polymers above natural polymers such as collagen, is that the 
latter could induce an immunologic response25. In addition, the scaffold described in 
the present study has a 95% porosity compared to an approximately 80% porosity of 
most other scaffolds11,26. The high porosity and permeability is required to increase 
the surface area for cell attachment, tissue ingrowth, and to facilitate adequate 
transport of nutrients and cellular waste products27. With decreasing porosity and 
permeability, nutrient and waste exchange of cells in the deeper regions is limited, 
leading to necrotic sites in the center of the scaffold11. Another advantage of a high 
porosity is that it, in general, will lead to a higher speed of resorption as less polymer 
material has to be degraded. Reducing the time foreign materials remain present 
in the body has been shown to lower immunological responses. Furthermore, with 
smaller amounts of polymer material to be degraded, lower acidic levels will be 
reached. Higher acidity levels are known to reduce tissue regeneration speed28. 
The high porosity of the material used in our study thus aims to ensure a faster 
resorption rate, a low immunological risk, and a high tissue regeneration speed. In 
addition, the use of a co-polymer from caprolactone and both isomers of lactic acid 
-98-
6
exclude crystalline regions in this material. It has been described that the presence of 
crystalline regions results in highly stable remnants and an increased inflammatory 
risk in a late degradation stage29.
With this PU material scaffolds were produced using modified TIPS to obtain 
anisotropic scaffolds with a channel like structure. Channels showed a ladder-like 
structure. Channel structure has been shown to be production technique dependent. 
The use of different solvent types results in different channel structures. In the 
present study, dioxane was used as a solvent. Dioxane is known to produce ladder-
like channels. In contrast, open channels can be created when benzene is used as a 
solvent, however, using benzene the channel walls do not contain pores19. Further 
studies with solvent types are needed to optimize channel wall structure.
The channels obtained had a diameter in the range of 20 µm as measured on nano-
CT images. These channels are smaller compared to the diameter of the circumferential 
collagen fiber bundles in the vascularized zone of human menisci. However, in the 
mean diameter calculations also the abundant smaller interconnective pores were 
included. Therefore the mean diameter size is skewed towards the smaller size. 
When comparing to the maximum channel size diameter, 40 µm, it was more close 
to that of the human collagen fiber bundles, 88 µm, but still smaller. The significance 
of this observation is not yet clear. Smaller diameter collagen bundles which are 
formed inside the scaffold would indicate that the formed tissue might have inferior 
mechanical properties compared to the native meniscus tissue. However, with the 
scaffolds used, this study does not allow the formation of thicker bundles since the 
maximal fiber bundle diameter is determined by the diameter of the channels in the 
anisotropic scaffold. Though we speculate that if the scaffold degrades, the cell rich 
and vascularized tissues in the scaffold will allow growth of the bundles into more 
mature collagen bundles. This effect could be enhanced by the increased loading 
during the degradation of the scaffold. If a further differentiation does not occur 
during degradation of the scaffold, scaffold properties should be redefined related 
to the channel diameter. A possible method to increase channel diameter would be 
decreasing the temperature gradient or changing polymer to solvent ratio19,20,22. 
It was shown that the isotropic scaffolds, with larger pore diameter, were fully 
filled with ingrown tissue at an earlier time point. The anisotropic scaffolds took 4 
weeks longer till full tissue ingrowth was realized. Difference in ingrowth speed is 
well explained by the smaller pore size of the anisotropic scaffold. Smaller pores are 
known to reduce tissue infiltration speed30. 
Most importantly, this study showed that pore architecture indeed guided collagen 
deposition and orientation. The isotropic scaffold showed a random collagen 
organization. This organization closely resembles the avascular zone of the meniscus 
1. The channels of the anisotropic scaffold guided alignment of the collagen fibers, 
similar to collagen fibers in the vascularized zone of the meniscus. This process was 
not being limited by the diameter of the channels . These differences in neo-tissue 
formation in isotropic and anisotropic scaffolds could be of great potential for tissue 
engineering of a total meniscus when both isotropic and anisotropic architectures 
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will be combined in one scaffold. In addition to meniscus tissue engineering, this 
scaffold could potentially be used for tissues with highly anisotropic properties such 
as cartilage, bone, tendon and ligament tissue31.
At 8 weeks macrophages and giant cells were visible, presumable digesting the 
polymer, however, the scaffolds retained their shape. After 24 weeks of implantation 
both scaffold types lost their mechanical integrity and appeared deformed. Literature 
shows that scaffold integrity should be retained for at least 8 weeks to facilitate 
fibrocartilage differentiation32,33. The newly formed collagen fibers were not able 
to provide shape integrity at 24 weeks. This means that the construct is too weak 
for load bearing applications, such as total meniscus replacement. However, in 
this animal experiment loads were virtually absent, whereas in meniscus tissue 
engineering applications, the scaffold may be exposed to considerable loads and 
deformations. It is known that meniscus cells increase collagen synthesis and 
that matrix differentiation increases as a response to mechanical forces34,35. These 
mechanical stimuli together with the scaffold architecture could induce an oriented 
meniscus-like tissue which is optimized towards its (mechanical) function and 
should be the focus of future studies. 
 
CONCLUSION  
This study showed that collagen formation can be guided by scaffold architecture 
in a non load bearing environment. Isotropic and anisotropic architectures resulted 
in neo-tissue closely resembling the meniscus avascular and vascularized zones 
respectively.
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ABSTRACT 
Lesions in knee joint articular cartilage have limited repair capacity. Many 
clinically available treatments induce a fibrous-like cartilage repair instead of hyaline 
cartilage. To induce hyaline cartilage repair we hypothesized that type I collagen 
scaffolds with fibers aligned perpendicular to the articular cartilage surface would 
result in qualitatively better tissue repair due to improved cellular influx from the 
subchondral bone. 
By specific freezing protocols, type I collagen scaffolds with isotropic and 
anisotropic fiber architectures were produced. Rabbits were operated on bilaterally 
and two full-thickness defects were created in each knee joint. The defect was left 
empty or inserted with isotropic, anisotropic with pores parallel or perpendicular to 
the cartilage surface. After 4 (n=13) and 12 (n=13) weeks, regeneration was scored 
qualitatively and quantitatively using histological analysis and a modified O’Driscoll 
score.
After 4 weeks all defects were completely filled with partially differentiated 
hyaline cartilage tissue. No differences in O’Driscoll scores were measured between 
empty defects and scaffold types. After 12 weeks all treatments led to hyaline 
cartilage repair visualized by increased glycosaminoglycan staining. Total scores 
were significantly increased for parallel anisotropic and empty defects over time 
(p<0.05). Remarkably, after both 4 and 12 weeks trabecular bone was formed 
orientated parallel to the surface of the articular cartilage in a limited number of 
defects treated with perpendicular anisotropic scaffolds. 
The results indicate that collagen scaffolds induce hyaline-like cartilage 
repair. Fiber architecture had no effect on cartilage repair, however, perpendicular 
anisotropic scaffolds showed a tendency for improved subchondral bone formation.
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INTRODUCTION 
Articular cartilage (AC) is a highly organized avascular tissue composed of 
chondrocytes embedded within an extracellular matrix of collagens, proteoglycans 
(PGs) and non-collagenous proteins. Type II collagen forms the structural skeleton 
of the tissue, which resists both the pressure from the PGs and the shear stresses 
produced during joint movement. In the deep or radial zone of AC, collagen fibers 
run perpendicular in orientation in respect to the AC surface, before arching over 
in the intermediate or transitional zone. In the regions closest to the surface of the 
cartilage, the superficial or tangential zone, the fibers lie in a parallel orientation to 
the articular surface1,2. 
Focal chondral and osteochondral defects are common injuries with a great 
impact on the patient’s life. Most defects are located on the medial femoral condyle 
with a mean defect size of ca. 2 mm2 3. Repair of these AC defects is limited due 
to the low mitotic activity levels of chondrocytes and their dense extracellular 
matrix surrounding, limiting chondrocyte migration from adjacent healthy articular 
cartilage to the defect site4. In addition, articular cartilage lacks vascularization, 
limiting repair from non-chondrocytic cells. The general concept in the orthopedic 
community is that if injuries to the articular cartilage remain untreated, these injuries 
will progress into more generalized osteoarthritis. 
The most frequently used repair technique for focal articular cartilage defects 
is microfracturing (MF)5. With this technique small drill holes are made in the 
subchondral bone, which creates a route for stem cells to enter into the defect site. 
These cells can subsequently differentiate and produce a fibro-cartilage or hyaline-
like cartilage tissue type. This technique is cheap, simple and can be applied by 
all surgeons. However, studies with midterm follow-up periods, showed that the 
repair tissue after MF is of a fibrous instead of a hyaline tissue type6-8. From animal 
studies it is known that this fibrous tissue is mechanically inferior to native hyaline 
cartilage9. Moreover, it might result in poor physical and chemical bonding to the 
adjacent healthy AC. Both might result in progressive failure at longer follow-up 
periods4. Therefore, better repair strategies are urgently needed.
The quality of repair tissue might be improved with tissue engineering and/or 
regenerative medicine applications. A minimal invasive, cost effective optimization 
could be to fill defects with ‘smart’ scaffolds10. In this approach the subchondral 
bone should be penetrated as in microfracturing and thereafter defects could be filled 
with a scaffold optimized to attract, guide, stimulate and differentiate bone marrow 
derived stem cells originating from the subchondral bone. In this way, defects 
could be filled more rapidly with a higher quality repair tissue compared to MF11,12. 
Previously, scaffolds, based on type I or II collagen, have been described that guide 
cell migration from the bone marrow into the defect and stimulate cartilage matrix 
production13. Buma et al. showed that attachment of chondroitin sulphate to isotropic 
type I and II based collagen scaffolds could facilitate cartilage repair when implanted 
in the knee joint of rabbits. However, tissue migration was limited, particularly in the 
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type II scaffolds, and did not reach the full defect thickness even after 12 weeks14. 
Since it has been shown that tissue formation is guided by the orientation of collagen 
fibers of the scaffold15,16, we speculated that by filling defects with anisotropic 
scaffolds, the defects would be filled more rapidly. Moreover, if collagen is produced 
along the pore orientation of these anisotropic scaffolds, the quality of the articular 
repair tissue could be improved.
The aim of this study was to investigate the effect of anisotropic type I collagen 
scaffolds on articular cartilage repair. We hypothesized that anisotropic scaffolds 
implanted with the fiber orientation perpendicular to the surface of the cartilage 
would result in a more native like cartilage repair compared to random, isotropic, 
collagen scaffolds in a full-thickness articular cartilage defect in rabbits.  
MATERIALS & METHODS 
Scaffold production
Isotropic porous collagenous scaffolds were prepared by freezing and lyophilizing 
an acidic dispersion of insoluble bovine type I collagen in 0.25 M acetic acid 15,17. 
After lyophilisation, vapor fixation was performed with 38% formaldehyde under 
vacuum for 30 min. Vapor cross-linking reaction was stopped by quenching 
remaining aldehydes with 30 mM NaBH4 in 1 M sodium phosphate buffer pH 6.5 
for 1 hour at 4OC. Subsequently, scaffolds were crosslinked using 1- ethyl-3-(3-
dimethyl aminopropyl) carbodiimide (EDC) (Fluka Chemie, Buchs, Switzerland) 
and N-hydroxysuccinimide (NHS) (Fluka Chemie)18.
Anisotropic collagenous scaffolds were prepared using a freezing gradient, 
resulting in an orientation of the collagen lamellae parallel to the temperature 
gradient19,20. These scaffolds were also crosslinked using formaldehyde vapor, 
quenched and EDC/NHS crosslinked as described above. Scaffolds were cut parallel 
and perpendicular to the orientation of the scaffold lamellae to obtain anisotropic 
scaffolds with fibers running perpendicular and parallel to the top surface respectively. 
Scaffolds were analyzed with scanning electron microscopy (SEM) to visualize the 
iso- and anisotropic architectures in collagen scaffolds, and crosslinking efficiency 
was measured using 2,4,6-trinitrobenzene sulphonic acid with a glycine calibration 
curve21,22.
Animal experiment 
For the in vivo experiment 26 skeletal mature female New Zealand white rabbits 
were used (mean weight 4.1kg; SEM ±0.12). All procedures were approved by 
the institutional animal ethics committee. Under general anesthesia a medial skin 
incision was made over the knee joint. The joint was opened with a medial para-
patellar incision, where after the patella was dislocated with the leg in full extension. 
Two cylindrical full thickness defects (4 mm diameter, 3 mm deep) were created in 
the patellar groove using a high-speed drill with manual physiological salt irrigation. 
A spacer was placed onto the 4 mm diameter drill and fixed 3 mm from the end 
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to standardize defect size. The two defects were separated by 4 mm of cartilage. 
Each defect was filled with one of the three scaffolds, i.e. isotropic, perpendicular 
anisotropic and parallel anisotropic. Empty defects were used as controls. Rabbits 
were bilaterally operated, thereby each rabbit received one scaffold of each 
experimental group and a control. The positions of the scaffolds were alternated 
with a random start. After insertion of the scaffolds, the patella was relocated and 
the knee was bend 3 times until 900 of flexion after which the patella was luxated 
again to check for proper insertion of the scaffolds. Finally, the wound was carefully 
closed in layers and the animals were allowed full weight bearing and normal daily 
activity in large rooms with saw dust coverage of the floor. After 4  (n=13) and 12 
weeks (n=13) the animals were sacrificed by an overdose of pentobarbital.
Histology
After sacrifice of the rabbits, the knees were inspected macroscopically and 
synovial tissue was visually analyzed for inflammatory changes. Tissue blocks 
containing the defects and directly surrounding bone, were dissected with an 
oscillating saw with irrigation of physiological saline to avoid heat production, 
fixed in 4% phosphate buffered (pH 7.4) formalin, and after decalcification with 
EDTA embedded in paraffin. Serial sections of 7 µm were stained with Hematoxylin/
Eosin, picrosirius red and Safranin O/fast green. Representative sections through the 
center of the defect were scored blindly by three of the authors (EdM, GH and PB). 
Sections were described qualitatively in which special attention was given to the 
location of the new cartilage-like tissue, the presence of fissures and the remodeling 
of the subchondral bone. Using a modification of the scoring system developed by 
O’Driscoll et al. a semi-quantitative score of the repair was made14,23. 
Statistical analysis
All data were expressed as mean ± SEM. Statistical analysis were performed with 
a Two-Way ANOVA with factors treatment/scaffold and time and a post-hoc LSD 
(SPSS v18, Chicago, IL, USA). P-values <0.05 were considered significant.
RESULTS 
A total of 27±4% and 24±6% of the available amine groups were used in the cross-
linking process for anisotropic and isotropic porous scaffolds, respectively. After 
lyophilization, isotropic scaffolds showed rounded pores surrounded by collagen 
sheets (Figure 1A). Anisotropic scaffolds made with the temperature gradient showed 
alignment of the collagen sheets with smaller crossing fibers (Figure 1B parallel 
anisotropic and 1C perpendicular anisotropic). The orientation of the collagen sheets 
was parallel to the heat gradient.
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After opening the joints no significant adhesions were found. In general, 
the synovial tissue had a normal appearance without signs of inflammation. The 
synovial fluid was clear and had a normal viscosity and consistency. Both joints 
of one rabbit of the 4-week group showed severe signs of infection (redness, pus, 
etc). This animal was excluded from the study. The host cartilage around defect 
sites showed macroscopically the normal transparent white/bluish color of control 
cartilage. After 4-week follow up, macroscopic inspection showed that all defects, 
including the controls, could be clearly discerned from the adjacent host cartilage 
and were all completely filled with material with a variable color, varying from white 
to transparent red. No difference was observed between scaffold types. The surface 
of the defect site was level with the adjacent host cartilage and had a similar contour. 
Defects of the 12-week groups were in general more white and resembled adjacent 
host cartilage more closely than those of the four-week group. In five perpendicular 
anisotropic scaffolds the transition between host and defect was clearly visible. In 
other cases this transition was difficult to see macroscopically.
4 weeks
After 4 weeks, the collagen scaffolds could still be seen embedded in newly 
formed tissues (Figures 2A, 2C, 2E, 2G and Figures. 3A, 3B). The collagen sheets 
were thicker in the isotropic scaffolds compared to anisotropic scaffolds (compare 
red fibers in Figs. 3A with 3B). All defects were almost completely filled with partial 
differentiated cartilage-like tissue as shown by the moderate GAG staining with 
Safranin O (Fig. 2 left panel). Between the different scaffold types or between controls 
and scaffolds there was no difference in repair as scored with the modified O’Driscoll 
method. Total scores ranged between 10.2 ± 1.3 for perpendicular anisotropic and 
11.5 ± 1.4 for empty defects (Figure 4). The contour of the implant surface was 
similar to that of the native trochlea (Figure 2 left panel). The surface of the implant 
site showed occasionally some mild superficial fibrillation (Figure 3C). The tissue 
at the surface contained lower cells numbers and was more fibrous compared to 
the tissues in the deeper parts, which was more chondrogenic. Integration between 
implant and host tissue was occasionally observed at the superficial articular cartilage 
side. However, no direct connection was present between the implants and the lateral 
borders of the subchondral bone (Figure 3D). A tight tissue connection between 
subchondral bone and the lower implant side seemed present in all defects (Figure 
3E), but bone remodeling at the bottom of the defect was still very limited or even 
Figure 1: Scanning electron microscopy images of (A) isotropic, (B)  parallel anisotropic and (C) perpendicular 
anisotropic collagen scaffolds. Scale bars represent 100 µm.
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completely absent after four weeks. In three of the defects filled with perpendicular 
anisotropic scaffolds a very specific pattern of new bone formation in the bottom 
of the defects was observed. Trabecular bone was formed with long thin trabeculae 
orientated parallel to surface of the articular cartilage in the direction perpendicular 
to the anisotropy of the scaffold (Figure 3F). The new bone seemed to originate from 
the exposed lateral aspect of the subchondral bone (Figure 3B). In defects filled 
with isotropic scaffolds, locations with less intense staining inside the scaffold were 
observed (Figure 2G). 
Figure 2: Safranin-O staining of empty defects (A, B), 
parallel anisotropic implants (C, D), perpendicular 
anisotropic implants (E, F), and isotropic implants 
(G, H) after 4 and 12 weeks respectively. In a number 
of samples integration of host articular cartilage with 
neo-tissue was observed (small arrows). Integration 
between scaffold and subchondral bone was absent 
in most samples (large arrows). In defects filled 
with isotropic scaffolds, locations with less intense 
staining inside the scaffold were observed (*). Scale 
bars represent 1 mm.
Figure 3: Safranin-O stained sections after 4 weeks 
of implantations. Isotropic implant (A) and a parallel 
anisotropic implant (B) with stained collagen fibers. 
Occasionally superficial cartilage fibrillation was 
observed (C; isotropic). Integration between implant 
and host tissue was observed at the superficial 
cartilage surface (D; perpendicular isotropic) and 
at the lower contact area with the subchondral 
bone (E; perpendicular anisotropic) while not at the 
lateral contact sides with the subchondral bone (D). 
Similar cases were observed in all implants types 
and controls. In some cases of the perpendicular 
anisotropic implant trabecular bone (*) regeneration 
was parallel to the articular cartilage surface (F; 
perpendicular anisotropic). Scale bars represent 
250µm.
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Figure 4: Mean total modified O’Driscoll score (± SEM) of isotropic, parallel anisotropic, perpendicular 
anisotropic and empty defects (* = p<0.05; 4 weeks n=12, and 12 weeks n=13).
Figure 5: Mean of the individual items of the modified O’Driscoll score (± SEM) of isotropic, parallel anisotropic, 
perpendicular anisotropic and empty defects (* = p<0.05; 4 weeks n=12, and 12 weeks n=13).
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12 weeks
All defects were completely filled with cartilage-like tissue (Figs. 2B, D, F, H). 
The intensity of the GAG staining was increased compared to the 4 weeks groups 
(Figure 2: compare left (4 weeks) and right (12 weeks) panel) as visualized by 
the increased intense red staining in the Safranin O stained sections. Quantitative 
scores for repair had significantly increased in time for parallel anisotropic and 
empty defects by 4.1 and 3.9 points respectively (Figure 4). For all treatments, the 
individual O’Driscoll score items showed a time dependant significant increase for 
Tissue type and Thickness (Figure 5). This significant increase was also measured for 
Degenerative changes, but not significantly for perpendicular anisotropic scaffolds. 
Cells in the repair tissue were mainly rounded single cells (occasionally in small 
clusters) surrounded by an intense metachromatically stained extracellular matrix 
(Figure 6A). The tissue thus more closely resembled hyaline cartilage-like tissue 
compared to the 4 weeks group. The surface of the defect was generally smooth, and 
followed the original contour of the trochlea (Figure 6B). On occasion a small partial 
thickness fissure was found. This fissure was always located in the central region of 
the defects and extended into the direction of the subchondral bone (Figure 6C). Two 
defects of the perpendicular anisotropic scaffolds showed new subchondral bone 
formation up to the original contour of the cartilage with a thin layer of fibrous tissue 
only on top (Figure 6D). After 12 weeks the isotropic scaffolds were still clearly 
visible in the defects while the anisotropic scaffolds were not recognizable after 12 
weeks (Figure2 right panel). Furthermore, isotropic scaffold did show locations with 
minor GAG staining (Figure 2H).  
DISCUSSION 
In general, we found no large effects of fiber orientation on cartilage regeneration 
and that all repair reactions were similar to that of the empty controls. Even though 
rabbits were skeletally mature, their relative young age could have had a beneficial 
effect on the self-repair capacity in the empty defects. Wei and Messner found that 
Figure 6: Mean of the individual items of the modified O’Driscoll score (± SEM) of isotropic, parallel anisotropic, 
perpendicular anisotropic and empty defects (* = p<0.05; 4 weeks n=12, and 12 weeks n=13).
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spontaneous healing of osteochondral defects in the knee joints of non skeletal 
mature rabbits resulted in a faster filling and earlier tissue specialization than in 
adolescent or older skeletal mature animals24. However, this model of a full thickness 
articular cartilage defect in the femur of rabbits remains a suitable model to study 
differences in cartilage repair between scaffold types14. For implantation we used 
collagenous scaffolds that guide the infiltration, proliferation, and differentiation of 
progenitor cells, and improve the healing response14. We chose cross-linked type 
I collagen scaffolds above type II collagen scaffolds since in our previous studies 
type II collagen scaffolds only revealed cartilaginous tissue at the superficial zone 
and at the interface of the matrix with the subchondral bone, leaving large areas 
of the matrix devoid of new tissue. We speculated that this was induced by rapid 
differentiation of stem cells into the cartilage phenotype before the defect was filled 
completely. Therefore, type I collagen scaffolds with an isotropic or anisotropic 
pore orientation were made and implanted into the defects. We hypothesized that a 
perpendicular orientation of collagen fibers to the articular cartilage surface enables 
improved guidance of the cells from the subchondral bone for improved complete 
thickness repair. 
In this study no blood vessels were found in the area of the original defect. This 
indicates that indeed cells from the subchondral bone populated the matrix without 
vascular invasion. The observation that cells can migrate quite easily in such type I 
collagenous matrices is not completely surprising since this was already demonstrated 
in a previous study14. The cells involved in matrix population are probably mainly 
derived from the bone marrow. Shapiro et al. demonstrated that chondrocytes from 
the residual adjacent cartilage did not participate in the re-population of full-thickness 
articular cartilage defects4. Repair was completely mediated by the proliferation and 
differentiation of mesenchymal cells from the marrow. We assume similar repair in 
this study. The contribution of repair cells from a synovial origin, however, cannot be 
ruled out. Hunziker et al. performed a study with partial thickness defects in rabbits 
in which the defects were filled with fibrin. Mesenchymal cells derived from the 
synovial membrane migrated across the articular cartilage surface into the defect, 
where they repaired the cavity with fibrous connective tissue25. With this in mind, 
we speculate that in our model also some repair along the latter route might have 
taken place. In all defects, particularly at the surface of the implants, bridges were 
formed between the new tissue in the defect and the host cartilage. In addition, only 
the bottom side, not the lateral sides, showed integration with host tissue indicating 
that the repair cells that fill the defect probably originated from the deeper parts of 
the subchondral bone directly under the defect site and did not originate from more 
laterally located subchondral bone.
All defects had hyaline-like cartilage repair tissue after 4 and 12 weeks of 
implantation although in general the GAG staining was more intense after 12 
weeks. We found no large effects of fiber orientation on cartilage regeneration. All 
scaffolds induced similar hyaline like cartilage repair. Surprisingly, it seemed as if 
the distribution of cells and matrix was more homogeneous in the empty defects 
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and the anisotropic scaffolds compared to the isotropic scaffolds. The influence of 
pore size, known to influence cell behavior 26, might have played a role since in 
this study the morphology of the scaffolds is quite different between the isotropic 
random and anisotropic scaffolds. Pore sizes of the isotropic scaffolds appeared to 
be larger and the collagen walls surrounding the pores were also thicker. Potentially, 
this could have had an effect on the penetration capacity of the cells into the pores 
of the scaffold. After 12 weeks the isotropic scaffolds were still clearly visible in 
the defects while the anisotropic scaffolds were not recognizable after 12 weeks, 
probably due to differences in resorption speed. Rapid degradation in anisotropic 
scaffolds may have resulted in a reduced effect of the collagen fiber alignment. 
When scaffolds are quickly degraded, they may not have had the time to guide the 
cells fully. Development of anisotropic scaffolds with thicker collagen walls may 
result in increased cell guidance and better cartilage formation. 
In the present study the tissue repair was in general better than found in clinical 
studies where a more fibrous tissue type was found after MF and ACI6-8. Further 
optimization of the developed scaffolds could induce an even better tissue repair. 
Instead of a homogenous architecture, scaffolds can be made with multiple 
architectures27. Such scaffolds, with an isotropic lower part and a parallel anisotropic 
upper part have only been tested in vitro with cultured chondrocytes, and resulted 
in engineered cartilage tissue that mimicked hyaline cartilage28,29. An interesting 
observation in the current study was that a limited number of perpendicular 
anisotropic scaffolds resulted in organized bone formation at 4 and 12 weeks post 
operation parallel to the AC surface and perpendicular to the direction of the collagen 
fibers. This is the first in vivo indication that based on the orientation of collagen, 
scaffolds could be designed which induce organized bone in the deeper parts or 
the defect and cartilage-like tissue in the more superficial areas of the defect. This 
type of scaffold might offer a new treatment option for deeper osteochondral defects 
(ICRS grade V defects). These defects are now treated with the sandwich technique 
in which first the bone defect is filled with bone graft and sealed from the rest of 
the defect with a Chondroguide collagen membrane as in the M-ACI technique30. A 
second collagen membrane is then placed over the cartilage defect and can be treated 
with conventional ACI techniques. 
Besides changing the architecture of collagen scaffolds, others have been mixing 
it with other macromolecules, such as GAGs to direct stem cell differentiation. 
Buma et al. showed a positive effect on chondrogenic differentiation of chondroitin 
sulphate14. Matsiko et al. showed that addition of hyaluronic acid to collagen 
increased mesenchymal stem cell infiltration, higher SOX9 expression and more 
cartilage matrix production in vitro when compared to collagen and chondroitin 
sulphate blends31. In addition to blending with matrix components, growth factors 
could be added to stimulate tissue regeneration32,33.
To increase regenerative capacity of the scaffold further, research could focus on 
cell seeded scaffold implantation. Scaffolds could be seeded with a variety of cells 
such as autologous or allologous chondrocytes, stem cells or co-cultures of these 
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two, with co-cultures being the most promising34. When implanted in osteochondral 
knee defects in rabbits cell-less scaffolds showed good repair tissue, however, tissue 
repair was even better when scaffolds were pre-seeded with cells35. Nonetheless, 
cost effectiveness of these cell seeding techniques remains unknown until long term 
studies are finished36.
CONCLUSION 
Collagen scaffolds are able to regenerate articular cartilage with hyaline-like 
cartilage. Differences in collagen scaffold fiber architecture resulted in similar 
cartilage repair. However, in a limited number of cases perpendicular anisotropic 
scaffolds seemed to have a positive effect on subchondral bone repair.
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CHAPTER ONE 
Menisci are crescent shaped fibro-cartilage structures located in pairs in the knee 
joint. Lesions, such as meniscus tears, are one of the most frequently occurring 
orthopedic traumas. Tears in the white zone of the meniscus have limited repair 
capacity due to the avascular nature of this part of the meniscus. Current clinical 
strategies to repair the damaged meniscus start with preservation of as much of 
meniscus tissue as possible by suturing the loose fragment to the main body of the 
meniscus. If fixation is unsuccessful, a partial meniscectomy will be performed. 
However, the inferior biomechanics of the remaining meniscus tissue will lead to 
the onset of osteoarthritis in a high percentage of patients. Two partial meniscus 
implants, Menaflex™ and Actifit®, are currently clinically available to replace the 
lost meniscus tissue with successful short term results. In case of a severely damaged 
peripheral rim, mechanical integrity of the meniscus is lost and a total meniscectomy 
is the preferred treatment. The current available treatment after total meniscectomy 
is implantation of a donor meniscus. However, the availability is limited and correct 
sizing is problematic. New approaches for total meniscus replacement  therefore 
strongly focus on tissue engineering. Scaffolds should have sufficient mechanical 
strength to allow tissue ingrowth and permit fibro-cartilage formation. Furthermore, 
an anisotropic channel-like porosity might be beneficial for the direct formation of 
anisotropic extracellular matrix mimicking that of the native meniscus. Subsequently, 
two options can be used. One is in vivo tissue engineering by implantation of an empty 
scaffold directly into the defect. The body will repair the defect. The second option 
is in vitro tissue engineering. By seeding cells prior to implantation of the scaffolds, 
implants show improved biological properties and repair after implantation.
CHAPTER TWO 
In this chapter we studied whether a previously developed polyurethane (PU) 
scaffold is applicable for in vitro meniscus tissue engineering purposes. The PU 
scaffold was composed of poly (D/L) lactic acid and polycaprolactone, considered 
as “soft” segments, and 1,4-butanidiisocyanate to obtain “hard” urethane segments. 
A 95% porous isotropic scaffold was produced using solvent leaching. Subsequently, 
goat meniscal fibrochondrocytes (MFCs) were isolated from goat menisci, seeded 
and cultured in these 3D porous scaffolds. Proliferation and matrix synthesis in the 
constructs were studied in standard medium and in TGF-beta supplemented medium. 
It was shown that the MFCs were able to adhere to the scaffold. In standard medium, 
proliferation and matrix synthesis did not increase in time. However, if TGF-beta 
was added to the culture medium proliferation increased almost four times while 
collagen production was increased over 15 times compared to cultures in standard 
medium. Furthermore, increased production of glycosaminoglycans was observed. 
Despite this increase in collagen and glycosaminoglycan production, the compressive 
stiffness of the constructs did not increase during these cultures. 
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In conclusion, the PU scaffold can be used for in vitro meniscus tissue 
engineering but surface optimization is recommended since the scaffold itself did 
not stimulate proliferation or matrix synthesis. A coating with bioactive molecules 
could increase the biological properties of the scaffold. Addition of TGF-beta to the 
culture medium had a positive effect on proliferation of MFCs and meniscus specific 
matrix production. Based on these results, it is recommended to further optimize the 
scaffold used for future meniscus tissue engineering. 
CHAPTER THREE 
As proposed in chapter two, coating of scaffolds could be useful to increase 
its biological properties. In this chapter, we aimed to coat the surface of a porous 
PU scaffold with heparin. Heparin is a bioactive macromolecule that can bind and 
gradually release growth factors, such as TGF-beta, VEGF and FGF. Moreover, 
heparin inhibits degradation of these growth factors. A two step reaction was 
developed to coat the PU surface with a layer of heparin. The first step was aminolysis 
of the porous scaffold with diamines resulting in a covalent bond of one of the amines 
onto the scaffold with the other amine free for further reaction. Subsequently, it 
was demonstrated that heparin could be cross-linked to this free amine via standard 
carbodiimide cross-linking. Immuno-histochemistry confirmed that there was a 
heparin coating on the entire surface throughout the complete 3D porous scaffold. 
Without the first aminolysis step, no heparin coating was detectable. Furthermore, 
the final heparin coating increased surface hydrophilicity, but the reaction reduced 
mechanical stiffness by almost 50% to 12.2kPa. 
This two-step coating procedure resulted in complete coating of the porous PU 
scaffold with heparin. In future applications, the heparin coating will potentially 
enable the binding of bioactive growth factors onto the PU scaffold. In addition, an 
increased surface hydrophilicity indicates that both cell adherence and migration 
into the scaffold could be improved. The reduction in mechanical stiffness might 
limit the application in an in vivo load-bearing environment. However, in an in 
vitro tissue engineering approach, meniscus cells cultured inside the construct can 
produce matrix and by that the mechanical properties of the construct during the 
culture period will increase before implantation. However, protocols to enable this 
should be further optimized.
CHAPTER FOUR 
The most favorable long term option for patients with a heavily damaged meniscus 
would be to replace this meniscus by a tissue engineered implant based on slowly 
resorbable polymers in combination with cells that produce new matrix. However, 
one of the reasons that these in vitro tissue engineered constructs are not clinically 
applied yet is the addition of fetal bovine serum (FBS) to most tissue culture media as 
growth stimulating supplement. FBS potentially contains bovine pathogens, thereby 
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increasing the risk of disease transfer or xeno-immunization. FBS is supplemented 
to culture media because of the positive effect on proliferation and matrix synthesis, 
mainly ascribed to its rich pool of growth factors. A potential effective replacement 
for FBS could be platelet rich plasma (PRP). These platelets can secrete a variety of 
growth factors which play an important role in inducing tissue regeneration. After 
informed consent was obtained, PRP was isolated from the blood of three healthy adult 
donors and human meniscus fibrochondrocytes were isolated from meniscus tissue 
which was removed during an arthroscopically performed partial meniscectomy in 
a young adult patient. Cells were cultured in monolayer and different culture media 
were tested. DMEM/F12+1%PSF was used as basal medium and supplemented with 
one of the following additives: 10% FBS, 5%, 10% or 20% PRP, or 5%, 10% or 20% 
of PPP (platelet poor plasma) (v/v). After 24hrs and 3 days of culture no differences 
were found in proliferation and gene expressions of extracellular matrix proteins. 
After 7 days of culture all PPP cultures showed a strongly reduced proliferation rate 
while medium supplemented with 10% and 20% PRP showed significantly higher 
cell numbers compared to all PPP concentrations and slightly higher cell numbers 
compared to the standard medium supplements with 10% FBS. Collagen type I gene 
expression was similar to the control FBS, while collagen type II was undetermined 
in all culture conditions. Aggrecan expression was increased in 10% and 20% PRP 
and in all PPP supplements compared to the FBS.
These experiments showed that medium supplemented with 10% and 20% 
PRP can fully replace FBS in meniscus fibrochondrocyte cell cultures with similar 
proliferation and matrix gene expressions. This could probably ease the clinical 
application of in vitro tissue engineered constructs for meniscus replacement but is 
also of value for tissue engineering of other tissues.
CHAPTER FIVE 
It has been generally accepted that tissue engineered constructs should closely 
resemble the in vivo mechanical and structural properties of the tissues they are 
intended to replace. Most native meniscus tissues have significant anisotropic 
extracellular matrix components and concomitant mechanical properties. However, 
most scaffolds produced so far were isotropic porous scaffolds. Tissues that are 
formed in these scaffolds are quite different from the anisotropic native meniscus 
tissue. Collagen is not orientated anisotropically and probably mechanical properties 
are also quite different. Thus, the formed tissues have no structural and functional 
relationships with the native tissues. Therefore, to obtain complete regeneration 
of tissues resembling anisotropic native tissues, a second differentiation step after 
resorption of the isotropic scaffold would be required. It is doubtful whether the 
required plasticity for this second differentiation step is still present in already final 
differentiated tissues. It would be much more efficacious if the newly formed tissues 
in the scaffold could differentiate directly into the anisotropic organization of the 
native tissues being replaced. Therefore, anisotropic scaffolds that enable such a 
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direct differentiation might be extremely helpful to realize this goal. Up to now, 
anisotropic scaffolds have been fabricated using modified conventional techniques, 
solid free-form fabrication techniques, and a few alternative methods. In this chapter 
an overview of current anisotropic scaffold fabrication techniques was presented and 
discussed. 
CHAPTER SIX 
Scaffolds which are currently used to treat patients are not suitable for the 
regeneration of a complete meniscus after a total meniscectomy. The organization 
of the regenerated meniscus tissue appeared to be different from that in the native 
meniscus. The collagen bundles formed were orientated in a random direction guided 
by the isotropic pore architecture of the scaffold. The morphology is therefore far 
different from the highly organized and anisotropic morphology, which is mainly 
present in the vascularized peripheral rim of the native meniscus. Moreover, 
these scaffolds are too weak. As proposed in chapters one and five, anisotropic 
scaffolds may induce anisotropic repair tissue. To test the effect of scaffold pore 
architecture on the ability to guide organized extracellular matrix formation, 
isotropic and anisotropic PU scaffolds were produced with two different solvent 
leaching procedures. In chapter two, a standard solvent leaching procedure (i.e. 
isotropic freezing condition) was used to obtain isotropic porous scaffolds. To obtain 
anisotropic porous scaffolds with channels inside, a thermal freezing gradient was 
applied (chapter 5, modified TIPS). These two different freezing techniques resulted 
in isotropic and anisotropic scaffolds with a degree of anisotropy of 0.39 and 0.18, 
respectively. Anisotropic scaffolds had a channel diameter of 20 ± 6.0µm while 
isotropic scaffolds had a larger pore diameter of 35 ± 14.7µm. Subsequently, these 
scaffolds were implanted subcutaneously in rats for 1, 4, 8 or 24 weeks. Since in 
this model mechanical loading is minimal, it allowed us to test the sole effect of 
scaffold pore architecture on extracellular matrix differentiation. Isotropic scaffolds 
obtained full tissue ingrowth after 8 weeks while anisotropic scaffolds showed full 
ingrowth after 24 weeks. Extracellular matrix infiltration in isotropic scaffolds was 
of an unorganized fibro-collagenous type. The anisotropic scaffolds showed tissue 
infiltration which was more organized with parallel aligned collagen fibers. The tissue 
of the anisotropic scaffold closely resembled the meniscal vascularized peripheral 
rim, while the isotropic scaffolds resembled tissue of the inner zone. This tissue 
orientation was only due to scaffold architecture and this showed to be an important 
factor in the regeneration of an isotropic organized extracellular matrix. Therefore 
we propose that a total meniscus implant should have an anisotropic peripheral rim 
and an isotropic inner zone. Whether these effects remain present in a load-bearing 
situation should be further investigated. 
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CHAPTER SEVEN 
Anisotropic scaffolds can be applied not only to induce meniscus tissue repair, 
but also to facilitate the repair of other, related tissues such as articular cartilage. 
In case of small size articular cartilage damage, in current clinical practice small 
holes are drilled into the subchondral bone to allow mesenchymal stem cells to 
enter the cartilage defect to induce repair. This technique is now known as micro-
fracturing. However, this leads to the generation of a fibrous cartilage-like repair 
tissue, mechanically inferior to the native hyaline cartilage. Previous studies in 
which isotropic collagen scaffolds were re-inserted into the drilled defect resulted 
in hyaline-like cartilage repair, however, the defect remained partly unhealed. 
Therefore, we tested if the insertion of anisotropic collagen scaffolds, with fibers 
perpendicular to the cartilage surface, could induce complete repair by improving 
cellular influx from the subchondral bone. Isotropic and anisotropic collagen type I 
scaffolds were produced via similar freezing protocols as described in chapter six. 
Isotropic scaffolds showed to have larger pores and thicker walls compared to the 
anisotropic scaffolds. Subsequently, two full thickness articular cartilage defects 
were created in both knees of rabbits. These defects were left empty, filled with the 
isotropic scaffold or with the anisotropic scaffold. In the latter case the scaffold was 
placed with the main direction of the pores parallel or perpendicular to the cartilage 
surface. After 4 weeks, all defects were completely filled with partially differentiated 
hyaline cartilage tissue. Sections were scored via a modified O’Driscoll score and 
showed no differences between empty defects and scaffold types. After 12 weeks of 
implantation, all treatments led to hyaline cartilage repair visualized by increased 
glycosaminoglycan staining. Total O’Driscoll scores were significantly increased for 
parallel anisotropic and empty defects over time (p<0.05). Furthermore, isotropic 
scaffolds were still visible in the defect while anisotropic scaffolds seemed to be 
completely resorbed after 12 weeks. Remarkably, after both 4 and 12 weeks trabecular 
bone was formed parallel to the surface of the articular cartilage in a limited number 
of defects treated with perpendicular anisotropic scaffolds. 
The results indicate that collagen scaffolds can induce hyaline-like cartilage repair. 
Fiber architecture had no effect on cartilage repair. This could be due to differences 
in pore sizes and wall thickness reducing the effect of anisotropic scaffolds.
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Chapter 9
 
Discussion and future perspectives
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Repair of damaged meniscus tissue remains challenging. The main goal after 
a meniscus tear is preservation of as much meniscus tissue as possible to prevent 
articular cartilage degradation. Tears can be sutured in order to fixate the loose 
fragment stable to the main body of the meniscus. It was also investigated whether 
tears can be glued with fibrin glue, resulting in mixed outcomes 1. The main problem 
with fibrin glue is the inadequate strength of the glue. Therefore, our department is 
developing stronger glues for enhanced meniscus repair. An additional improvement 
can be mixing stem cells inside the glue to promote healing 2. If fixation fails or in 
case of complex tears, (partial) meniscectomy will be the logical next procedure to 
follow. For partial meniscus replacement, two scaffolds, Actifit® and Menaflex™, 
are currently available to treat patients with reported positive effects on tissue repair 
and function 3. In case of total meniscus replacement, donor meniscus tissue is the 
single clinical option 4. However, the correct size of a donor meniscus is of great 
importance on proper knee joint biomechanics 5,6. Due to insufficient sizing of the 
donor menisci, and in addition the risk of disease transfer, the number of donor 
transplantations remains limited. Nowadays, roughly two different options for 
total meniscus replacement are being evaluated. One focuses on a solid permanent 
implant, the other on a tissue engineered construct. By omitting biologic aspects, 
solid permanent implants can be obtained and produced faster and clinical approval 
is more easy. These implants can be attractive for elderly patients with mild 
osteoarthritis and in which tissue regeneration is limited. However, correct sizing of 
the implant is crucial since it cannot remodel or adapt itself in case of a mismatch in 
geometrical parameters with the native meniscus. Furthermore, it remains unknown 
if these implants will endure the large and repetitive strains and forces applied by 
in vivo activities for a number of decades. So positive effects should be found in 
the older patient category before such implants can be applied in younger patients. 
Therefore, younger patients potentially benefit more from implants able to fully form 
and replace the defect with native tissue and reduce the effect of long term foreign 
body reaction. In addition, cost effectiveness of a treatment remains crucial as well. 
In general, tissue engineering is a more expensive approach compared to using a 
permanent implant. To be cost effective, these tissue engineered constructs need to 
increase quality of life of the patient for a large number of years. 
In this thesis, a new potential polyurethane (PU) meniscus scaffold based on D/L 
lactic acid and caprolactone with urethane blocks has been described and tested. This 
PU scaffold has a 95% porosity and thereby has a higher porosity compared to the 
Menaflex™ scaffold (80% porosity). Higher porosities are known to improve cell 
penetration and matrix synthesis 7,8. Another advantage of a high porosity is that it, in 
general, will lead to a faster resorption as less polymer material has to be degraded. 
Reducing the time foreign materials remain present in the body has been shown to 
lower the risk on immunological responses. In addition, with smaller amounts of 
polymer material to be degraded, lower acidic levels of tissue in the direct vicinity 
will be reached. It has been described that higher acidity levels reduce the tissue 
regeneration speed 9. The PU scaffold has been shown to allow meniscus cell culture. 
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However, proliferation in our studies was limited, but, stimulation with TGF-beta 
increased proliferation. Heparin, a glycosaminoglycan, is able to bind a variety 
of growth factors, such as TGF-beta, VEGF and FGF, thereby enabling a retained 
bioactivity and gradual release of the growth factor 10,11. This release can potentially 
stimulate cells over longer periods of time, but needs to be investigated in more detail. 
In theory, the developed coating procedure based on aminolysis and subsequent cross-
linking of heparin, could be applicable to a wide variety of polymer scaffolds, not 
only to the one described in this thesis. However, further research is needed to show 
its efficacy. Furthermore, other macromolecules, besides heparin, could be cross-
linked to the free amine, e.g. collagens and chondroitin sulphate 12,13. The main pitfall 
with this coating technique is cleavage of polymer chains during the aminolysis, 
resulting in reduced mechanical stiffness. This would not be a problem if the scaffold 
would be used in non load-bearing tissues. However, when applied as replacement 
for load-bearing meniscus tissue, the mechanical properties might become inferior 
and chondroprotection cannot be maintained 14. To maintain mechanical properties 
the aminolysis step might be performed with a shorter incubation period, but this 
will also reduce the amount of macromolecules available for cross-linking on the 
surface. Another option could be to incorporate free amines during synthesis of a 
new polymer. This would make aminolysis step superfluous and thereby not alter the 
mechanical properties of the new construct. However, in the application foreseen by 
us, an in vitro tissue engineered meniscus construct, the initial reduced mechanical 
properties of the scaffold might be less significant. If cells are pre-cultured in optimal 
conditions, matrix synthesized by these cells will improve mechanical properties in 
time 15. However, it remains under investigation if optimization of culture conditions 
will lead to a tissue engineered meniscus construct that will enable the replacement 
of the complete meniscus. We showed that in our scaffold seeded with meniscal 
fibrochondrocytes, matrix synthesis increased under influence of TGF-beta, but this 
did not lead to increased mechanical properties. A low seeding density can be the 
cause why we did not find improved mechanical properties. Another reason could be 
that these used meniscal fibrochondrocytes are differentiated cells which might be 
less potent for regeneration. Others investigated additional cell types for improved 
meniscus tissue engineering, such as chondrocytes, mesenchymal stem cells or co-
cultures of these cell types 16. They showed that co-cultures of stem cells with MFCs 
induced better meniscus tissue regeneration than MFCs alone and should therefore 
be the focus of future research. Besides chemical stimulation, mechanical stimulation 
could be investigated for improved tissue regeneration. It is known that cells behave 
differently under mechanical stimulation 17. Various bioreactors have been fabricated 
to copy in vivo biomechanics/loading situations during in vitro culture conditions. 
These bioreactors can apply compression, tensile, shear stress or even combinations 
of these stresses 17,18. These studies showed that mechanical stimulations result in cell 
differentiation, proliferation and matrix synthesis, thereby improving the quality of 
the final in vitro tissue engineered meniscus construct. 
When pre-culturing cells for a clinically used tissue engineered construct, a 
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number of hurdles have to be taken. One of these hurdles is to avoid the issue of 
fetal bovine serum. FBS is a mix of potent growth factors able to stimulate a wide 
variety of cell types, hence it is widely used in scientific research. However, due to 
its bovine origin, FBS could contain bovine pathogens thereby increasing the risk of 
disease transfer 19. We showed that replacing bovine serum by platelet rich plasma 
could maintain similar proliferation and matrix gene expression in case of meniscus 
cell cultures. This increases the potential for clinical application of meniscus cell 
cultured implants. Furthermore, this platelet rich plasma could be easily and safely 
obtained from patients own blood or from donors.
Significant improvements are made in optimizing culture conditions (e.g. serum, 
growth factors, coatings and bioreactors), however, additional alterations should 
be considered, especially when aiming for total meniscus regeneration. Both 
Menaflex™ and Actifit® are isotropic porous scaffolds. Plain isotropic scaffolds 
are not ideal for complete meniscus tissue regeneration 20. These scaffolds result in 
unorganized tissue differentiation thereby unable to cope with the high mechanical 
stresses the menisci endure. When analyzing the meniscus’ extracellular matrix, 
well defined topographies are observed. The inner zone may have an isotropic 
matrix organization, but the vascularized peripheral rim has a clear anisotropic 
matrix organization with large collagen fibers oriented in a parallel, circumferential 
orientation 21. These fibers redirect the forces necessary for shock absorption. We 
showed that anisotropic porous scaffolds are of great importance to guide similar 
anisotropic matrix regeneration. Therefore, to create a total meniscus implant, we 
hypothesize that the scaffold should consist of an anisotropic outer rim and an 
isotropic inner zone. These complex structures are difficult to obtain via the freeze 
drying procedure used in this thesis. However, improved fabrication techniques, 
such as 3D fiber depositioning and stereolithography became available. The latter 
would be the preferred option since this technique enables complex structures via 
computer aided design models 22. Using these models, complex anisotropic porous 
architectures can be produced and the final constructs can be resized into patient 
specific anatomical geometries. Subsequently, these constructs can be used for in 
vitro cell culture and finally be implanted into the patient.
An important factor not addressed yet is scaffold degradation. Degradation of the 
scaffold should be in balance with tissue infiltration and differentiation. If degradation 
of the scaffold is too fast, new tissue cannot cope with the high stresses inside the knee 
joint. In our study about articular cartilage defects we hypothesize that the lack of 
difference in repair might be a result of relatively fast degradation of the anisotropic 
collagen scaffolds. After 12 weeks, only the isotropic scaffolds were still visible in 
histology, whereas the anisotropic scaffolds already disappeared. When anisotropic 
scaffolds degrade, they might lose their anisotropic properties resulting in similar 
outcomes as isotropic scaffolds. To investigate critical time for pore structure to 
influence cell migration and cartilage repair, slower degrading scaffolds should be 
created and tested in the future. This can be achieved by increasing the amount of 
cross-links in case of collagen scaffolds. 
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Tissue engineering of a total meniscus remains challenging. The experiments 
described in this thesis resulted in tools to improve properties of a total tissue 
engineered meniscus implant. Future research should focus on meniscus scaffolds 
with porosities similar to the meniscus collagen fiber architecture, i.e. an anisotropic 
outer rim and an isotropic inner zone. To improve surface hydrophilicity, and thereby 
cell migration, these scaffolds can be coated with heparin to which additional growth 
factors such as TGF-beta can be coupled. This will enhance biological properties of 
the tissue engineered construct during in vitro cell culture. Further improvements 
of the construct can be achieved by investigating the effects of co-cultures and 
mechanical stimulation on tissue proliferation and differentiation. The final tissue 
engineered construct should be tested in an in vivo total meniscus transplantation 
model to study its chondroprotective capacity. 
The last two decades the Orthopedic Research Lab investigated and improved 
meniscus tissue engineering. This resulted in enhanced research techniques necessary 
to reach the ultimate goal of total meniscus replacement. The improvements shown 
in this thesis will contribute to this development and the development of a tissue 
engineered meniscus construct.
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HOOFDSTUK 1
De meniscus is een halvemaanvormige structuur en bestaat uit fibreus kraakbeen. 
De menisci liggen in paren in het kniegewricht en spelen een belangrijke rol in 
de schokdemping. Een veel voorkomend klinisch probleem is het optreden van 
scheuren de menisci. Scheuren die optreden in het doorbloede deel van de meniscus 
kunnen meestal hersteld worden met hechtingen. Echter, wanneer de scheur gelegen 
is in het niet-doorbloede deel van de meniscus falen hechtingen vaker. Via  een 
kijkoperatie kan het “los” zittende stuk van de meniscus worden verwijderd. Het 
resterende meniscusweefsel biedt hierdoor een slechtere schokdemping met als 
gevolg een grotere kans op kraakbeenschade. Momenteel zijn er twee implantaten 
beschikbaar, Menaflex™ en Actifit®, die kunnen worden gebruikt om het verwijderde 
meniscusweefsel te vervangen. Beide implantaten zijn gemaakt van poreuze 
materialen die worden ingehecht op de plek waar meniscusweefsel is verwijderd. 
Nieuw weefsel kan vervolgens in de poriën van dit implantaat ingroeien en zo het 
beschadigde en verwijderde deel van de meniscus vervangen. Deze techniek biedt 
goede uitkomsten op de korte termijn. Echter wanneer de buitenste rand van de 
meniscus is ingescheurd, kan de meniscus niet meer goed herstellen en zal deze vaak 
in zijn geheel moeten worden verwijderd. Een donormeniscus is dan nog de enig 
resterende optie. Een donormeniscus is echter moeilijk te verkrijgen en met name het 
vinden van een meniscus met de juiste afmetingen blijkt in de praktijk erg lastig. Om 
deze redenen worden er veel studies gedaan naar het maken van meniscusweefsel 
in het laboratorium ter vervanging van de donormeniscus. Om een meniscus in het 
laboratorium te kunnen maken is een dragermateriaal, een zogenaamde “scaffold”, 
nodig die stevig genoeg is om de krachten in het kniegewricht te kunnen weerstaan, 
de ingroei van weefsel in de scaffold toelaat, en vervolgens de omvorming van dit 
ingegroeide weefsel in fibreus kraakbeen kan stimuleren. Middels een tweetal opties 
kan dit proces worden bewerkstelligd. De eerste optie is het implanteren van een 
lege scaffold in het kniegewricht, waarna het lichaam zelf voor weefselingroei en 
oriëntatie van de nieuw gevormde weefsel zal zorgen. De tweede methode is om 
de scaffold in het laboratorium te voorzien van cellen en deze cellen vervolgens te 
stimuleren om weefsel te maken. Hierdoor zou na implantatie een sneller herstel 
kunnen plaatsvinden. 
HOOFDSTUK 2
Allereerst is bestudeerd of een reeds bestaande polyurethaanscaffold (PU) 
geschikt is om in het laboratorium meniscuscellen op te zaaien en te laten groeien. 
Deze PU scaffold is een combinatie van poly (D/L) lactaat, een zogenaamd “zachte” 
segment, en 1,4-butaandiisocyanaat, een zogenaamd “hard” segment. Er werd een 
95% poreuze PU scaffold gemaakt met een willekeurige structuur van de poriën. 
Vervolgens werden meniscuscellen geïsoleerd uit geitenmenisci, gezaaid op deze 3D 
scaffolds en gekweekt in het laboratorium in een “normaal” kweekmedium en in een 
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kweekmedium waaraan de groeifactor TGF-beta was toegevoegd. De proliferatie 
en eiwitproductie van de gekweekte cellen werd bestudeerd. Deze studie liet zien 
dat de meniscuscellen in staat zijn om aan de PU scaffold te hechten. Na zes weken 
werd gevonden dat cellen die waren gekweekt in het “normale” kweekmedium 
nauwelijks waren geprolifereerd en geen eiwit te hebben geproduceerd. Echter, in 
de groep waar TGF-beta aan het medium was toegevoegd was  het aantal cellen 4x 
zo hoog geworden. Verder was de productie van collageen, een van de belangrijkste 
eiwitten in de meniscus, zelfs 15x zo hoog in deze groep. De productie van 
glycosaminoglycanen, een andere belangrijke component van de meniscus, werd 
ook gestimuleerd door de toevoeging van TGF-beta aan het kweekmedium. Ondanks 
de toename in eiwitproductie bleven de mechanische eigenschappen van de scaffold 
echter  onveranderd. 
Geconcludeerd kan worden dat deze PU scaffold geschikt is om meniscuscellen 
in te kweken. De toevoeging van TGF-beta aan het medium liet een duidelijk positief 
effect zien op meniscuscelkweken. Op basis van deze resultaten wordt aangeraden 
het oppervlakte van deze PU scaffold te voorzien van een bioactieve coating die 
cellen kan stimuleren te prolifereren en tevens de productie van meniscuseiwitten 
aanzet.
HOOFDSTUK 3
Een voorbeeld van een dergelijke bioactieve coating is heparine. Heparine is een 
molecuul dat in staat is om groeifactoren te binden en daarna geleidelijk weer los te 
laten. Ook is heparine in staat om afbraak van deze groeifactoren te voorkomen. Om 
heparine aan de PU scaffold te binden onderzochten we een twee-stapsreactie. De 
eerste stap is een aminolysestap, die ervoor zorgt dat er vrije aminogroepen aan het 
oppervlakte van de scaffold komen. Vervolgens wordt in de tweede stap heparine aan 
deze vrije aminogroepen gekoppeld. We zijn erin geslaagd het gehele oppervlakte 
van de 3D PU scaffolds te coaten met heparine. Het coatingsproces zorgde ervoor 
dat de oppervlakte minder waterafstotend werd, maar tevens verlaagde het de 
stijfheid van de scaffold. Het veranderde oppervlakte van de scaffolds zorgt  ervoor 
dat cellen makkelijker kunnen hechten en dieper in de scaffold kunnen ingroeien. De 
lagere stijfheid kan echter de toepasbaarheid van de uiteindelijke scaffolds beperken 
voor het gebruik in meniscusdefecten. Een mogelijke oplossing voor dit probleem 
zou kunnen zijn om in het laboratorium cellen in de scaffolds te kweken en de 
eiwitproductie van deze cellen te stimuleren en daarmee verbeterde mechanische 
eigenschappen te creëren.
HOOFDSTUK 4
Bij het maken van een gekweekt meniscusimplantaat wordt er standaard 
koeienserum aan het kweekmedium toegevoegd. Dit serum bevat onder andere 
groeifactoren die een stimulerende werking hebben op de gekweekte cellen. Echter, 
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vanwege de dierlijke afkomst en het daarbij horende risico op overdracht van 
ziektekiemen is het niet toegestaan met koeienserum gekweekte meniscusscaffolds 
te implanteren bij patiënten. Een mogelijke vervanging voor dit serum is plasma dat 
verrijkt is met bloedplaatjes (PRP). De plaatjes in dit plasma kunnen een variatie aan 
groeifactoren afgeven. Het PRP kan geïsoleerd worden uit eigen bloed van een patiënt 
of uit bloed van donoren. Om te onderzoeken of PRP het koeienserum kan vervangen 
tijdens het opkweken van meniscusfibroblasten is van drie gezonde donoren bloed 
afgenomen en hieruit het PRP geïsoleerd. Uit een tijdens een kijkoperatie verwijderd 
loszittend stukje meniscusweefsel van een patiënt zijn meniscuscellen geïsoleerd. 
Deze cellen zijn opgekweekt in kweekmedium met PRP, plaatjesarm plasma (PPP) of 
koeienserum. Vervolgens is onderzocht of de cellen goed groeien en of er op mRNA 
niveau een aanzet wordt gemaakt belangrijke meniscuseiwitten te produceren. Er 
werd geen verschil gevonden tussen de celkweken tot 3 dagen. Na 7 dagen groeiden 
de cellen in het PRP medium net zo goed als in koeienserum, terwijl de groei in het 
PPP medium was gestopt. De eiwitproductie was in alle groepen gelijk aan die in 
het koeienserum. Hiermee is aangetoond dat koeienserum volledig vervangen kan 
worden door PRP. Door koeienserum te vervangen door PRP is het gebruik van een 
in het laboratorium gekweekte meniscus  een stap dichter bij de klinische toepassing 
gekomen.
HOOFDSTUK 5
Het is belangrijk dat implantaten vergelijkbare mechanische en 
weefseleigenschappen hebben met het weefsel dat ze moeten gaan vervangen. De 
meniscus zelf heeft een duidelijk georiënteerde structuur. In de buitenste zone liggen 
grote collageenbundels parallel aan elkaar in de halve maan vorm van de meniscus. 
Het is dan ook van belang dat de scaffold deze weefseloriëntatie stimuleert. Dit kan 
worden bereikt door een scaffold te vervaardigen met eenzelfde poriestructuur als 
de “echte” meniscus. Echter, scaffolds die nu gebruikt worden zijn nog niet voorzien 
van een dergelijke georiënteerde poriestructuur. In dit hoofdstuk geven we een 
overzicht van productiemethoden waarmee scaffolds kunnen worden gemaakt met 
een vooraf bepaalde poriestructuur. De voor- en nadelen van  elke  productiemethode 
komen uitgebreid aan bod.
HOOFDSTUK 6
Een methode om georiënteerde scaffolds te maken is het materiaal tijdens het 
invriezen bloot te stellen aan een koudegradiënt. Deze methode is toegepast op de PU 
scaffolds die gebruikt zijn in hoofdstuk 2 en 3. Door middel van deze invriesmethode 
met koudegradiënt werden scaffolds met kanalen die parallel aan elkaar lopen 
vervaardigd. Via de standaard invriesmethode werden scaffolds verkregen met een 
random poriestructuur zoals ook gebruikt in de hoofdstukken 2 en 3. Vervolgens is 
onderzocht hoe weefsel ingroeit in beide typen scaffolds. Een goede methode om 
-139-
10
dit te bestuderen is het implanteren van deze scaffolds onder de huid van ratten. 
Hierdoor kan de invloed van de poriestructuur op weefselingroei worden bestudeerd 
in afwezigheid van mechanische belasting. Na 8 weken waren de scaffolds met een 
random poriestructuur volledig ingegroeid met nieuw weefsel terwijl de scaffolds 
met parallelle kanalen pas na 24 weken volledig waren ingegroeid. De scaffolds 
met parallelle kanalen lieten echter wel eenzelfde weefseloriëntatie zien als de 
buitenste zone van de meniscus. De scaffolds met de random poriestructuur lieten 
een ongeorganiseerde weefseloriëntatie zien die meer op de binnenste zone van 
de meniscus lijkt. Op basis van deze resultaten zou  een meniscusscaffold met een 
buitenste zone met kanalen en een binnenste zone met random poriën moeten worden 
gecreëerd. Dit construct zou uiteindelijk verder onderzocht  moeten worden in een 
omgeving waarin krachten op de scaffold werken  om te kunnen bestuderen  wat de 
invloed van deze krachten op de weefselingroei is.
HOOFDSTUK 7
De meniscus is niet het enige weefsel waar de oriëntatie van de scaffold van belang 
is. Dit is bijvoorbeeld ook het geval bij kraakbeenweefsel. Een klein kraakbeendefect 
kan worden hersteld middels een operatie waarbij kleine gaatjes in het subchondrale 
bot worden geboord. Dit stimuleert stamcellen om zich vanuit het onderliggende 
beenmerg te verplaatsen naar het kraakbeen waar ze dan nieuw kraakbeenachtig 
weefsel te gaan maken. Het nieuw gemaakte kraakbeen is echter wel van een minder 
goede kwaliteit in vergelijk met “originele” kraakbeen. In eerdere studies van de 
afdeling Orthopedie samen met de afdeling Matrix Biochemie is kraakbeenherstel 
na implantatie van verschillende collageenscaffolds met een random poriestructuur 
onderzocht. Met name scaffolds op basis van type II collageen induceerden een 
beter kraakbeenherstel. Echter, het oppervlakte van het nieuwe kraakbeen bestond 
voornamelijk uit fibreus weefsel. In dit hoofdstuk is gekeken naar het effect van 
collageenscaffolds met een georiënteerde poriestructuur op het kraakbeenherstel. 
De hypothese was dat door de georiënteerde poriestructuur de stamcellen 
zich beter kunnen verplaatsen naar het oppervlakte van het kraakbeendefect 
wat vervolgens zou kunnen resulteren in een beter of mogelijk zelfs volledig 
kraakbeenherstel. De georiënteerde scaffolds zijn met een vergelijkbare methode 
gemaakt,  zoals beschreven in hoofdstuk 6, namelijk door gebruik te maken van een 
temperatuurgradiënt tijdens invriezen. De scaffolds met een random poriestructuur 
bleken grotere poriën en dikkere poriewanden te hebben in vergelijking met de 
scaffolds met een georiënteerde poriestructuur. Vervolgens werden deze scaffolds 
bestudeerd in een konijnen kraakbeenmodel. Er werden kleine gaatjes geboord in 
het kraakbeen van de knie van deze konijn, waarna deze gaatjes werden opgevuld 
met een scaffold met random of met georiënteerde poriën, of werden leeg gelaten. 
Scaffolds met georiënteerde poriën werden geplaatst met de porieoriëntatie loodrecht 
of parallel aan het kraakbeenoppervlakte. Na 4 en 12 weken werd de kwaliteit van 
de weefselingroei beoordeeld op basis van weefselcoupes. Na 4 weken was de eerste 
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aanzet tot kraakbeenherstel gelijk in alle vier de groepen. Na 12 weken werd er 
in alle groepen kraakbeenherstel aangetroffen. Scaffolds met georiënteerde poriën 
parallel verlopend aan het oppervlak van het kraakbeen en lege defecten lieten zelfs 
een verbeterd herstel zien in vergelijking met de situatie na 4 weken. Verder waren de 
random scaffolds nog steeds zichtbaar terwijl de georiënteerde scaffolds geresorbeerd 
waren. De resultaten laten zien dat deze scaffolds in staat zijn om kraakbeenherstel 
te stimuleren. Deze stimulatie blijkt echter niet afhankelijk van de oriëntatie van 
de kanalen in de scaffold. Mogelijk werden potentiële verschillen gemaskeerd door 
andere factoren, zoals de aanwezigheid van kleinere poriën en dunnere wanden in de 
georiënteerde scaffolds. Dit zal verder moeten worden onderzocht.
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